MXPA02002122A - Controlled availability of formulation components, compositions and laundry methods employing same. - Google Patents
Controlled availability of formulation components, compositions and laundry methods employing same.Info
- Publication number
- MXPA02002122A MXPA02002122A MXPA02002122A MXPA02002122A MXPA02002122A MX PA02002122 A MXPA02002122 A MX PA02002122A MX PA02002122 A MXPA02002122 A MX PA02002122A MX PA02002122 A MXPA02002122 A MX PA02002122A MX PA02002122 A MXPA02002122 A MX PA02002122A
- Authority
- MX
- Mexico
- Prior art keywords
- group
- aryl
- heterocyclic ring
- radicals
- substituted
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 276
- 238000000034 method Methods 0.000 title claims abstract description 90
- 238000009472 formulation Methods 0.000 title abstract description 19
- 239000003054 catalyst Substances 0.000 claims abstract description 229
- 238000004061 bleaching Methods 0.000 claims abstract description 196
- 125000003118 aryl group Chemical group 0.000 claims description 228
- 125000000623 heterocyclic group Chemical group 0.000 claims description 218
- 125000000217 alkyl group Chemical group 0.000 claims description 183
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 180
- -1 anionic radicals Chemical class 0.000 claims description 166
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 160
- 125000002877 alkyl aryl group Chemical group 0.000 claims description 130
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 128
- 125000003545 alkoxy group Chemical group 0.000 claims description 121
- 150000001875 compounds Chemical class 0.000 claims description 117
- 239000007844 bleaching agent Substances 0.000 claims description 97
- 229910052736 halogen Inorganic materials 0.000 claims description 94
- 229910052757 nitrogen Inorganic materials 0.000 claims description 92
- 150000002367 halogens Chemical class 0.000 claims description 91
- 229910052739 hydrogen Inorganic materials 0.000 claims description 90
- 229930194542 Keto Natural products 0.000 claims description 89
- 125000000468 ketone group Chemical group 0.000 claims description 89
- 102000004190 Enzymes Human genes 0.000 claims description 85
- 108090000790 Enzymes Proteins 0.000 claims description 85
- 229940088598 enzyme Drugs 0.000 claims description 85
- BZWKPZBXAMTXNQ-UHFFFAOYSA-N sulfurocyanidic acid Chemical compound OS(=O)(=O)C#N BZWKPZBXAMTXNQ-UHFFFAOYSA-N 0.000 claims description 79
- 229920006395 saturated elastomer Polymers 0.000 claims description 69
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 claims description 67
- 239000004744 fabric Substances 0.000 claims description 66
- 239000004094 surface-active agent Substances 0.000 claims description 66
- 238000005406 washing Methods 0.000 claims description 56
- 150000001412 amines Chemical class 0.000 claims description 51
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 50
- 239000003795 chemical substances by application Substances 0.000 claims description 48
- 239000012190 activator Substances 0.000 claims description 44
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 44
- 229910052760 oxygen Inorganic materials 0.000 claims description 44
- 239000001301 oxygen Substances 0.000 claims description 43
- 239000003599 detergent Substances 0.000 claims description 42
- 239000002253 acid Substances 0.000 claims description 41
- 125000002837 carbocyclic group Chemical group 0.000 claims description 40
- 125000001424 substituent group Chemical group 0.000 claims description 33
- 238000004140 cleaning Methods 0.000 claims description 32
- 150000003839 salts Chemical class 0.000 claims description 31
- 125000005129 aryl carbonyl group Chemical group 0.000 claims description 30
- 125000004181 carboxyalkyl group Chemical group 0.000 claims description 30
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 29
- 108091005804 Peptidases Proteins 0.000 claims description 26
- 102000035195 Peptidases Human genes 0.000 claims description 26
- 125000002947 alkylene group Chemical group 0.000 claims description 25
- 125000002091 cationic group Chemical group 0.000 claims description 25
- 125000000129 anionic group Chemical group 0.000 claims description 24
- 239000004365 Protease Substances 0.000 claims description 23
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 21
- 238000012546 transfer Methods 0.000 claims description 21
- 150000007513 acids Chemical class 0.000 claims description 20
- 150000001768 cations Chemical class 0.000 claims description 19
- SJGALSBBFTYSBA-UHFFFAOYSA-N oxaziridine Chemical compound C1NO1 SJGALSBBFTYSBA-UHFFFAOYSA-N 0.000 claims description 19
- 108090001060 Lipase Proteins 0.000 claims description 18
- 102000004882 Lipase Human genes 0.000 claims description 18
- 108010084185 Cellulases Proteins 0.000 claims description 17
- 102000005575 Cellulases Human genes 0.000 claims description 17
- 239000004367 Lipase Substances 0.000 claims description 17
- 239000000654 additive Substances 0.000 claims description 17
- 125000003368 amide group Chemical group 0.000 claims description 17
- 235000019421 lipase Nutrition 0.000 claims description 17
- 230000000996 additive effect Effects 0.000 claims description 15
- 239000002738 chelating agent Substances 0.000 claims description 15
- 229910052751 metal Inorganic materials 0.000 claims description 15
- 239000002184 metal Substances 0.000 claims description 15
- OIWIYLWZIIJNHU-UHFFFAOYSA-N 1-sulfanylpyrazole Chemical compound SN1C=CC=N1 OIWIYLWZIIJNHU-UHFFFAOYSA-N 0.000 claims description 13
- 108010065511 Amylases Proteins 0.000 claims description 12
- 102000013142 Amylases Human genes 0.000 claims description 12
- 235000019418 amylase Nutrition 0.000 claims description 12
- 230000002401 inhibitory effect Effects 0.000 claims description 11
- 150000002500 ions Chemical class 0.000 claims description 11
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims description 11
- MWNQXXOSWHCCOZ-UHFFFAOYSA-L sodium;oxido carbonate Chemical class [Na+].[O-]OC([O-])=O MWNQXXOSWHCCOZ-UHFFFAOYSA-L 0.000 claims description 10
- 239000006260 foam Substances 0.000 claims description 8
- 125000004417 unsaturated alkyl group Chemical group 0.000 claims description 8
- 102000003992 Peroxidases Human genes 0.000 claims description 7
- 229940025131 amylases Drugs 0.000 claims description 7
- 239000002270 dispersing agent Substances 0.000 claims description 7
- 230000002209 hydrophobic effect Effects 0.000 claims description 7
- 229920000831 ionic polymer Polymers 0.000 claims description 7
- 239000002304 perfume Substances 0.000 claims description 7
- 239000003381 stabilizer Substances 0.000 claims description 7
- FCJSHPDYVMKCHI-UHFFFAOYSA-N phenyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OC1=CC=CC=C1 FCJSHPDYVMKCHI-UHFFFAOYSA-N 0.000 claims description 6
- 108700020962 Peroxidase Proteins 0.000 claims description 5
- 239000003945 anionic surfactant Substances 0.000 claims description 5
- 239000000976 ink Substances 0.000 claims description 5
- 239000003981 vehicle Substances 0.000 claims description 5
- CDWQJRGVYJQAIT-UHFFFAOYSA-N 3-benzoylpiperidin-2-one Chemical compound C=1C=CC=CC=1C(=O)C1CCCNC1=O CDWQJRGVYJQAIT-UHFFFAOYSA-N 0.000 claims description 4
- 229940077388 benzenesulfonate Drugs 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 150000002978 peroxides Chemical class 0.000 claims description 4
- 125000005342 perphosphate group Chemical group 0.000 claims description 4
- 159000000000 sodium salts Chemical class 0.000 claims description 4
- KYVZSRPVPDAAKQ-UHFFFAOYSA-N 2-benzoyloxybenzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1OC(=O)C1=CC=CC=C1 KYVZSRPVPDAAKQ-UHFFFAOYSA-N 0.000 claims description 3
- GGAVUMZUOHJGGM-UHFFFAOYSA-N 2-decanoyloxybenzenesulfonic acid Chemical compound CCCCCCCCCC(=O)OC1=CC=CC=C1S(O)(=O)=O GGAVUMZUOHJGGM-UHFFFAOYSA-N 0.000 claims description 3
- GZFRVDZZXXKIGR-UHFFFAOYSA-N 2-decanoyloxybenzoic acid Chemical compound CCCCCCCCCC(=O)OC1=CC=CC=C1C(O)=O GZFRVDZZXXKIGR-UHFFFAOYSA-N 0.000 claims description 3
- MQWCVVYEJGQDEL-UHFFFAOYSA-N 3-(4-nitrobenzoyl)azepan-2-one Chemical compound C1=CC([N+](=O)[O-])=CC=C1C(=O)C1C(=O)NCCCC1 MQWCVVYEJGQDEL-UHFFFAOYSA-N 0.000 claims description 3
- JNIYAMTYWPMEGP-UHFFFAOYSA-N ClC1=CC=CC(C(=O)C2C(NCCCC2)=O)=C1 Chemical compound ClC1=CC=CC(C(=O)C2C(NCCCC2)=O)=C1 JNIYAMTYWPMEGP-UHFFFAOYSA-N 0.000 claims description 3
- FHHJDRFHHWUPDG-UHFFFAOYSA-N peroxysulfuric acid Chemical class OOS(O)(=O)=O FHHJDRFHHWUPDG-UHFFFAOYSA-N 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- FNPBLXRYUROGSR-UHFFFAOYSA-N 2-undec-10-enoyloxybenzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1OC(=O)CCCCCCCCC=C FNPBLXRYUROGSR-UHFFFAOYSA-N 0.000 claims description 2
- 108010064785 Phospholipases Proteins 0.000 claims description 2
- 102000015439 Phospholipases Human genes 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 150000003254 radicals Chemical group 0.000 claims 198
- FRPJTGXMTIIFIT-UHFFFAOYSA-N tetraacetylethylenediamine Chemical group CC(=O)C(N)(C(C)=O)C(N)(C(C)=O)C(C)=O FRPJTGXMTIIFIT-UHFFFAOYSA-N 0.000 claims 4
- 125000003277 amino group Chemical group 0.000 claims 3
- SBIWALRETKPJEV-UHFFFAOYSA-N 2-dodecoxybenzenesulfonic acid Chemical compound CCCCCCCCCCCCOC1=CC=CC=C1S(O)(=O)=O SBIWALRETKPJEV-UHFFFAOYSA-N 0.000 claims 2
- 150000005840 aryl radicals Chemical class 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- 241000726103 Atta Species 0.000 claims 1
- 239000003708 ampul Substances 0.000 claims 1
- 239000002800 charge carrier Substances 0.000 claims 1
- 230000008602 contraction Effects 0.000 claims 1
- 150000002831 nitrogen free-radicals Chemical class 0.000 claims 1
- 125000005415 substituted alkoxy group Chemical group 0.000 claims 1
- 239000000243 solution Substances 0.000 description 103
- 239000000047 product Substances 0.000 description 66
- 108010055059 beta-Mannosidase Proteins 0.000 description 55
- 238000012360 testing method Methods 0.000 description 51
- 102100032487 Beta-mannosidase Human genes 0.000 description 44
- 230000000694 effects Effects 0.000 description 43
- 108090000765 processed proteins & peptides Proteins 0.000 description 42
- 229920001184 polypeptide Polymers 0.000 description 37
- 102000004196 processed proteins & peptides Human genes 0.000 description 37
- 150000004965 peroxy acids Chemical class 0.000 description 36
- 229920002000 Xyloglucan Polymers 0.000 description 30
- 239000000975 dye Substances 0.000 description 30
- 108010059892 Cellulase Proteins 0.000 description 29
- 239000000463 material Substances 0.000 description 29
- 150000001413 amino acids Chemical class 0.000 description 23
- 108020004414 DNA Proteins 0.000 description 22
- 238000000354 decomposition reaction Methods 0.000 description 22
- 241000894007 species Species 0.000 description 22
- 241000228215 Aspergillus aculeatus Species 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- 239000002609 medium Substances 0.000 description 20
- 125000000539 amino acid group Chemical group 0.000 description 19
- 229910001868 water Inorganic materials 0.000 description 18
- 238000002835 absorbance Methods 0.000 description 17
- 239000007788 liquid Substances 0.000 description 17
- 239000000758 substrate Substances 0.000 description 16
- 239000011572 manganese Substances 0.000 description 15
- 239000002773 nucleotide Substances 0.000 description 15
- 125000003729 nucleotide group Chemical group 0.000 description 15
- 108091028043 Nucleic acid sequence Proteins 0.000 description 14
- 238000007792 addition Methods 0.000 description 14
- 238000006467 substitution reaction Methods 0.000 description 14
- 229920000642 polymer Polymers 0.000 description 13
- 108091033319 polynucleotide Proteins 0.000 description 13
- 239000002157 polynucleotide Substances 0.000 description 13
- 102000040430 polynucleotide Human genes 0.000 description 13
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 12
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 11
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 11
- 235000011941 Tilia x europaea Nutrition 0.000 description 11
- 229910000323 aluminium silicate Inorganic materials 0.000 description 11
- 239000004571 lime Substances 0.000 description 11
- 229920005646 polycarboxylate Polymers 0.000 description 11
- 239000000344 soap Substances 0.000 description 11
- 229910052748 manganese Inorganic materials 0.000 description 10
- 241000193830 Bacillus <bacterium> Species 0.000 description 9
- 239000008187 granular material Substances 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- 150000002678 macrocyclic compounds Chemical class 0.000 description 9
- 229920000057 Mannan Polymers 0.000 description 8
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000010941 cobalt Substances 0.000 description 8
- 229910017052 cobalt Inorganic materials 0.000 description 8
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 8
- 230000006378 damage Effects 0.000 description 8
- 230000000670 limiting effect Effects 0.000 description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 8
- 239000011734 sodium Substances 0.000 description 8
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 7
- 239000004382 Amylase Substances 0.000 description 7
- 108090000787 Subtilisin Proteins 0.000 description 7
- 125000004429 atom Chemical group 0.000 description 7
- 239000002585 base Substances 0.000 description 7
- 239000011651 chromium Substances 0.000 description 7
- 239000008367 deionised water Substances 0.000 description 7
- 229910021641 deionized water Inorganic materials 0.000 description 7
- 239000000945 filler Substances 0.000 description 7
- 239000001257 hydrogen Substances 0.000 description 7
- 239000003446 ligand Substances 0.000 description 7
- 239000002736 nonionic surfactant Substances 0.000 description 7
- 150000004760 silicates Chemical class 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 229910052723 transition metal Inorganic materials 0.000 description 7
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 6
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 6
- 241000223198 Humicola Species 0.000 description 6
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- LUEWUZLMQUOBSB-GFVSVBBRSA-N mannan Chemical class O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-GFVSVBBRSA-N 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 150000003624 transition metals Chemical class 0.000 description 6
- 239000010457 zeolite Substances 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical class [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 5
- 229920002324 Galactoglucomannan Polymers 0.000 description 5
- 229920000926 Galactomannan Polymers 0.000 description 5
- 229920002581 Glucomannan Polymers 0.000 description 5
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical class ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 150000001450 anions Chemical class 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 230000000295 complement effect Effects 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- SBOJXQVPLKSXOG-UHFFFAOYSA-N o-amino-hydroxylamine Chemical class NON SBOJXQVPLKSXOG-UHFFFAOYSA-N 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 4
- WLDGDTPNAKWAIR-UHFFFAOYSA-N 1,4,7-trimethyl-1,4,7-triazonane Chemical compound CN1CCN(C)CCN(C)CC1 WLDGDTPNAKWAIR-UHFFFAOYSA-N 0.000 description 4
- 235000014469 Bacillus subtilis Nutrition 0.000 description 4
- 229920002498 Beta-glucan Polymers 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 229910021536 Zeolite Inorganic materials 0.000 description 4
- 125000001931 aliphatic group Chemical group 0.000 description 4
- 108090000637 alpha-Amylases Proteins 0.000 description 4
- 239000012736 aqueous medium Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 230000003197 catalytic effect Effects 0.000 description 4
- 229940106157 cellulase Drugs 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 239000010949 copper Substances 0.000 description 4
- 108010005400 cutinase Proteins 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 238000005538 encapsulation Methods 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 238000007046 ethoxylation reaction Methods 0.000 description 4
- 238000013100 final test Methods 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 238000005342 ion exchange Methods 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 239000005022 packaging material Substances 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 3
- CFPOJWPDQWJEMO-UHFFFAOYSA-N 2-(1,2-dicarboxyethoxy)butanedioic acid Chemical compound OC(=O)CC(C(O)=O)OC(C(O)=O)CC(O)=O CFPOJWPDQWJEMO-UHFFFAOYSA-N 0.000 description 3
- FAGGUIDTQQXDSJ-UHFFFAOYSA-N 3-benzoylazepan-2-one Chemical compound C=1C=CC=CC=1C(=O)C1CCCCNC1=O FAGGUIDTQQXDSJ-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 244000063299 Bacillus subtilis Species 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 3
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 229920001503 Glucan Polymers 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- SCKXCAADGDQQCS-UHFFFAOYSA-N Performic acid Chemical compound OOC=O SCKXCAADGDQQCS-UHFFFAOYSA-N 0.000 description 3
- 241000589516 Pseudomonas Species 0.000 description 3
- 108010056079 Subtilisins Proteins 0.000 description 3
- 102000005158 Subtilisins Human genes 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 3
- 238000005054 agglomeration Methods 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 150000001340 alkali metals Chemical class 0.000 description 3
- 102000004139 alpha-Amylases Human genes 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 239000003093 cationic surfactant Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 238000013270 controlled release Methods 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 125000004093 cyano group Chemical group *C#N 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- VTIIJXUACCWYHX-UHFFFAOYSA-L disodium;carboxylatooxy carbonate Chemical compound [Na+].[Na+].[O-]C(=O)OOC([O-])=O VTIIJXUACCWYHX-UHFFFAOYSA-L 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 230000002538 fungal effect Effects 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 108010002430 hemicellulase Proteins 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000002563 ionic surfactant Substances 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 230000000116 mitigating effect Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 150000001451 organic peroxides Chemical class 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 108010042388 protease C Proteins 0.000 description 3
- 238000012552 review Methods 0.000 description 3
- 229960001922 sodium perborate Drugs 0.000 description 3
- 229940045872 sodium percarbonate Drugs 0.000 description 3
- YKLJGMBLPUQQOI-UHFFFAOYSA-M sodium;oxidooxy(oxo)borane Chemical compound [Na+].[O-]OB=O YKLJGMBLPUQQOI-UHFFFAOYSA-M 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 108010083879 xyloglucan endo(1-4)-beta-D-glucanase Proteins 0.000 description 3
- BETLSGXAHKBRAR-UHFFFAOYSA-N 10-ethylphenothiazine-4-carboxylic acid Chemical compound C1=CC=C(C(O)=O)C2=C1N(CC)C1=CC=CC=C1S2 BETLSGXAHKBRAR-UHFFFAOYSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- LWYAUHJRUCQFCX-UHFFFAOYSA-N 4-dodecoxy-4-oxobutanoic acid Chemical compound CCCCCCCCCCCCOC(=O)CCC(O)=O LWYAUHJRUCQFCX-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- 101100289061 Drosophila melanogaster lili gene Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 108010029541 Laccase Proteins 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 2
- 241001292348 Salipaludibacillus agaradhaerens Species 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- BCKXLBQYZLBQEK-KVVVOXFISA-M Sodium oleate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC([O-])=O BCKXLBQYZLBQEK-KVVVOXFISA-M 0.000 description 2
- 239000004902 Softening Agent Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- BGRWYDHXPHLNKA-UHFFFAOYSA-N Tetraacetylethylenediamine Chemical compound CC(=O)N(C(C)=O)CCN(C(C)=O)C(C)=O BGRWYDHXPHLNKA-UHFFFAOYSA-N 0.000 description 2
- 102000004357 Transferases Human genes 0.000 description 2
- 108090000992 Transferases Proteins 0.000 description 2
- 241000223259 Trichoderma Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 238000005899 aromatization reaction Methods 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 150000007942 carboxylates Chemical group 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000004927 clay Substances 0.000 description 2
- 239000012459 cleaning agent Substances 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 239000012933 diacyl peroxide Substances 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000002979 fabric softener Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229940059442 hemicellulase Drugs 0.000 description 2
- 125000001183 hydrocarbyl group Chemical group 0.000 description 2
- 239000003752 hydrotrope Substances 0.000 description 2
- 238000010952 in-situ formation Methods 0.000 description 2
- 108010062085 ligninase Proteins 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 2
- 239000004005 microsphere Substances 0.000 description 2
- 239000012038 nucleophile Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 150000004967 organic peroxy acids Chemical class 0.000 description 2
- 150000004843 oxaziridines Chemical class 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- XCRBXWCUXJNEFX-UHFFFAOYSA-N peroxybenzoic acid Chemical compound OOC(=O)C1=CC=CC=C1 XCRBXWCUXJNEFX-UHFFFAOYSA-N 0.000 description 2
- JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical class [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 125000003367 polycyclic group Chemical group 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- MSFGZHUJTJBYFA-UHFFFAOYSA-M sodium dichloroisocyanurate Chemical compound [Na+].ClN1C(=O)[N-]C(=O)N(Cl)C1=O MSFGZHUJTJBYFA-UHFFFAOYSA-M 0.000 description 2
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 2
- 229940048086 sodium pyrophosphate Drugs 0.000 description 2
- 235000019832 sodium triphosphate Nutrition 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 108010075550 termamyl Proteins 0.000 description 2
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 2
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- VKZRWSNIWNFCIQ-WDSKDSINSA-N (2s)-2-[2-[[(1s)-1,2-dicarboxyethyl]amino]ethylamino]butanedioic acid Chemical compound OC(=O)C[C@@H](C(O)=O)NCCN[C@H](C(O)=O)CC(O)=O VKZRWSNIWNFCIQ-WDSKDSINSA-N 0.000 description 1
- FYGDTMLNYKFZSV-WFYNLLPOSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,3s,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-WFYNLLPOSA-N 0.000 description 1
- IOEPOEDBBPRAEI-UHFFFAOYSA-N 1,2-dihydroisoquinoline Chemical compound C1=CC=C2CNC=CC2=C1 IOEPOEDBBPRAEI-UHFFFAOYSA-N 0.000 description 1
- ITWBWJFEJCHKSN-UHFFFAOYSA-N 1,4,7-triazonane Chemical compound C1CNCCNCCN1 ITWBWJFEJCHKSN-UHFFFAOYSA-N 0.000 description 1
- ILAPVZVYHKSGFM-UHFFFAOYSA-N 1-(carboxymethoxy)ethane-1,1,2-tricarboxylic acid Chemical class OC(=O)COC(C(O)=O)(C(O)=O)CC(O)=O ILAPVZVYHKSGFM-UHFFFAOYSA-N 0.000 description 1
- OSSNTDFYBPYIEC-UHFFFAOYSA-N 1-ethenylimidazole Chemical compound C=CN1C=CN=C1 OSSNTDFYBPYIEC-UHFFFAOYSA-N 0.000 description 1
- ICFDTWPLDBJRBV-UHFFFAOYSA-N 10-methylphenoxazine Chemical compound C1=CC=C2N(C)C3=CC=CC=C3OC2=C1 ICFDTWPLDBJRBV-UHFFFAOYSA-N 0.000 description 1
- YXNJFMQJGMQROS-UHFFFAOYSA-N 2-(nonanoylamino)hexaneperoxoic acid Chemical compound CCCCCCCCC(=O)NC(C(=O)OO)CCCC YXNJFMQJGMQROS-UHFFFAOYSA-N 0.000 description 1
- QDCPNGVVOWVKJG-VAWYXSNFSA-N 2-[(e)-dodec-1-enyl]butanedioic acid Chemical group CCCCCCCCCC\C=C\C(C(O)=O)CC(O)=O QDCPNGVVOWVKJG-VAWYXSNFSA-N 0.000 description 1
- WDKWVKZMTODAHS-UHFFFAOYSA-N 2-aminohexaneperoxoic acid Chemical compound CCCCC(N)C(=O)OO WDKWVKZMTODAHS-UHFFFAOYSA-N 0.000 description 1
- GLVYLTSKTCWWJR-UHFFFAOYSA-N 2-carbonoperoxoylbenzoic acid Chemical compound OOC(=O)C1=CC=CC=C1C(O)=O GLVYLTSKTCWWJR-UHFFFAOYSA-N 0.000 description 1
- QDCPNGVVOWVKJG-UHFFFAOYSA-N 2-dodec-1-enylbutanedioic acid Chemical compound CCCCCCCCCCC=CC(C(O)=O)CC(O)=O QDCPNGVVOWVKJG-UHFFFAOYSA-N 0.000 description 1
- ZDKYIHHSXJTDKX-UHFFFAOYSA-N 2-dodecanoyloxybenzenesulfonic acid Chemical compound CCCCCCCCCCCC(=O)OC1=CC=CC=C1S(O)(=O)=O ZDKYIHHSXJTDKX-UHFFFAOYSA-N 0.000 description 1
- GCVQVCAAUXFNGJ-UHFFFAOYSA-N 2-hexadecylbutanedioic acid Chemical compound CCCCCCCCCCCCCCCCC(C(O)=O)CC(O)=O GCVQVCAAUXFNGJ-UHFFFAOYSA-N 0.000 description 1
- DXPLEDYRQHTBDJ-UHFFFAOYSA-N 2-pentadec-1-enylbutanedioic acid Chemical compound CCCCCCCCCCCCCC=CC(C(O)=O)CC(O)=O DXPLEDYRQHTBDJ-UHFFFAOYSA-N 0.000 description 1
- MWTDCUHMQIAYDT-UHFFFAOYSA-N 2-tetradecylbutanedioic acid Chemical compound CCCCCCCCCCCCCCC(C(O)=O)CC(O)=O MWTDCUHMQIAYDT-UHFFFAOYSA-N 0.000 description 1
- CMLFRMDBDNHMRA-UHFFFAOYSA-N 2h-1,2-benzoxazine Chemical compound C1=CC=C2C=CNOC2=C1 CMLFRMDBDNHMRA-UHFFFAOYSA-N 0.000 description 1
- VNTAONUWHQBAMC-UHFFFAOYSA-N 3-phenothiazin-10-ylpropanoic acid Chemical compound C1=CC=C2N(CCC(=O)O)C3=CC=CC=C3SC2=C1 VNTAONUWHQBAMC-UHFFFAOYSA-N 0.000 description 1
- NJMWXCOSLAUOGE-UHFFFAOYSA-N 4,11-dimethyl-1,4,8,11-tetrazabicyclo[6.6.2]hexadecane Chemical compound C1CN(C)CCCN2CCN(C)CCCN1CC2 NJMWXCOSLAUOGE-UHFFFAOYSA-N 0.000 description 1
- XSVSPKKXQGNHMD-UHFFFAOYSA-N 5-bromo-3-methyl-1,2-thiazole Chemical compound CC=1C=C(Br)SN=1 XSVSPKKXQGNHMD-UHFFFAOYSA-N 0.000 description 1
- AVLQNPBLHZMWFC-UHFFFAOYSA-N 6-(nonylamino)-6-oxohexaneperoxoic acid Chemical compound CCCCCCCCCNC(=O)CCCCC(=O)OO AVLQNPBLHZMWFC-UHFFFAOYSA-N 0.000 description 1
- KCAZSAYYICOMMG-UHFFFAOYSA-N 6-hydroperoxy-6-oxohexanoic acid Chemical compound OOC(=O)CCCCC(O)=O KCAZSAYYICOMMG-UHFFFAOYSA-N 0.000 description 1
- AUZAZRRDIPGJLT-UHFFFAOYSA-N 7,7-dichloro-4,11-dimethyl-1,4,8,11-tetrazabicyclo[6.6.2]hexadecane;manganese Chemical compound [Mn].C1CN(C)CCC(Cl)(Cl)N2CCN(C)CCCN1CC2 AUZAZRRDIPGJLT-UHFFFAOYSA-N 0.000 description 1
- BDDLHHRCDSJVKV-UHFFFAOYSA-N 7028-40-2 Chemical compound CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O BDDLHHRCDSJVKV-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 101710184263 Alkaline serine protease Proteins 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- WLDHEUZGFKACJH-ZRUFZDNISA-K Amaranth Chemical compound [Na+].[Na+].[Na+].C12=CC=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(O)=C1\N=N\C1=CC=C(S([O-])(=O)=O)C2=CC=CC=C12 WLDHEUZGFKACJH-ZRUFZDNISA-K 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 101000740449 Bacillus subtilis (strain 168) Biotin/lipoyl attachment protein Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 108010073997 Bromide peroxidase Proteins 0.000 description 1
- 125000002853 C1-C4 hydroxyalkyl group Chemical group 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical class NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 241001432959 Chernes Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 102000011413 Chondroitinases and Chondroitin Lyases Human genes 0.000 description 1
- 108010023736 Chondroitinases and Chondroitin Lyases Proteins 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 241001459693 Dipterocarpus zeylanicus Species 0.000 description 1
- 108010083608 Durazym Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 101000581940 Homo sapiens Napsin-A Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- SHBUUTHKGIVMJT-UHFFFAOYSA-N Hydroxystearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OO SHBUUTHKGIVMJT-UHFFFAOYSA-N 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 102100027612 Kallikrein-11 Human genes 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 102000003820 Lipoxygenases Human genes 0.000 description 1
- 108090000128 Lipoxygenases Proteins 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- WAEMQWOKJMHJLA-UHFFFAOYSA-N Manganese(2+) Chemical compound [Mn+2] WAEMQWOKJMHJLA-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- GYCMBHHDWRMZGG-UHFFFAOYSA-N Methylacrylonitrile Chemical compound CC(=C)C#N GYCMBHHDWRMZGG-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 150000001204 N-oxides Chemical class 0.000 description 1
- 229910021333 Na2Si Inorganic materials 0.000 description 1
- 102100027343 Napsin-A Human genes 0.000 description 1
- 239000006057 Non-nutritive feed additive Substances 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 108010059820 Polygalacturonase Proteins 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- 101710180012 Protease 7 Proteins 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 241000145542 Pseudomonas marginata Species 0.000 description 1
- 101000968491 Pseudomonas sp. (strain 109) Triacylglycerol lipase Proteins 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- 108091007187 Reductases Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 101001069700 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Saccharolysin Proteins 0.000 description 1
- 240000005499 Sasa Species 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- 239000004115 Sodium Silicate Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 101710152431 Trypsin-like protease Proteins 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- FTAFPYPZCUYXPM-UHFFFAOYSA-N [Mn+2].ClC1(N2CCN(CCCN(CCN(CC1)CCCC)CC2)C)Cl.[Mn+2].ClC2(N1CCN(CCCN(CCN(CC2)CC2=CC=CC=C2)CC1)CC1=CC=CC=C1)Cl Chemical compound [Mn+2].ClC1(N2CCN(CCCN(CCN(CC1)CCCC)CC2)C)Cl.[Mn+2].ClC2(N1CCN(CCCN(CCN(CC2)CC2=CC=CC=C2)CC1)CC1=CC=CC=C1)Cl FTAFPYPZCUYXPM-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 150000003855 acyl compounds Chemical class 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 229910000318 alkali metal phosphate Inorganic materials 0.000 description 1
- 229910052910 alkali metal silicate Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 108010030291 alpha-Galactosidase Proteins 0.000 description 1
- 102000005840 alpha-Galactosidase Human genes 0.000 description 1
- 108010084650 alpha-N-arabinofuranosidase Proteins 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229940108720 amaranth dye Drugs 0.000 description 1
- 230000003625 amylolytic effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000010936 aqueous wash Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- ADKBGLXGTKOWIU-UHFFFAOYSA-N butanediperoxoic acid Chemical compound OOC(=O)CCC(=O)OO ADKBGLXGTKOWIU-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 229910052681 coesite Inorganic materials 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000000205 computational method Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 229910052906 cristobalite Inorganic materials 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 150000001923 cyclic compounds Chemical class 0.000 description 1
- UNWDCFHEVIWFCW-UHFFFAOYSA-N decanediperoxoic acid Chemical compound OOC(=O)CCCCCCCCC(=O)OO UNWDCFHEVIWFCW-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000006389 diacetylation reaction Methods 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 238000004851 dishwashing Methods 0.000 description 1
- 239000004815 dispersion polymer Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- BRDYCNFHFWUBCZ-UHFFFAOYSA-N dodecaneperoxoic acid Chemical compound CCCCCCCCCCCC(=O)OO BRDYCNFHFWUBCZ-UHFFFAOYSA-N 0.000 description 1
- NFDRPXJGHKJRLJ-UHFFFAOYSA-N edtmp Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CCN(CP(O)(O)=O)CP(O)(O)=O NFDRPXJGHKJRLJ-UHFFFAOYSA-N 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 229940071087 ethylenediamine disuccinate Drugs 0.000 description 1
- 108010093305 exopolygalacturonase Proteins 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 108010066429 galactomannanase Proteins 0.000 description 1
- 239000007897 gelcap Substances 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 230000008570 general process Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 150000004966 inorganic peroxy acids Chemical class 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 108010011519 keratan-sulfate endo-1,4-beta-galactosidase Proteins 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- LGAILEFNHXWAJP-BMEPFDOTSA-N macrocycle Chemical class N([C@H]1[C@@H](C)CC)C(=O)C(N=2)=CSC=2CNC(=O)C(=C(O2)C)N=C2[C@H]([C@@H](C)CC)NC(=O)C2=CSC1=N2 LGAILEFNHXWAJP-BMEPFDOTSA-N 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 235000012243 magnesium silicates Nutrition 0.000 description 1
- FBDWCTWJJMORIU-UHFFFAOYSA-N magnesium;hexahydrate Chemical compound O.O.O.O.O.O.[Mg] FBDWCTWJJMORIU-UHFFFAOYSA-N 0.000 description 1
- 150000002697 manganese compounds Chemical class 0.000 description 1
- 229910001437 manganese ion Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 125000005341 metaphosphate group Chemical group 0.000 description 1
- 108010020132 microbial serine proteinases Proteins 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 150000002763 monocarboxylic acids Chemical class 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- ONLRKTIYOMZEJM-UHFFFAOYSA-N n-methylmethanamine oxide Chemical compound C[NH+](C)[O-] ONLRKTIYOMZEJM-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- IQZPDFORWZTSKT-UHFFFAOYSA-N nitrosulphonic acid Chemical compound OS(=O)(=O)[N+]([O-])=O IQZPDFORWZTSKT-UHFFFAOYSA-N 0.000 description 1
- FJDUDHYHRVPMJZ-UHFFFAOYSA-N nonan-1-amine Chemical compound CCCCCCCCCN FJDUDHYHRVPMJZ-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 125000000864 peroxy group Chemical group O(O*)* 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
- PTMHPRAIXMAOOB-UHFFFAOYSA-N phosphoramidic acid Chemical class NP(O)(O)=O PTMHPRAIXMAOOB-UHFFFAOYSA-N 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920002006 poly(N-vinylimidazole) polymer Polymers 0.000 description 1
- 229920003214 poly(methacrylonitrile) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001444 polymaleic acid Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 238000006268 reductive amination reaction Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 239000003340 retarding agent Substances 0.000 description 1
- AJTVWPGZWVJMEA-UHFFFAOYSA-N ruthenium tungsten Chemical compound [Ru].[Ru].[W].[W].[W] AJTVWPGZWVJMEA-UHFFFAOYSA-N 0.000 description 1
- 150000003333 secondary alcohols Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000002210 silicon-based material Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- PFUVRDFDKPNGAV-UHFFFAOYSA-N sodium peroxide Chemical compound [Na+].[Na+].[O-][O-] PFUVRDFDKPNGAV-UHFFFAOYSA-N 0.000 description 1
- 235000019351 sodium silicates Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229910052682 stishovite Inorganic materials 0.000 description 1
- 125000005156 substituted alkylene group Chemical group 0.000 description 1
- 125000005650 substituted phenylene group Chemical group 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 150000004685 tetrahydrates Chemical class 0.000 description 1
- MSLRPWGRFCKNIZ-UHFFFAOYSA-J tetrasodium;hydrogen peroxide;dicarbonate Chemical compound [Na+].[Na+].[Na+].[Na+].OO.OO.OO.[O-]C([O-])=O.[O-]C([O-])=O MSLRPWGRFCKNIZ-UHFFFAOYSA-J 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 125000005208 trialkylammonium group Chemical group 0.000 description 1
- 229910052905 tridymite Inorganic materials 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 229910009112 xH2O Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/39—Organic or inorganic per-compounds
- C11D3/3902—Organic or inorganic per-compounds combined with specific additives
- C11D3/3905—Bleach activators or bleach catalysts
- C11D3/3907—Organic compounds
- C11D3/3917—Nitrogen-containing compounds
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
- C11D17/0039—Coated compositions or coated components in the compositions, (micro)capsules
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/26—Organic compounds containing nitrogen
- C11D3/28—Heterocyclic compounds containing nitrogen in the ring
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D2111/00—Cleaning compositions characterised by the objects to be cleaned; Cleaning compositions characterised by non-standard cleaning or washing processes
- C11D2111/10—Objects to be cleaned
- C11D2111/12—Soft surfaces, e.g. textile
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/39—Organic or inorganic per-compounds
- C11D3/3902—Organic or inorganic per-compounds combined with specific additives
- C11D3/3905—Bleach activators or bleach catalysts
- C11D3/3907—Organic compounds
- C11D3/3917—Nitrogen-containing compounds
- C11D3/392—Heterocyclic compounds, e.g. cyclic imides or lactames
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/39—Organic or inorganic per-compounds
- C11D3/3902—Organic or inorganic per-compounds combined with specific additives
- C11D3/3905—Bleach activators or bleach catalysts
- C11D3/3907—Organic compounds
- C11D3/393—Phosphorus, boron- or silicium-containing compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Detergent Compositions (AREA)
Abstract
The present invention relates to a method for the controlled availability of formulation components, such as organic catalysts, into a wash solution. More particularly, the present invention relates to products and bleaching compositions containing such formulation components and laundry methods employing such formulation components.
Description
CONTROLLED AVAILABILITY OF COMPONENTS OF FORMULATION, COMPOSITIONS AND LAUNDRY METHODS THAT USE THE SAME
FIELD OF THE INVENTION
The present invention discloses a method for the controlled availability of formulation components, such as organic catalysts, in a wash solution. More particularly, the present invention describes bleaching products and compositions containing said formulation components and washing methods employing said formulation components.
BACKGROUND OF THE INVENTION
In recent years oxygen bleaching agents have become more popular in personal and home care products to facilitate the removal of stains and dirt. Bleaching agents are particularly desirable for their stain removal, dirty fabric cleaning, bleaching and hygiene properties, as well as for their inhibition of dye transfer. Oxygen bleaching agents have found acceptance in laundry products such as detergents, in automatic dishwashing products and cleaners
"-á» * »« * of hard surfaces Oxygen bleaching agents, however, are somewhat limited in their effectiveness.Some disadvantages that are frequently encountered include damage to fabric color and damage In addition, oxygen bleaching agents tend to be extremely dependent on the temperature scale, so the colder the solution where they are used, the less effective the bleaching action will be. Oxygen bleaching in solution to be effective requires temperatures above 60 ° C. To solve the problem of temperature dependence mentioned above, a class of compounds known as "bleach activators" has been developed. bleaching, typically perhydrolyzable acyl compounds with a residue group such as oxybenzenesulfonate, react with the active oxygen group, typically hydrogen peroxide or its anion, to form a more effective peroxyacid oxidant. The peroxyacid compound subsequently oxidizes the stained or dirty substrate material. However, bleach activators are also somehow temperature dependent. Bleach activators are most effective at temperate water temperatures of around 40 ° C to about 60 ° C. At water temperatures of less than about 40 ° C, the peroxy acid compound loses some of its bleaching effectiveness.
Various attempts have been made as demonstrated in the US patent nos. 5,360,568, 5,360,569 and 5,370,826 all to Madison et al., To develop a bleaching system that is effective under lower temperature water conditions. However, the dihydroisoquinoline bleach boosters shown in these references, when combined with peroxygen compounds, undergo desiderated decomposition, particularly when in the presence of wash solution components. The US patent nos. 5,576,282 and 5,817,614 both to Miracle et al. show further attempts in the development of a bleaching system comprising organic catalysts which is effective under water conditions of lower temperature and which is safe for colors. However, the prior art has failed to show or teach the delayed (controlled) addition of formulation components, such as organic catalysts, in accordance with the present invention. By virtue of the aforementioned, researchers have been looking for a method to mitigate (or control) the decomposition of the organic catalyst, particularly before contact with the oxidizable spot. Accordingly, the need remains for an effective method that provides organic catalysts and compositions containing organic catalysts that provide effective bleaching even at lower water temperatures, which provides stability in unwanted organic catalyst decomposition and which maximizes the performance of the peracid in the wash cycle.
BRIEF DESCRIPTION OF THE INVENTION
This need is covered by the present invention wherein the methods for providing organic catalysts, especially bleach impeller compounds, bleaching species, modified amines, modified amine oxides, sulfonimines, phosphonimines, N-acylimines and / or thiodiazole dioxides are provided. Unlimited examples of the benefits provided by the organic catalyst administration methods of the present invention include: superior bleaching effectiveness even at lower water temperatures; prevention of decomposition of organic catalysts that generally occurs during pre-mixing periods prior to the addition of fabrics that require cleaning (eg, stained fabrics); peracid permission to perform bleaching on stained fabrics that require cleaning prior to the administration of organic catalysts to maximize the concentration of peracid with fabric stains; and descent of peracid concentrations by bleaching, thus reducing the level of organic catalyst decomposition by means of the presence of excessive peracid in the wash solution.
^^^^^ jg ^ & ^ aj In one aspect of the present invention, there is provided a method for washing a fabric that requires cleaning comprises the administration of an organic catalyst by means of a controlled availability method such as define Test Protocols I, II and / or III shown below, in conjunction with or without, preferably with, a peroxygen source for a wash solution containing the fabric. In another aspect of the present invention, there is provided a bleaching composition comprising an organic catalyst capable of becoming available (chemically available to interact with other compounds) by means of a controlled availability method as defined in Test Protocols I, II and / or III, shown below, for performing bleaching when provided to a washing solution, in conjunction with or without, preferably with, a source of peroxygen. In still another aspect of the present invention, a product is provided comprising an organic catalyst capable of becoming available (chemically available to interact with other compounds) by means of a controlled availability method as defined by Test Protocols I, II and / or III, shown below, for performing bleaching in the form of ink transfer inhibition when provided to a washing solution, in conjunction with or without, preferably with, a source of peroxygen. In yet another aspect of the present invention, a product is provided comprising an organic catalyst capable of becoming available (chemically available to interact with other compounds) by means of a controlled availability method as defined by Test Protocols I, II and / or III, shown below, to perform bleaching when provided to a washing solution, in conjunction with or without, preferably with, a peroxygen source, the product further includes instructions for using the organic catalyst to clean a fabric that so require, the instructions include the step of administering a quantity of the product comprising the organic catalyst, in conjunction with or without a peroxygen source, to a wash solution containing the fabric such that at least a majority of the said organic catalyst is administered by means of a means of administration to the washing solution after that the fabric is added to the washing solution. Surprisingly, it has been found that an available organic catalyst (chemically available to interact with other compounds) by means of a controlled availability method as defined by Test Protocols I, II and / or III, shown below, in a solution of wash that. contains a source of peroxygen and a fabric that requires cleaning provides an improved bleaching performance compared to an instantly available organic catalyst (chemically available to interact with other compounds) in the wash solution. By controlling the availability of the organic catalysts of the present invention in a wash solution containing a peroxygen source and a fabric by means of a controlled availability method as defined by Test Protocols I, II and / or III, shown below, the peroxygen / peracid source can bleach during the early stage of the wash cycle when its concentration is at the highest level, and at the same time exposure of the organic catalysts can be avoided. highest concentration level of the peroxygen / peracid source, thus reducing the organic catalyst decomposition. The organic catalysts can then be made available (chemically available to interact with other compounds, eg peracid) by means of a controlled availability method as defined by Test Protocols I, II and / or III, as shown below. . Once available in the wash solution, the organic catalysts can react with the remaining available peracid to form the oxygen transfer agents (bleaching species) that can oxidize the spots. This results in the added benefits of optimizing the peroxygen / peracid source and the organic catalysts. Without being limited by theory, organic catalysts, particularly bleach driving compounds, react with a peroxygen source, preferably a peracid, to form the oxygen transfer agents (bleaching species). Several routes of decomposition can lead to the decomposition of the bleach-driving compound or the oxygen transfer agent, leading to the decomposition products that can also react with the peroxygen / peracid source. Accordingly, the control of the availability of the organic catalysts, and in this way the control of the synchronization of the contact between the organic catalysts and any peroxygen / peracid source in a washing solution allows said peroxygen sources / percents present in the wash solution perform a maximum bleaching on selected spots of a fabric before coming into contact with the organic catalysts. Under typical washing conditions, since the peracid clots with the stain more slowly than the oxygen transfer agent, there is often oxygen available in the peracid form present at the end of the wash cycle. The oxygen available at the end of the wash cycle is at a lower concentration, which results in a lower bleaching index, and at the time of completion of the wash, results in the waste of the remaining peracid. Actually, as the wash cycle proceeds, the concentration (after the perhydrolysis is complete) begins to decrease due to peracid bleaching spots and stains. The bleaching performed by the peracid is relatively slow (from a kinetic point of view, especially at lower wash bath temperatures), and it is necessary to maximize the wash time and maximize the peracid concentration to maximize spot removal. It is important and necessary to allow a high peracid concentration to work on certain oxidizable stains, and subsequently allow the organic catalyst to work in a complementary group of oxidizable stains. It is known that the perished react quickly with organic catalysts that form a kind of bleach, which subsequently reacts rapidly with oxidizable spots. Accordingly, the object of the present invention is to provide: a method for administering an organic catalyst by means of a controlled availability method as defined by Test Protocols I, II and / or III, which demonstrates improved performance even in lower temperature solutions as well as being able to mitigate (or control) undesired decomposition and maximize peracid performance at an early stage of the wash cycle; a method for washing a fabric that needs to be cleaned by administering an organic catalyst in a controlled availability method as defined by Test Protocols I, II and / or III, shown below, for a wash solution that contains the cloth; a bleaching composition comprising an organic catalyst capable of becoming available by means of a controlled availability method as defined by Test Protocols I, II and / or III, shown below, for a wash solution that already contains a fabric which requires cleaned. A person skilled in the art will recognize these and other objects, features and advantages of the present invention from the following description and the appended claims.
All percentages, ratios and proportions mentioned herein are on a weight basis unless otherwise indicated. All the documents cited herein are incorporated by reference in the present invention.
DETAILED DESCRIPTION OF THE INVENTION
The present invention shows highly useful and novel methods for the administration of organic catalyst compounds, also known as organic catalysts ("bleach driving compounds", "bleaching species", "modified amines", "modified amine oxides", sulfonimines, phosphinimines, thiodiazole dioxides and mixtures thereof), by means of a controlled availability method as defined by Test Protocols I, II and / or III, shown below, for a wash solution containing a fabric that requires cleaning ( that is, stained / dirty cloth). The controlled availability methods for administering organic catalysts of the present invention provide improved bleaching effectiveness even in lower temperature applications at the same time that they can mitigate (or control) undesired decomposition. As a result, the organic catalysts and the methods of using them according to the present invention result in a greater mitigation of undesired decomposition, which leads to an efficiency
***
improved catalyst, which leads to improved bleaching and thus improves performance. In addition, the organic catalysts and methods of use thereof according to the present invention maximize the performance of the peracid at an early stage of the wash cycle, resulting in improved overall performance. The controlled availability methods as defined by Test Protocols I, II and / or III, shown below, allow organic catalysts to become chemically available to interact with other compounds in a washing solution in a controlled manner (less than total amount 10 of organic catalyst that becomes available at one time) rather than in a sum total manner (total amount of organic catalyst that becomes available at one time) •
Definitions 15"Which becomes available" in the present invention means, becoming chemically available to interact with other compounds. "Peroxygen source" as used in the present invention means materials that generate peroxygen compounds, which may include the same peroxygen compounds. Examples include, but are not limited to, bleach activators, percents, percarbonate, perborate, hydrogen peroxide, bleach compounds, and / or bleach species (eg, oxazyridiniums).
"Peroxygen compounds" as used in the present invention includes perishes and peroxides (eg, hydrogen peroxide, alkylhydroperoxides, etc. "Peracid" as used in the present invention means a peroxyacid such as peroxycarboxylic acid and / or peroxymonosulfuric acid (trademark OXONE) and its salts The methods for the administration of organic catalysts of the present invention act in conjunction with or without, preferably with conventional peroxygen bleach sources, to provide the effectiveness of improved bleaching and superior mitigation of undesired decomposition mentioned above.
Organic Catalyst Compounds Unlimited examples of organic catalyst compounds, such as bleach impellants and bleach species are described in US Pat. Nos. 5,041, 232, 5,045,223, 5,047,163, 5,310,925, 5,413,733, 5,360,568, 5,482,515, 5,550,256, 5,360,569, 5,478,357, 5,370,826, 5,442,066, 5,576,282, 5,760,222, 5,753,599, 5,652,207 and 5,817,614, published PCT applications WO 98/23602, WO 95/13352, WO 95/13353, WO 95/13351, WO 97/06147 and WO 98/23717, and EP 728 182. The organic catalyst compounds of the present invention and bleaching compositions (products) containing said
Organic catalyst compounds that are particularly useful in the methods of the present invention are organic catalyst compounds and compositions containing the same that satisfy the conditions outlined in Test Protocols I, II and / or III, shown below. Preferably, the organic catalyst compounds of the present invention, more preferably the organo-based organic catalyst compounds of the present invention, include, but are not limited to, bleach-driving compounds, modified amines, modified amine oxides, sulfonimines, phosphinimides, thiodiazole dioxides and mixtures thereof.
I. Bleach Trapping Compounds Bleach impeller compounds, preferably the mineral-based bleach impellants, of the present invention include, but are not limited to, aryliminium cations, aryliminium polyions, which have a charge net of about +3 to about -3, and zwitterionics of aryliminium, which have a net charge of about +3 to about -3. A preferred organic catalyst according to the present invention and for use in the bleaching compositions of the present invention is a bleach-driving compound selected from zwitterionics of aryliminium or its oxaziridinium bleaching species because unlike the aryliminium cations and / or oxaziridinium cations, the
. . . .. J ^ .A ^ -JA.
Zwitterionic agents provide effective bleaching without resulting in an unacceptable level of color damage in fabrics.
a.- Aryliminium cations and polions
The aryliminium cations and the aryliminium polions, which have a charge
net of around +3 to about -3, are represented by the
formula [I]:
[I] wherein R2 and R3 are independently selected from substituted or unsubstituted, saturated or unsaturated radicals selected from the group consisting of radicals of H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen , halogen, cyano, sulfonate, alkoxy, keto, carboxylic and carboalkoxy; R1 and R4 are selected from substituted or unsubstituted, saturated or unsaturated radicals selected from the group consisting of radicals of H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, alkoxy , keto and carboalkoxy; and X is a counterion compatible with bleaching of
preference, of appropriate load balance; and v is an integer from 1 to 3.
Preferably, the aryliminium cations and aryliminium polions, which have a net charge of about +3 to about -3, are represented by the formula [XI]:
[XO where m is 1 to 3 when G is present and m is 1 to 4 when G is not present; and n is an integer from 0 to 4; each R20 is independently selected from a substituted or unsubstituted radical selected from the group consisting of radicals of H, alkyl, cycloalkyl, aryl, fused aryl, heterocyclic ring, fused heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate , alkoxy, keto, carboxylic and carboalkoxy, and either of the two R20 substituent atoms may combine to form a fused aryl, fused heterocyclic or fused carbocyclic ring; R18 may be a substituted or unsubstituted radical which is selected from the group consisting of radicals of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic and carboalkoxy; R19 is a radical selected from the group consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl and substituted or unsubstituted, saturated or unsaturated heterocyclic ring; G is selected from the group consisting of (1) -O-; (2) -N (R23) -; and (3) -N (R23R24) -; R21-R24 are substituted or unsubstituted radicals that are independently selected from the group consisting of H, oxygen, straight or branched C1-C4 alkyl, alkyls, alkoxys, aryls, alkaryls, aralkyls, cycloalkyls, and heterocyclic rings; as long as any of the R18, R19, R20, R21-R24 can be joined with any other of the R18, R19, R20, R21-R24 to form part of a common ring; any pair R21-R22 may be combined to form a carbonyl; any adjacent R21-R24 may join to form unsaturation; and wherein any group of substituent atoms R21 -R24 may be combined to form a substituted unsubstituted or unsubstituted fused portion; X is an appropriate charge balance counter-ion, preferably a compatible bleach counter-ion; and v is an integer from 1 to 3. More preferably, the aryliminium cations and the aryliminium polions, which have a net charge of about +3 to about -3, as represented by formula [IX], include those of the formula [XI] wherein R18 is H or methyl and R19 is H or substituted or unsubstituted, saturated or unsaturated C1-C4 alkyl.
b.- Zwitterionic Aryliminium Agents The zwitterionic agents of aryliminium, which have a net charge of about +3 to about -3, are represented by the formula [II]:
OD where R 5 -R 7 are independently selected from substituted or unsubstituted radicals selected from the group consisting of H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate radicals, alkoxy, keto, carboxylic and carboalkoxy; The radical represented by the formula is also present in this formula:
where Zp is covalently bound to To, and Zp- is selected from the group consisting of -CO2 -, - SO3, -OSO3-, -SO2- and -OSO2- and p is 1, 2 or 3; T0 is selected from the group consisting of alkyl, cycloalkyl, aryl, alkaryl, aralkyl and substituted or unsubstituted, saturated or unsaturated heterocyclic ring. Preferably, zwitterionic aryliminium agents, which have a net charge of about +3 to about -3, are represented by the formula [XII]: [XII]
where m is 1 to 3 when G is present and m is 1 to 4 when G is not present; and n is an integer from 0 to 4; each R26 is independently selected from a substituted or unsubstituted radical which is selected from the group consisting of H, alkyl, cycloalkyl, aryl, fused aryl, heterocyclic ring, fused heterocyclic ring, nitrogen, halogen, cyano, sulfonate radicals , alkoxy, keto, carboxylic and carboalkoxy, and any of the neighboring R26 substituent atoms may be combined to form a fused aryl, fused carbocyclic ring or fused heterocyclic ring; R25 can be a substituted or unsubstituted radical selected from the group consisting of radicals of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic and carboalkoxy; also present in this formula the radical represented by the formula:
where Zp- is covalently bound to T0, and Zp- is selected from the group consisting of -CO2 -, - SO3, -OSO3-, -SO2- and -OSO2- and p is 1, 2 or 3;
T0 is selected from the group consisting of: where q is an integer from 1 to 8; R29 is independently selected from substituted or unsubstituted radicals which are selected from the group consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, alkylene, heterocyclic ring, alkoxy, arylcarbonyl, carboxyalkyl, and linear or branched amide groups; G is selected from the group consisting of (1) -O-; (2) -N (R30) -; and (3) -N (R30R31) -; R27, R28, R30 and R31 are substituted or unsubstituted radicals that are independently selected from the group consisting of H, oxygen, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, alkyl, heterocyclic ring, alkoxy, arylcarbonyl groups, carboxyalkyl groups and amines groups; any of R25, R26, R27, R28, R30 and R31 can be joined with any other of R25, R26, R27, R28, R30 and R31 to form part of a common ring; any pair R27-R28 can be combined to form a carbonyl; any adjacent R27-R31 may join to form unsaturation; and wherein any group of substituent atoms R27 -R3 can be combined to form a substituted or unsubstituted molten unsaturated portion. The most preferred are zwitterionic aryliminium agents, which have a net charge of about +3 to about -3, such as it is represented by the formula [XII], and include those of the formula [XII] where R25 is H or methyl, and for the radical represented by the formula:
^ .¿n ^ t
Zp- is -CO2-, - SO3, or -OSO3-, and p is 1 or 2, even more preferably Zp- is -SO3- or -OSO3- and p is 1.
II.- Modified Amine / Amine Oxide Compounds The amine oxide and / or modified amine compounds of the present invention include, but are not limited to, modified amines and modified amine oxides with a net charge of about +3. to about 10 -3.
a.- Modified amines • Modified amines are represented by the formulas [Vj and [VI]:
[V] [VI] • where R9-R10 are independently selected from radicals
20 substituted or unsubstituted which are selected from the group consisting of radicals of H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic and carboalkoxy and charge anionic and / or cationic radicals; R8 and R11, when present, are radicals which are selected from the group consisting of radicals of H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, alkoxy, keto, and carboalkoxy and anionic and / or cationic charge bearing the radicals; R12 is a residue group, the protonic form of which has a pKa value (H2O reference) that falls within the following scale: 37 > pKa > -2; with the proviso that any R8-R12, when present, can be combined to form a fused aryl, fused heterocyclic or fused carbocyclic ring; and the radical represented by the formula is also present in this formula: wherein Zp- is covalently bound to T0, and Zp- is selected from the group consisting of -CO2 -, - SO3) -OSO3-, - SO2- and -OSO2- and p is 1, 2 or 3; T0 is selected from the group consisting of alkyl, cycloalkyl, aryl, alkaryl, aralkyl and substituted or unsubstituted, saturated or unsaturated heterocyclic ring. Preferably, the modified amines are represented by the formulas [XV] and [XVI]:
[XV] [XVQ where m is 1 to 3 when G is present and m is 1 to 4 when G is not present; and n is an integer from 0 to 4; R34 is a radical selected from the group consisting of unsaturated, saturated or unsaturated hydroxy, perhydroxy, alkoxy, peralkoxy, carboxylic, percarboxylic, sulfonate and persulfonate radicals; each R 35 is independently selected from a substituted or unsubstituted radical selected from the group consisting of radicals of H, alkyl, cycloalkyl, aryl, fused aryl, heterocyclic ring, fused heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate , alkoxy, keto, carboxylic 0 and carboalkoxy, and either of the two neighboring R 35 substituent atoms can be combined to form a fused aryl, fused or fused carbocyclic heterocyclic ring; R32 may be a substituted or unsubstituted radical selected from the group consisting of radicals of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic and carboalkoxy; R33 can be a substituted or unsubstituted, saturated or unsaturated radical which is selected from the group consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring and also in this formula the radical represented by the formula
where Zp- is covalently bound to T0, and Zp- is selected from the group consisting of -CO2 -, - SO3, -OSO3-, -SO2- and -OSO2- and p is 1, 2 or 3;
T0 is selected from the group consisting of
where q is an integer from 1 to 8; R38 is independently selected from substituted or unsubstituted radicals which are selected from the group consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, alkylene, heterocyclic ring, alkoxy, arylcarbonyl, carboxyalkyl, and linear or branched amide groups; G is selected from the group consisting of (1) -O-; (2) -N (R39) -; and (3) -N (R39R40) -; R36, R37, R39 and R40 are substituted or unsubstituted radicals which are independently selected from the group consisting of H, oxygen, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, alkyl, heterocyclic ring, alkoxy, arylcarbonyl groups, carboxyalkyl groups and amines groups; any of R32, R33, R34, R35, R36, R37, R39 and R40 can be joined with any other of R32, R33, R34, R35, R36, R37, R39 and 4o to form part of a common ring; any pair R36-R37 can be combined to form a carbonyl; any adjacent R36, R37, R39 and R40 can join to form unsaturation; and wherein any group of substituent atoms R36, R37, R39 and R40 can be combined to form a substituted unsubstituted or unsubstituted fused portion. Examples of such modified amides include, but are not limited to those with a radical R34 which are selected from a group consisting of saturated, substituted or unsubstituted hydroxy, perhydroxy, alkoxy, peralkoxy, carboxyl, percarboxyl, sulfonate and persulfonate radicals. or unsaturated. Preferably, the radical R34 is selected from the group consisting of substituted or unsubstituted hydroxy, perhydroxy, alkoxy and peralkoxy radicals, saturated or unsaturated. The following examples are intended to exemplify said modified amines of the present invention, but do not necessarily mean that they limit or rather define the scope of this invention.
More preferably, for the modified amines represented by the formulas [XV] and [XVI], R34 is a residue group, the protonic form of which has a pKa value (H2O reference) that falls
~ L..A. t. > ? 4piya ~ ¡* .ifrlau? T._ within the following scale: 30 > pKa > 0; more preferably 23 > pKa > 3; even more preferably 21 > pKa > 9; more preferably 17 > pKa > 1. Preferably, for the modified amines represented by the formulas [XV] and [XVI], R12 is selected from the group consisting of substituted or unsubstituted hydroxy, prehydroxy, alkoxy and peralkoxy radicals, saturated or unsaturated. More preferably, for the modified amines represented by the formulas [XV] and [XVI] wherein said R12 is selected from the group consisting of hydroxy or perhydroxy. Even more preferred modified amines, as represented by formulas [XV] and [XVI], include those modified amines with a net charge of about +1 to about -1 where R32 is H or Me; R34 is a radical selected from the group consisting of hydroxy or perhydroxy radicals; R35 is independently selected from the group consisting of radicals of H, alkyl, nitrogen, halogen, sulfonate, alkoxy, carboxyl and carboalkoxy and / or Zp- is -CO2 -, - SO3, or -OSO3-. For modified amines, R12 is a residue group (LG), the protonic form of which has a pKa value (reference of H20) that falls within the following scale: 37 > pKa > 2; preferably 30 > pKa > 0; more preferably 23 > pKa > 3; even more preferably 17 > pKa > eleven; more preferably R12 is a residue group consisting of substituted or unsubstituted hydroxy, perhydroxy, alkoxy and peralkoxy radicals, saturated or unsaturated; and any R8-R12 may be combined to form fused aryl, fused carbocyclic ring or fused heterocyclic ring.
b.- Modified amine oxides The modified amine oxides of the present invention are represented by the formulas [VII] - [X]:
[VIO [VIII]
[IX] P]
wherein R8-R10 are independently selected from substituted or unsubstituted radicals which are selected from the group consisting of H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate radicals , alkoxy, keto, carboxyl and carboalkoxy and cationic and / or anionic charge bearing radicals; R11 is a radical selected from the group consisting of radicals of H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxyl and carboalkoxy and radicals carriers of cationic and / or anionic charge; R12 is a residue group, the protonic form of which has a value p a (reference
- «•» - * • "of H20) falling within the following scale: 37> pKa> 2, with the proviso that any R8-R12, when present, can be combined to form fused aryl, ring fused carbocyclic or fused heterocyclic ring, and also in this formula is represented radical 5 represented by the formula:
where Zp- is covalently bound to T0, and Zp- is selected from the group consisting of -CO2 -, - SO3, -OSO3-, -SO2- and -OSO2- and p is 1, 2 or 10 3; T0 is selected from the group consisting of substituted or unsubstituted, saturated or unsaturated alkyl, cycloalkyl, aryl, alkaryl, aralkyl and heterocyclic ring. • Preferably, for the modified amino-oxides represented by the formulas [VII] - [X], R12 is a residue group, the protonic form of 15 which has a pKa value (reference of H20) that falls within the following scale : 30 > pKa > 0; more preferably 23 > pKa > 3; even more preferably 21 > pKa > 9; more preferably 17 > pKa > 11. Preferably, for the modified amines represented by
• the formulas [XV] and [XVI], R12 is selected from the group consisting of 20 substituted or unsubstituted, saturated or unsaturated hydroxy, prehydroxy, alkoxy and peralkoxy radicals. More preferably, for the modified aminoxides represented by the formulas [XV] and [XVI] wherein said R12 is selected from the group consisting of hydroxy or perhydroxy.
- * J? *? UJ & ißi Also preferably, the modified amine oxides are represented by the formulas [XVII] - [XX]:
[XVIO [XVIIUM
[XIX] [XX]
where m is 1 to 3 when G is present and m is 1 to 4 when G is not present; and n is an integer from 0 to 4; R34 is a radical selected from the group consisting of saturated, unsaturated, substituted or unsubstituted hydroxy, perhydroxy, alkoxy, peralkoxy, carboxylic, percarboxylic, sulfonate and persulfonate radicals; each R 35 is independently selected from a substituted or unsubstituted radical selected from the group consisting of radicals of H, alkyl, cycloalkyl, aryl, fused aryl, heterocyclic ring, fused heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate , alkoxy, keto, carboxylic and arboalkoxy, and either of the two neighboring R35 substituent atoms can be combined to form a fused aryl, fused heterocyclic or fused carbocyclic ring; R32 may be a substituted or unsubstituted radical which is selected from the group consisting of radicals of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic and carboalkoxy; R33 can be a substituted or unsubstituted, saturated or unsaturated radical selected from the group consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring and also in this formula the radical represented by the formula is present
where Zp- is covalently bound to T0, and Zp- is selected from the group consisting of -CO2 -, - SO3, -OSO3-, -SO2- and -OSO2- and p is 1, 2 or 3;
T0 is selected from the group consisting of
where q is an integer from 1 to 8; R38 is independently selected from the substituted or unsubstituted radicals which are selected from the group consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, alkylene, heterocyclic ring, alkoxy, arylcarbonyl, carboxyalkyl and linear amide groups or branched G is selected from the group consisting of (1) -O-; (2) -N (R39) -; and (3) -N (R39R40) -; R36, R37, R39 and R40 are radicals
& Substituted or unsubstituted, which are independently selected from the group consisting of H, oxygen, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, alkylene, heterocyclic ring, alkoxy, arylcarbonyl groups, carboxyalkyl groups and amines; any of R32, R33, R34, R35, R38, R37, R39 and R40 can be joined with any other of R32, R33, R34, R35, R36, R37, R39 and R40 to form part of a common ring; any pair R36-R37 can be combined to form a carbonyl; any adjacent R36, R37, R39 and R40 can join to form unsaturation; and wherein any group of substituent atoms R36, R37, R39 and R40 can be combined to form a substituted unsubstituted or unsubstituted fused portion. Examples of such modified amides include, but are not limited to those with a radical R34 which are selected from a group consisting of saturated, substituted or unsubstituted hydroxy, perhydroxy, alkoxy, peralkoxy, carboxyl, percarboxyl, sulfonate and persulfonate radicals. or unsaturated. Preferably, the radical R34 is selected from the group consisting of substituted or unsubstituted hydroxy, perhydroxy, alkoxy and peralkoxy radicals, saturated or unsaturated.
More preferably, for modified amino-oxides represented by formulas [XV] and [XVI], R34 is a residue group, the protonic form of which has a pKa value (H2O reference) that falls
15 within the following scale: 30 > pKa > 0; more preferably 23 > pKa > 3; even more preferably 21 > pKa > 9; more preferably 17 > pKa > 1. Preferably, for the modified amino-oxides represented by the formulas [XV] and [XVI], R34 is selected from the group consisting of hydroxy, prehydroxy, alkoxy and substituted peralkoxy radicals or
20 unsubstituted, saturated or unsaturated. More preferably, for the modified aminoxides represented by the formulas [XV] and [XVI], R34 is selected from the group consisting of hydroxy or perhydroxy.
The most preferred modified amino-oxides, as represented by formulas [XVII] and [XX], include those modified amino-oxides with a net charge of about +1 to approximately -1 where R32 is H or Me; R34 is a radical selected from the group consisting of hydroxy or perhydroxy radicals; R35 is independently selected from the group consisting of radicals of H, alkyl, nitrogen, halogen, sulfonate, alkoxy, carboxyl and carboalkoxy and / or Zp- is -CO2 -, - SO3, or -OSO3-. For the modified aminoxides, R12 is a residue group (LG), the protonic form of which has a pKa value (reference of H20) that falls within the following scale: 37 > pKa > 2; preferably 30 > pKa > 0; more preferably 23 > pKa > 3; even more preferably 17 > pKa > eleven; more preferably R12 is a residue group consisting of substituted or unsubstituted hydroxy, perhydroxy, alkoxy and peralkoxy radicals, saturated or unsaturated; and any R8-R12 may be combined to form fused aryl, fused carbocyclic ring or fused heterocyclic ring. Unlimited examples of appropriate modified amine compounds (modified amines and / or modified aminoxides) (and the pKa value (H2O reference) of the protonic form of R12) according to the present invention include, but are not limited to:
p at 10.5 P, 11.6 p a 13
p a i5.7 pKa_20 pKa _ 28 PK, 37
The modified amine compounds of the present invention act in conjunction with the peroxygen source to provide a more effective bleaching system. Peroxygen sources are well known in the art and the peroxygen source employed in the present invention can comprise any of these well-known sources, including peroxygen compounds as well as compounds that under conditions of consumer use provide an effective amount of peroxygen in situ. The source of peroxygen can include a source of hydrogen peroxide, the in situ formation of a peracid anion through the reaction of a source of hydrogen peroxide and a bleach activator, the preformed peracid compounds or mixtures of sources of suitable peroxygen. Of course, a person skilled in the art will recognize that other sources of peroxygen can be used without having to take as reference the scope of the invention. Preferably, the peroxygen source is an organic and / or inorganic peracid.
IV. Sulfomins. phosphomines. N-acylimines, thiodiazole dioxides
The sulfonamines, phosphomines, N-acylimines and thiodiazole dioxides of the present invention are represented by the formulas [XXIa], [XXIb], [XXII] and [XXIII], respectively:
[XXIa] pCKIb] [XXN] [XXIII]
^. ^. AAa, ^^ .. 4 .-. . ...
wherein R41-R44, when present, are independently selected from substituted or unsubstituted, saturated or unsaturated radicals which are selected from the group consisting of radicals of H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic and carboalkoxy; with the proviso that any R41-R44 can be joined with any other R41-R44 to form a common ring, including a fused aryl, fused heterocyclic ring or fused carbocyclic ring.
II.- Bleaching species Bleaching species (oxaziridiniums, oxaziridines) can also be used directly according to the present invention. The bleaching species of the present invention include, but are not limited to, oxaziridinium cations, oxaziridinium polions, which have a net charge of about +3 to about -3, zwitterionic oxaziridinium, having a net charge of about from +3 to about -3, oxaziridine sulfonimines, oxaziridine phosphonimines, thiodiazole oxaziridine dioxides, and mixtures thereof. The organic catalysts, especially the aryliminium cations, aryliminium, zwitterionic aryliminium, sulfonimines, phosphonimines, thiodiazole dioxides of the present invention act in conjunction with a source of peroxygen, when present to increase the effectiveness of bleaching. Without being limited by theory, it is believed that the organic catalysts react with the peroxygen source to form a more active bleaching species, an oxaziridine and / or quaternary oxaziridinium compound, are represented by the following reaction by way of example:
The oxaziridinium and / or oxaziridine compounds may have increased or preferred activity at lower temperatures relative to the peroxygen compound.
a.- Oxaziridinium cations and polys Oxaziridinium cations and polions, which have a charge
20 net of around +3 to about -3, are represented by the formula [III]:
[H
wherein R2-R3 are independently selected from substituted or unsubstituted radicals which are selected from the group consisting of H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate radicals , alkoxy, keto, carboxylic and carboalkoxy; R1 and R4 are radicals which are selected from the group consisting of radicals of H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, alkoxy, keto, and carboalkoxy; and X is an appropriate charge balance counter ion, preferably a compatible bleach counter ion; and v is an integer from 1 to 3. Preferably, the oxaziridinium cations and polions, which have a net charge of about +3 to about -3, are represented by the formula [XIII]:
[XIII] where m is 1 to 3 when G is present and m is 1 to 4 when G is not present; and n is an integer from 0 to 4; R20 is independently selected from a substituted or unsubstituted radical selected from the group consisting of radicals of H, alkyl, cycloalkyl, aryl, fused aryl, heterocyclic ring, fused heterocyclic ring, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic and carboalkoxy, and either of the two R20 substituent atoms may be combined to form a fused aryl, fused or fused carbocyclic heterocyclic ring; R 8 can be a substituted or unsubstituted radical which is selected from the group consisting of radicals of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic and carboalkoxy; R19 can be a substituted or unsubstituted, saturated or unsaturated radical which is selected from the group consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring. G is selected from the group consisting of (1) -O-; (2) -N (R23) -; and (3) -N (R23 R24) -; R21 R24 are substituted or unsubstituted radicals which are independently selected from the group consisting of H, oxygen, C1-C4 alkyl, linear or branched, alkylems, alkoxys, aryls, alkaryls, arylakyls, cycloalkyls and heterocyclic rings; as long as any of the R18, R19, R21 and R24 can be joined with any other of the R18 ', R19', R21 'and R24 to form part of a common ring; any pair R21 '-R22 may be combined to form a carbonyl; any adjacent R21-R24 can join to form unsaturation; and where any group
.. ^ t ^ at- of substituent atoms R21"R24 may be combined to form a substituted unsubstituted or unsubstituted fused portion and wherein any group of substituent atoms R21" R24 may be combined to form a substituted unsubstituted or unsubstituted fused portion; X is an appropriate charge balance counter-ion, preferably a compatible bleach counter-ion; and v is an integer of 1 to 3. The most preferred oxaziridinium cations and oxaziridinium polys have a net charge of about +3 to about
-3, are represented by the formula [XIII], include those of the formula [XIII] wherein R18 is H or methyl, and R9 is H or a cycloalkyl and C1-C4 alkyl, substituted or unsubstituted, saturated or unsaturated.
b.- Oxaziridinium zwitterionics Oxaziridinium zwitterionic agents, which have a net charge of about +3 to about -3, are represented by the formula [IV]:
[IV]
wherein R5-R7 are independently selected from substituted or unsubstituted radicals which are selected from the group consisting of radicals of H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, damage, sulfonate , alkoxy, keto, carboxylic and carboalkoxy; The radical represented by the formula is also present in this formula:
where Zp- is covalently bound to T'0, and Z'p- is selected from
of the group consisting of -CO2 -, - SO3, -OSO3-, -SO2- and -OSO2- and p is 1, 2 or 3; T'0 is selected from the group consisting of alkyl, cycloalkyl, aryl, alkaryl, aralkyl and substituted or unsubstituted, saturated or unsaturated heterocyclic ring. Preferably, the zwitterionic agents, which have a net charge of about +3 to about -3, are represented by the formula [XIV]:
[XIV] where m is 1 to 3 when G is present and m is 1 to 4 when G is not present; and n is an integer from 0 to 4; R26 is independently selected to
starting from a substituted or unsubstituted radical selected from the group consisting of radicals of H, alkyl, cycloalkyl, aryl, fused aryl, ring
heterocyclic, fused heterocyclic ring, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic and carboalkoxy, and either
Í:. ... *? aá ü & Neighboring R 26 substituent atoms may be combined to form a fused aryl, fused heterocyclic ring or fused carbocyclic ring; R 25 can be a substituted or unsubstituted radical selected from the group consisting of radicals of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic and carboalkoxy; and also in this formula is present the radical represented by the formula
-T -ZT
where Z'p- is covalently bound to T'0, and Z'p- is selected from the group consisting of -CO2 -, - SO3, -OSO3-, -SO2- and -OSO2- is already 1 or 3;
T'0 is selected from the group consisting of
where q is an integer from 1 to 8; R29 is independently selected from substituted or unsubstituted radicals which are selected from the group consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, alkylene, heterocyclic ring, alkoxy, arylcarbonyl, carboxyalkyl, and linear or branched amide groups; G is selected from the group consisting of (1) -O-; (2) -N (R30 ') -; and (3) -N (R30'R31 ') -; R27 ', R28', R30 'and R31' are substituted or unsubstituted radicals which are independently selected from the group consisting of H, oxygen, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, alkyl, heterocyclic ring, alkoxy, arylcarbonyl groups , carboxyalkyl groups and amines groups; any of R25, R26, R27, R28 ', R30' and R31 'can be joined with any other of R25', R26 ', R27', R28 ', R30' and R31 'to form part of a common ring; any pair R27-R28 can be combined to form a carbonyl; any adjacent R27-R31 may join to form unsaturation; and wherein any group of substituent atoms R27-R31 may be combined to form a substituted unsubstituted or substituted unsaturated portion. The most preferred zwitterionic aryliminium agents, having a net charge of about +3 to about -3, as represented in formula [XIV], include those of formula [XIV] wherein R25 is H or methyl, and for the radical represented by the formula:
Z'p- is -CO2 -, - SO3, or -OSO3-, and p is 1 or 2. c) Sulfonimines. phosphonimines. N-acylimines. oxaziridine thiodiazole dioxides The oxaziridine sulfonimines [XXIVa], phosphonimines [XXIVb], N-acylimines [XXV] and thiodiazole dioxides [XXVI] and [XXVII] are represented as follows: [XXIVa] [XXlVb] [XXV] ]
[xxvo] where R41 -R44, when present, are independently selected from substituted or unsubstituted radicals which are selected from the group consisting of H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring radicals , silyl, nitrogen, halogen, cyano, sulfonate,
15 alkoxy, keto, carboxylic and carboalkoxy; as long as any of the R41-R4 can be joined with other R41-R44 to form part of a common ring, including a fused aryl, fused carbocyclic ring or fused heterocyclic ring. Appropriate examples of X ", an anionic counterion, include, but
• 20 are not limited to: BF-, OTS ', and other anionic counterparts shown in WO / 97/06147, WO 95/13352, WO 95/13353, WO 95/13351, WO 98/23717, US Pat. Nos. 5,360,568, 5,360,569, 5,482,515, 5,550,256, 5,478,357,
* ..- ** ^. * b * 5,370,826, 5,442,066, EP 728 182 B1 and RU 1 215 656. Preferably, the anionic counterion is compatible with bleaching. For any structure that does not carry a net charge, no counter-ion is associated with the compound. For any structure bearing a negative net charge, appropriate examples of X +, a cationic counterion include, but are not limited to Na +, K +, H +. For any structure bearing a net multiple charge, suitable examples of anionic and cationic counterparts include, but are not limited to, those described above.
Other Organic Catalyst Compounds In addition to the bleach compounds, bleaching species and modified amines and aminoxides shown above, the organic catalyst compounds can be any compound known in the art that is capable of reacting with a peracid to form a transfer agent. oxygen (a bleach)
Concentration of organic catalyst compounds The organic catalyst compounds of the present invention can be added to a washing solution at levels of about 0.00001% (0.0001 ppm) to about 10% (100 ppm) by weight of the composition, and preferably around from 0.0001% (0.001 ppm) to about 2% (20 ppm) by weight of the composition, more preferably from about 0.005% (0.05 ppm) to about 0.5% (5 ppm), even more preferably around 0.01 % (0.1 ppm) to approximately 0.2% (2 ppm). More preferably from about 0.02% (0.2 ppm) to about 0.1% (1 ppm) Preferably, the bleaching compositions of the bleaching composition of the present invention comprise an amount of organic catalyst compound such that the resulting concentration The bleach impeller compound in a wash solution is from about 0.001 ppm to about 5 ppm. In addition, preferably the bleaching compositions of the present invention comprise an amount of peroxygen compound, when present, and an amount of organic catalyst compound, such that the molar ratio resulting from said peroxygen compound for organic catalyst compound. in a wash solution it is preferably greater than 1: 1, more preferably greater than 10: 1, even more preferably greater than 50: 1. Preferred molar ratio scales of peroxygen compound to cationic organic catalyst compound range from about 30,000: 1 to about 10: 1, even more preferably from about 10,000: 1 to about 50: 1, even more preferably still from about 5,000: 1 to about 100: 1, still still with a greater preference of about 3,500: 1 to about 150: 1.
The conversion values (in ppm) are provided for exemplification purposes, based on a product concentration in use of 1000 ppm. A 1000 ppm wash solution of a product containing 0.2% organic catalyst compound by weight results in an organic catalyst compound concentration of 2 ppm. Similarly, a 3500 wash solution of a product containing 0.2% organic catalyst product by weight results in an organic catalyst compound concentration of 6.5 ppm. The method of administration of organic catalyst compounds of the present invention and the method of administration of bleaching compositions (products) containing said organic catalyst compounds which are particularly useful in the methods of the present invention are the organic catalyst compounds and the compositions which contain those which satisfy the preferred method for bleaching a stained substrate in an aqueous medium with a peroxygen source and with an organic catalyst compound whose structures are defined in the present invention and wherein said medium contains active oxygen of the peroxygen compound of the tracer. from 0.05 to about 250 ppm per liter of medium, and said organic catalyst compound from about 0.001 ppm to about 5 ppm, preferably from about 0.01 ppm to about 3 ppm, more preferably from about 0.1 ppm to about 2 ppm. ppm, and with greater preference of about 0.2 ppm to about 1 ppm.
Said preferred method for bleaching a stained substrate in an aqueous medium with a peroxygen source and with an organic catalyst compound is of particular value for those applications wherein the color security of the stained substrate that requires cleaning is at stake. In such applications the preferred embodiment (eg, 0.01 ppm to about 3 ppm) is of particular importance in terms of obtaining acceptable fabric color security. For other applications where the color security of the stained substrate that requires cleaning is less important, it may be preferred to use a higher concentration in use.
Decomposition of organic catalysts Organic catalysts, specifically the bleach-promoting compounds of the present invention are susceptible to decomposition by means of various decomposition routes including, but not limited to, the route of aromatization. The aromatization (decomposition) reaction of 6-membered ring bleach impellers is well known in the art, as exemplified, without being limited by theory, in Hanquet et al., Tetrahedron 1993, 49, p. 423-438 and as it is established later:
f? int? ltt
their means of decomposition include, but are not limited to, attacking the bleach-driving compound and / or in the bleaching species by nucleophiles, including but not limited to attacking by means of hydroxide anion, perhydroxide anion, carboxylate anion, percarboxylate anion and other nucleophiles present under washing conditions. For example, and without being limited by theory, the decomposition reaction of a 6-membered oxaziridinium ring, the general process of which can lead to the reduction of bleaching efficiency, as shown below:
Methods for controlled availability of organic catalysts It has been surprisingly found that an organic catalyst that is available under a controlled availability method as defined in Test Protocols I, II and / or III, as defined below, provides improved bleaching performance. in comparison with an organic catalyst that is available in an uncontrolled availability method as defined in Test Protocols I, II and / or III, as defined below, in the wash solution contained in the fabrics. Any suitable means and / or method for administration of the organic catalysts of the present invention can be used by a controlled availability method as defined in the
Protocol I, II and / or III, as defined below, in accordance with the present invention. The following are non-limiting examples of the means of administration and / or methods that are within the scope of the present invention:
Means of administration A means of administration in accordance with the present invention can be any means which is capable of controlling the availability of an organic catalyst of the present invention such that the organic catalyst is made available in the washing solution by a method of availability. controlled as defined in the Protocols of
Test I, II and / or III, as defined below. Appropriate means of administration include, but are not limited to, adding a controlled release material, such as an encapsulation or agglomerate or other type of controlled release material, containing an organic catalyst of the present invention wherein the release material The controlled catalyst controls the availability of the organic catalyst such that the organic catalyst is made available in the washing solution by a controlled availability method as defined in the Protocol Tests I, II and / or III, as defined below. Preferably, the controlled release material controls the availability of the organic catalyst until after a peroxygen source, if any, has been released and preferably, has had time to perform the bleaching and / or after the fabric has been added to. the washing solution.
Addition of encapsulated organic catalyst As discussed above, another suitable means of administration according to the present invention is to add encapsulated organic catalysts, with or without detergent components to a washing solution, before or after a peroxygen source, if any , it has been added to the washing solution and / or before or after a cloth that requires cleaning has been added to the washing solution. Encapsulated organic catalysts may include, but are not limited to, bleaching compositions containing the organic catalyst of the present invention, wherein the bleaching compositions resist the release of the majority of the amount of the organic catalyst to a wash solution. until after a source of peroxygen, if any, has been released and preferably, has had time to perform the bleaching and / or after the fabric requiring cleaning has been added to the washing solution. For example, if the organic catalyst is added to a wash solution before the addition of a cloth requiring cleaning to the wash solution, then the encapsulated organic catalyst resists the release of the organic catalyst until after the fabric has been added. to the washing solution. Typically, this period is about 2 minutes, more preferably 1 minute, more preferably 1 second to about 10 minutes, preferably 7 minutes, more preferably 5 minutes. However, on rare occasions this period can be up to 24 hours or more. On the other hand, if the encapsulated organic catalysts are added to a wash solution containing a cloth that requires cleaning, then the encapsulated organic catalysts preferably resist the release of the organic catalysts until after any peracid present in the wash solution has performed the bleaching on the fabric. Typically, this period is about 2 minutes, more preferably 1 minute, more preferably 1 second to about 10 minutes, preferably 7 minutes, more preferably 5 minutes. Any suitable encapsulation material known to those skilled in the art can be used. Examples of such encapsulation materials suitable for encapsulating the organic catalyst of the present invention include, but are not limited to microspheres made of plastic, such as thermoplastics, acrylonitrile, methacrylonitrile, polyacrylonitrile, polymethacrylonitrile, and mixtures thereof.; and / or silicon materials such as glass. Microspheres are commercially available from Expancel of Sweden (an Akzo Nobel company) under the trademark EXPANCEL®; PQ Corp. under the trademarks PM 6545, PM 6550, PM 7220, PM 7228, EXTENDOSPHERES®, LUXSIL®, Q-CEL®, SPHERICEL®; and Malinckrodt under the trademark ALBUMEX®. Other suitable encapsulation materials include biopolymers, such as starch and polyethylene glycols and paraffin waxes as described in U.S. Patent No. 5,703,034 to Offshack et al., Owned by The Procter & Gamble Company. Encapsulated organic catalysts comprise one or more organic catalysts of the present invention and optionally may comprise one or more of the following detergent components: filler salts, surfactants, other bleaching agents, enzymes, preferably bleach-stable enzymes, chelators, detergency builders, dye transfer inhibiting agents, perfumes, fabric softening agents, soil release agents, and brighteners. A non-limiting example of an appropriate form for the organic catalyst is a gel capsule.
Agglomerates containing organic catalyst As discussed above, another suitable means of administration according to the present invention is to add an agglomerate containing the organic catalyst of the present invention to a washing solution, before or after a source of peroxygen, if it exists, it has been added to the washing solution and / or before or after a cloth that requires cleaning has been added to the washing solution. The agglomerated organic catalysts may include, but are not limited to, bleaching compositions containing the organic catalyst of the present invention, wherein the bleaching compositions resist the release of the majority of the amount of the organic catalyst to a washing solution. after a source of peroxygen, if any, has been released and preferably, it has had time to perform the bleaching and / or after the fabric requiring cleaning has been added to the washing solution. For example, if the agglomerate containing an amount of an organic catalyst is added to a wash solution before the addition of a cloth requiring cleaning to the wash solution, then the agglomerate resists the release of the organic catalyst until after The fabric has been added to the washing solution. Typically, this period is about 2 minutes, more preferably 1 minute, more preferably 1 second to about 10 minutes, preferably 7 minutes, more preferably 5 minutes. However, on rare occasions this period can be up to 24 hours or more.
On the other hand, if the agglomerate containing an amount of an organic catalyst is added to a wash solution after a cloth that requires cleaning has been added to the wash solution, then the agglomerate preferably resists the release of the organic catalyst until after that any peracid present in the wash solution has performed the bleaching of any stain on the fabric. Typically, this period is about 2 minutes, more preferably 1 minute, more preferably 1 second to about 10 minutes, preferably 7 minutes, more preferably 5 minutes. Any suitable agglomerate material known to those skilled in the art can be used. Examples of agglomeration materials suitable for the agglomeration of organic catalyst of the present invention include, but are not limited to, solids, water-soluble ionizable materials such as organic acids, salts of organic and inorganic acid, and mixtures thereof. Examples of such agglomeration materials are described in U.S. Patent Nos. 5,540,855 to Baillely et al., And 5,482,642 to Agar et al., Both owned by The Procter & Gamble Company. The agglomerates containing the organic catalyst comprise one or more organic catalysts of the present invention and optionally may comprise one or more of the following detergent components: filler salts, surfactants, other bleaching agents, enzymes, preferably bleach-stable enzymes , chelators, detergency builders, dye transfer inhibiting agents, perfumes, fabric softening agents, soil release agents, and brighteners.
Bleaching compositions comprising organic catalyst In addition to the encapsulates and agglomerates discussed above, the organic catalysts of the present invention can be used together with a peroxygen source in other bleaching compositions, regardless of their form. For example, organic catalysts can be used in a laundry additive product. The bleach-reinforcing compounds of the present invention can be used, with or without, preferably with a peroxygen source in a bleaching composition. In the bleaching compositions of the present invention, the peroxygen source can be present at levels of about 0.1% (1 ppm) to about 60%
(600 ppm) by weight of the composition, and preferably about 1%
(10 ppm) to about 40% (400 ppm) by weight of the composition, and the organic catalyst compound can be present from about 0.00001% (0.0001 ppm) to about 10% (100 ppm) by weight of the composition, and preferably from about 0.0001% (0.001 ppm) to about 2% (20 ppm) by weight of the composition, more preferably from about 0.005% (0.05 ppm) to about 0.5% (5 ppm), even more preferably around from 0.01% (0.1 ppm) to approximately 0.2% (2 ppm). Most preferably from about 0.02% (0.2 ppm) to about 0.1% (1 ppm). The conversion values (in ppm) are provided for example purposes, based on a concentration of product in use of 1000 ppm. A 1000 ppm wash solution of a product containing 0.2% organic catalyst compound by weight results in a concentration of organic catalyst compound of 2 ppm. Similarly, a 3500 ppm wash solution of a product containing 0.2% organic catalyst compound by weight results in a concentration of organic catalyst compound of 6.5 ppm. The concentration of preferred bleach-enhancing compounds is based on a molecular weight of the bleach-enhancing compound of about 300 grams / mole, although the bleach-enhancing compounds can preferably have molecular weights of about 150 to 1000 grams / mole, or even higher for oligomeric or polymeric bleach-reinforcing compounds. For example, in the bleaching compositions of the present invention, when the bleach-enhancing compound is more preferably present from about 0.005% (0.05 ppm) to about 0.5% (5 ppm), the molar concentration (M) of the reinforcing compound bleaching will be 1.7 x 10"8 M to 1.7 x 10" 5M). In case of using an organic catalyst compound of higher m.w. in the bleaching compositions of the present invention, the preferred molar concentration will remain unchanged, while the preferred concentration of weight (in ppm) will be increased accordingly. For example, a bleach-enhancing compound with a molecular weight of about 600 grams / mole would be present more preferably from about 0.01% 5 (0.1 ppm) to about 1.0% (10 ppm). For oligomeric or polymeric bleach-enhancing compounds, the most preferred molar concentration will be based on the monomeric unit associated with the active iminium site or
• Oxaziridinium. The method for administration of organic compounds
10 catalysts of the present invention and the means for administration of bleaching compositions (products) containing said organic catalyst compounds which are particularly useful in the methods of the present invention are the organic catalyst compounds and the compositions containing the same which satisfies the preferred method for
15 bleaching a stained substrate in aqueous media with a peroxygen source and with an organic catalyst compound whose structures are defined in the present invention and wherein said medium contains active oxygen of the peroxygen compound from about 0.05 to about 250 ppm by weight. liter of the medium, and said organic catalyst compound of
20 about 0.001 ppm to about 5 ppm, preferably from about 0.01 ppm to about 3 ppm, more preferably from about 0.1 ppm to about 2 ppm, and more preferably from about 0.2 ppm to about 1 ppm.
Said preferred method for bleaching a stained substrate in an aqueous medium with a peroxygen source and with an organic catalyst compound is of particular interest for those applications in which the color security of the stained substrate requiring cleaning is a concern. In these applications the preferred modality (for example, 0.01 ppm to about 3 ppm) is of particular importance in terms of achieving acceptable fabric color safety. For other applications where the color security of the stained substrate requiring cleaning is less concerning, a higher concentration in use may be preferred. The organic catalysts of the present invention particularly useful in the bleaching compositions of the present invention preferably have the ability to be available in a wash solution comprising the bleach compositions containing the organic catalyst by a controlled availability method as defined in Test Protocols I, II and / or III, described later. Organic catalysts can inherently be available in a washing solution containing the organic catalysts by a controlled availability method as defined in Test Protocols I, II and / or III, which are described below. Alternatively, the bleaching compositions containing the organic catalysts can be prepared in such a way that the organic catalysts are available in a washing solution containing the bleaching compositions by a controlled availability method as defined in Test Protocols I, II and / or III, described later. The bleaching compositions of the present invention can be used beneficially in laundry applications, difficult surface cleaning, applications for automatic washing machines, whitening and / or bleaching applications associated with wood pulp and / or textiles, anti-microbial applications and / or disinfectants, as well as cosmetic applications such as dentures, teeth, hair and skin. However, because of the unique advantages of increased effectiveness in lower temperature solutions and superior mitigation of unwanted decompositions of organic catalysts, the organic catalysts of the present invention are ideally suited for laundry applications such as fabric bleaching and / or the bleaching of dyes (for example, inhibition of dye transfer) by the use of bleaching containing detergents or laundry bleach additives. Additionally, the organic catalyst of the present invention can be used in granular, powder, stick, paste, foam, gel and liquid compositions. Accordingly, the bleaching compositions of the present invention may include various additional detergent components that are desired in laundry applications. Such components include, but are not limited to, detersive surfactants, others
.
bleaching agents including other bleach catalysts, detergency builders, chelating agents, enzymes, polymeric soil release agents, brighteners and various other detergent components. Compositions including any of these several additional detergent components preferably have a pH of from about 6 to about 12, more preferably from about 8 to about 10.5 in a 1% solution of the bleaching composition. The bleaching compositions preferably include at least one detersive surfactant, at least one chelating agent, at least one detersive enzyme and preferably have a pH of from about 6 to about 12, more preferably from about 8 to about 10.5 in an aqueous solution. 1% of the bleaching composition. It is desirable that the bleaching composition additionally include a source of peroxygen, as described broadly below. The bleaching composition may also include powder or liquid compositions containing a source of hydrogen peroxide or a source of peroxygen as broadly defined below. If the bleaching composition includes a source of hydrogen peroxide, it is desirable that the laundry additive product further includes a bleach activator, as described broadly below. In another embodiment of the present invention, a method for laundry of a fabric that requires washing is provided. The preferred method comprises contacting the fabric with a laundry solution. The fabric can comprise almost any fabric that can be washed under normal conditions of consumer use. The laundry solution comprises a bleaching composition, as is widely described herein. Water temperatures are preferably from about 0 ° C to about 50 ° C or higher. The water to fabric ratio is preferably from about 1: 1 to about 15: 1. The laundry solution may further include at least one additional detergent component selected from the group consisting of detersive surfactants, other bleaching agents, chelating agents, detersive enzymes and mixtures thereof. Preferably, the laundry solution has a pH of from about 8 to about 10.5 in a 1% solution of the bleaching composition. In accordance with another aspect of the present invention, a laundry additive product is provided. The laundry additive product comprises an organic catalyst, as described extensively above. A laundry additive product as such would ideally be suitable for inclusion in a washing process when additional bleaching effectiveness is desired. Such instances may include, but are not limited to, laundry applications of low temperature solution. The organic catalysts of the present invention particularly useful in the laundry additive products of the present invention preferably have the ability to be available in a
... * t. i i.
washing solution comprising the laundry additive products containing the organic catalysts by a controlled availability method as defined in Test Protocols I, II and / or III, described below. Organic catalysts can inherently be available in a wash solution containing the organic catalysts by a controlled availability method as defined in Test Protocols I, II and / or III, which are described below. Alternatively, the additive products of Laundry containing the organic catalysts can be prepared in such a way that the organic catalysts are available in a washing solution containing the laundry additive products by a controlled availability method as defined in Test Protocols I, II and / or III, described later. It is desirable that the laundry additive products additionally include a source of peroxygen, as described broadly below. The laundry additive products may also include powder or liquid compositions containing a source of hydrogen peroxide or a peroxygen source as broadly defined below. Also, if the laundry additive product includes a source of hydrogen peroxide, it is desirable that the laundry additive product further includes a bleach activator, as described broadly below.
Preferably, the laundry additive product is packaged in dosage form to be added to a laundry process where a peroxygen source is used and an improved bleaching effectiveness is desired. Said single dosage form may comprise a pill, tablet, gelcap or other single dosage unit such as pre-measured powders or liquids. A filler or carrier material may be included to increase the volume of the composition if desired. Suitable fillers or carriers can be selected, but are not limited, from various sulfate, carbonate and silicate salts as well as talc, clay 10 and the like. The fillers or carriers for liquid compositions can be water or low molecular weight primary and secondary alcohols including polyols and diols. Examples include methanol, ethanol, propanol and isopropanol. Monohydric alcohols can also be used. The compositions may contain from about 5% to about 15 90% of said materials. Acidic fillers can be used to reduce the pH. A preferred bleaching composition is a bleaching composition comprising: (a) a bleaching system comprising a source of peroxygen; and (b) an organic catalyst;
wherein the organic catalyst is available in a washing solution containing said bleaching composition by a controlled availability method as defined in Test Protocols I, II and / or III,
Bleaching system In addition to the organic catalyst of the present invention, the bleaching compositions of the present invention preferably comprise a bleaching system. Bleaching systems typically comprise a source of peroxygen. Peroxygen sources are well known in the art and the peroxygen source employed in the present invention can comprise any of these well known sources, including peroxygen compounds as well as compounds that under the conditions of user use provide an effective amount of peroxygen in situ The source of peroxygen may include a source of hydrogen peroxide, the in-situ formation of a peracid anion through the reaction of a source of acid peroxide and a bleach activator, preformed peracid compounds, and mixtures of peroxide sources. peroxygen appropriate. Of course, a person skilled in the art will recognize that other sources of peroxygen can be employed without departing from the scope of the invention. Preferably, the peroxygen source is selected from the group consisting of: (i) preformed peracid compounds are selected from the group consisting of percarboxylic acids and salts, percarbonic acids and salts, perimidic acids and salts, acids and peroxymonosulfuric salts, and mixtures thereof, and (ii) sources of hydrogen peroxide selected from the group consisting of perborate compounds, percarbonate compounds, perphosphate compounds and mixtures thereof, and a bleach activator. When present, the peroxygen sources (peracid and / or hydrogen peroxide sources) will typically be at levels of about 1%, preferably from about 5%, to about 30%, preferably about 20% by weight of the composition. If present, the amount of the bleach activator will typically be about 0.1%, preferably about 0.5% to about 60%, preferably about 40% by weight, of the bleaching composition comprising the bleaching agent plus the bleach activator.
a) Preformed Peracids The preformed peracid compound as used in the present invention is any convenient compound that is stable and that under conditions of consumer use provides an effective amount of peracid anion. Of course, the organic catalysts of the present invention can be used together with a preformed acid compound selected from the group consisting of percarboxylic acids and salts, percarbonic acids and salts, acids and perimidic salts, acids and salts
. ^ aaiM.si peroximonosulfuricos, and mixtures thereof, examples of which are described in U.S. Patent No. 5,576,282 to Miracle et al. A class of suitable organic peroxycarboxylic acids have the general formula: # II Y-R-C-O-OH
wherein R is a substituted alkylene or alkylene group containing from 1 to about 22 carbon atoms or a substituted phenylene or phenylene group, and Y is hydrogen, halogen, alkyl, aryl, -C (O) OH or -C ( O) OOH. Organic peroxyacids suitable for use in the present invention may contain either one or two peroxy groups and may be aliphatic or aromatic. When an organic peroxycarboxylic acid is aliphatic, the unsubstituted peracid has the general formula:
II Y- (CH2) n-C-O-OH wherein Y may be, for example, H, CH3, CH2CI, C (O) OH, or C (O) OOH; and n is an integer from 0 to 20. When the peroxycarboxylic acid is aromatic, the unsubstituted peracid has the general formula:
where Y can be hydrogen, alkyl, alkylhalogen, halogen, C (O) OH or C (O) OOH. The monoperoxy acids useful in the present invention include alkyl and aryl peroxyacids such as: (i) peroxybenzoic acid and substituted ring peroxybenzoic acid, for example, peroxy-a-naphthoic acid, monoperoxyphthalic acid (magnesium salt hexahydrate), and acid or -carboxybenzamidoperoxyhexanoic (sodium salt); 5 (ii) aliphatic, substituted aliphatic, and arylalkyl monoperoxy acids, for example, peroxylauric acid, peroxystearic acid, N-nonanoylaminoperoxycaproic acid (NAPCA), N, N- (3-octylsuccinoyl) aminoperoxycaproic acid (SAPA) and N, N- acid phthaloylaminoperoxycaproic. 10 (PAP); (iii) amidoperoxyacids, for example, monononylamide of peroxysuccinic acid (NAPSA) or peroxyadipic acid (NAPAA). Typical diperoxy acids useful in the present invention include diperoxy acids and aryldiperoxy acids such as: (iv) 1,2-diperoxydecanedioic acid; (v) 1,9-diperoxyazelaic acid; (vi) diperoxybrassilic acid; diperoxysebacic acid and diperoxyisophthalic acid; (vii) 2-decyliperoxybutane-1,4-dioic acid; 20 (viii) 4,4'-sulfonylbisperoxybenzoic acid. Such bleaching agents are described in U.S. Patent 4,483,781, Hartman, issued November 20, 20, 1984, U.S. Patent 4,634,551 to Burns et al., European Patent Application 0,133,354,
Jtfím¿ilf? '. A & -. Ét ± j &B J Banks et al. Published on February 20, 1985, and US Patent 4,412,934, Chung et al., Issued November 1, 1983. Sources also include 6-nonylamino-6-oxoperoxycaproic acid as broadly described in US Patent 4,634,551, issued on January 6, 1987 to Burns et al. Persulfate compounds such as for example OXONE, manufactured commercially by E.l. DuPont de Nemours of Wilmington, DE can also be employed as an appropriate source of peroxymonosulfuric acid.
b) Sources of hydrogen peroxide The source of hydrogen peroxide can be any source of hydrogen peroxide and be present at said levels as widely described in US patent 5,576,282. For example, the source of hydrogen peroxide can be selected from the group consisting of perborate compounds, percarbonate compounds, perphosphate compounds and mixtures thereof. The sources of hydrogen peroxide are described in detail in Kirk Othmer, Encyclopedia of Chemical Technology, 4th Ed (1992, John Wiley &Sons), Vol. 271-300"Bleaching Agents (Survey)", and include the various forms of sodium perborate and sodium percarbonate, including various coated and modified forms. The preferred source of hydrogen peroxide used herein may be any convenient source, including the same
..to? A hydrogen peroxide. For example, perborate, for example, can be used in the present sodium perborate (any hydrate but preferably the mono- or tetrahydrate), sodium carbonate peroxyhydrate or equivalent percarbonate salts, sodium pyrophosphate peroxyhydrate, urea 5 peroxyhydrate, sodium peroxide. Sources of available oxygen such as persulfate bleaching (e.g., OXONE, manufactured by DuPont) are also useful. Particularly, sodium perborate monohydrate and sodium percarbonate are preferred. Mixtures of any convenient source of hydrogen peroxide can also be used. A preferred percarbonate bleach comprises dry particles having an average particle size ranging from about 500 micrometers to about 1,000 micrometers, not more than about 10% by weight of said particles being less than about 200 micrometers. micrometers and not more than about 10% by weight of said particles that
15 are larger than about 1, 250 micrometers. Optionally, the percarbonate can be coated with a silicate, borate or water-soluble surfactants. Percarbonate is available from various commercial sources such as FMC, Solvay and Tokai Denka. The compositions of the present invention can also
To understand as the bleaching agent a chlorine-type bleaching material. Such agents are well known in the art, and include for example sodium dichloroisocyanurate ("NaDCC"). However, chlorine bleaches are less preferred for compositions comprising enzymes.
b) Bleach activators Preferably, the peroxygen source in the composition is formulated with an activator (peracid precursor). The activator is present at levels of about 0.01%, preferably about 0.5%, more preferably about 1% to about 15%, preferably about 10%, more preferably about 8%, by weight of the composition. A bleach activator as used in the present invention is a compound that when used in conjunction with a source of hydrogen peroxide leads to the in-situ production of the peracid
10 corresponding to the bleach activator. Various non-limiting examples of activators are widely described in U.S. Patent No. 5,576,282, U.S. Patent 4,915,854 and U.S. Patent 4,412,934. See also US 4,634,551 for other typical bleaches and activators useful in the present invention. The activators are selected from the group consisting of tetraacetyl ethylene diamine (TAED), benzoylcaprolactam (BzCL),
4-Nitrobenzoylcaprolactam, 3-chlorobenzoylcaprolactam, benzoyloxybenzenesulfonate (BOBS), nonanoyloxybenzenesulfonate (NOBS), phenylbenzoate (PhBz), decanoyloxybenzenesulfonate (C10-OBS),
Benzoylvalerolactam (BZVL), octanoyloxybenzenesulfonate (Ce-OBS), perhydrolyzable esters and mixtures thereof, most preferably benzoylcaprolactam and benzoylvalerolactam. Particularly preferred bleach activators in the pH range of about 8 to
approximately 9.5 are those selected that have a group of residual OBS or VL. Preferred hydrophobic bleach activators include, but are not limited to, nonanoyloxybenzenesulfonate (NOBS), 4- (N- (nonanoyl) amino hexanoyloyl-benzenesulfonate sodium salt (HACA-OBS), an example thereof is described in U.S. Patent No. 5,523,434, lauroyloxybenzenesulfonate, (LOBS or C? 2-OBS), 10-undecenoyloxybenzenesulfonate (UDOBS or Cn-OBS with unsaturation at position 10), and decanoyloxybenzoic acid (DOBA). Preferred bleach activators are those described in US Pat. No. 5,698,504 Christie et al., Issued December 16, 1997; USA 5,695,679 Christie et al. issued on December 9, 1997; US 5,686,401 Willey et al., Issued November 11, 1997; USA 5,686,014 Hartshom et al., Issued November 11, 1997; USA 5,405,412 Willey
15 et al., Issued April 11, 1995; US 5,405,413 Willey et al., Issued April 11, 1995; US 5,130,045 Mitchel et al., Issued July 14, 1992; and US 4,412,934 Chung et al., issued November 1, 1983, and co-pending US patent applications of series Nos. 08 / 709,072, 08 / 064,564, all are incorporated herein by reference. • 20 The mole ratio of the peroxygen bleaching compound
(as AvO) with the bleach activator in the present invention is generally at least 1: 1, preferably around 20: 1, more
preferably from about 10: 1 to about 1: 1, preferably at about 3: 1. The substituted quaternary bleach activators can also be included. The bleaching compositions present preferably comprise a substituted quaternary bleach activator (QSBA) or a substituted quaternary peracid (QSP), more preferably the above. Preferred QSBA structures are further described in US 5,686,015 Willey et al., Issued November 11, 1997.; US 5,654,421 Taylor et al., Issued August 5, 1997; US 5,460,747 Gosselink et al., Issued October 24, 1995; US 5,584,888 Miracle et al., Issued December 17, 1996; and US 5,578,136 Taylor et al., issued November 26, 1996; all are incorporated in the present invention by reference. Highly preferred bleach activators useful herein are amide-substituted as described in US 5,698,504, US 5,695,679, and US 5,686,014 each of which are recited herein. Preferred examples of said bleach activators include: (6-octanamidocaproyl) oxybenzenesulfonate,
(6-nonanamidocaproyl) oxybenzenesulfonate, (6-decanamido caproyl) oxybenzenesulfonate and mixtures thereof. Other useful activators, described in US 5,698,504, US 5,695,679, US 5,686,014 each of which is cited herein above and US 4,966,723 Hodge et al., Issued October 30, 1990, include benzoxazine activators, such as a ring of C6H4, to which a portion of -C (O.}. OC (R) = N- is melted in the positions 1,2, depending on the activator and specific application, good bleaching results of the bleaching systems can be obtained having a pH in use of from about 6 to about 13, preferably from about 9.0 to about 10.5 Typically, for example, activators with electron extraction portions are used for pH ranges close to neutral or sub-neutral. Alkalis and retarding agents can be used to ensure said pH Acyl lactam activators, as described in the USA
5,698,504, US 5,695,679 and US 5,686,014, each of which is cited in the present above, are very useful here, especially the acyl caprolactams (see for example WO 94-28102 A) and acyl valerolactams (see EUA 5,503,639 Willey et al. , issued April 2, 1996 incorporated herein by reference).
d) Organic peroxides, especially diacyl peroxides In addition to the bleaching agents described above, the bleaching compositions of the present invention can optionally include organic peroxides. Organic peroxides are amply illustrated in Kirk Othmer, Encyclopedia of Chemical Technology, Vol. 17, John Wiley and Sons, 1982 on pages 27-90 and especially on pages 63-72, all incorporated herein by reference. If a diacyl peroxide is used, it will preferably be one that exerts minimal adverse impact on staining / film formation.
e) Metal containing bleach catalysts Bleaching compositions may also optionally include metal-containing bleach catalysts, preferably manganese and bleach catalysts containing cobalt. One type of metal-containing bleach catalyst is a catalyst system comprising a transition metal cation of defined bleach catalytic activity, such as copper, iron, titanium, ruthenium tungsten, molybdenum, or manganese cations, a auxiliary metal cation having little or no catalytic bleaching activity, such as zinc or aluminum cations, and a sequestering material having defined stability constants for the catalytic and auxiliary metal cations, particularly ethylenediaminetetraacetic acid, ethylenediaminetetra (methylene phosphonic acid) ) and water-soluble salts thereof. Said catalysts are described in US 4,430,243 Bragg, issued February 2, 1982.
20 i.) Manganese metal complexes If desired, the compositions herein can be catalyzed by a manganese compound. Such compounds and levels of use are well known in the art and include, for example,
mjn ^^ * ..
manganese-based catalysts described in US 5,576,282 Miracle et al., issued November 19, 1996; US 5,246,621 Favre et al., Issued September 21, 1993; US 5,244,594 Favre et al., Issued September 14, 1993; USA 5,194,416 Jureller et al., Issued March 16, 5, 1993; US 5,114,606 van Vliet et al., Issued May 19, 1992; and European Patent Applications Pub. Nos. 549,271 A1, 549,272 A1, 544,440 A2, and 544,490 A1; Preferred examples of these catalysts -f include Mnlv2 (u-O) 3 (1, 4,7-trimethyl-1,4,7-triazacyclononane) 2. (PF6) 2,
Mn "l2 (uO)? (U-OAc) 2 (1, 4,7-trimethyl-1, 4,7-triazacyclononane) 2 (CI04) 2, 10 MnN4 (uO) 6 (1, 4,7 -triazacyclononane) 4 (C104) 4, Mnl "MnIV4 (uO) 1 (u-OAc) 2- (1, 4,7-trimethyl-1, 4,7-triazacyclononane) 2 (CI04) 3, Mnlv ( 1, 4,7-trimethyl-1, 4,7-triazacyclononane) - (OCH 3) 3 (PFe), and mixtures thereof. Other metal-based bleach catalysts include those described in US 4,430,243, included above by reference herein and
15 US 5,114,611 van Kralingen, issued May 19, 1992. The use of manganese with several complex ligands to improve bleaching is also described in the following Regek 4,728,455, issued March 1, 1988; US 5,284,944 Madison, issued February 8, 1994; US 5,246,612 van Dijk et al., Issued September 21, 1993; USA
• 20 5,256,779 Kerschner et al., Issued October 26, 2993; US 5,280,117 Kerschner et al., Issued January 18, 1994; US 5,274,147 Kerschner et al., Issued December 28, 1993; USA 5,153,161 Kerschner et al., Issued October 6, 1992; US 5,227,084 Martens et al., Issued July 13, 1993.
ii) Cobalt metal complexes The cobalt bleach catalysts herein are known and described, for example, in US 5,597,936 Perkins et al., issued January 28, 1997; US 5,595,967 Miracle et al., January 21, 1997; US 5,703,030 Perkins et al., Issued December 30, 1997; and M. L. Tobe, "Base Hydrolysis of Transition-Metal Complexes", Adv. Inorg. Bioinorg. Mech., (1983), 2, pages 1-94. More preferred cobalt catalysts useful herein are salts of cobalt pentaaminacetate having the formula [Co (NH3) 5OAc] Ty, wherein "OAc" represents an acetate portion and "Ty" is an anion, and especially chloride of cobalt pentaaminacetate [Co (NH3) 5OAc] CI2; as well as [Co (NH3) 5OAc] (OAc) 2; [Co (NH3) 5OAc] (PF6) 2; [Co (NH3) 5OAc] (SO4); [Co (NH3) 5OAc] (BF4) 2; and [Co (NH3) 5OAc] (NO3) 2 (in the present "CAP"). These cobalt catalysts are easily prepared by known processes, such as those shown for example in US 5,597,936, US 5,595,967, US 5,703,030, cited hereinbefore, Tobe article and references therein, and US Patent 4,810,410, Diakun et al, issued March 7, 1989, J. Chem. Ed. (1989), 66 (12), 1043-45; The Synthesis and Characterization of Inorganic Compounds, W.L. Jolly (Prentice-Hall, 1970), pp. 461-3; Inorg. Chern., 18,
í. . & m e X-a ^ -f t 1497-1502 (1979); Inorg. Chem., 21, 2881-2885 (1982); Inorg. Chem., 18, 2023-2025 (1979); Inorg. Synthesis, 173-176 (1960); and Journal of Physical Chemistry, 56. 22-25 (1952).
iii) Transition metal complexes of macropolycyclic rigid liquids The compositions herein may also appropriately include as bleach catalyst a transition metal complex of a macropolycyclic rigid ligand. The phrase "macropolicíclico rigid ligand" is abbreviated "MRL" in some occasions as it is analyzed below. The amount used is an effective amount in a catalytic form, suitably about 1 ppb or more, for example up to about 99.9%, more typically about 0.001 ppm or more, preferably from about 0.05 ppm to about 500 ppm (in where "ppb" denotes parts per billion in weight and "ppm" denotes parts per million in weight). Appropriate transition materials for example MN are illustrated below. "Macropolycyclic" means an MRL that is a macrocycle and is polycyclic. "Polycyclic" means at least bicyclic. The term "rigid" as used in the present invention includes "having a superstructure" and "cross bridge". "Rigid" has been defined as the restricted inverse of flexibility, see D.H. Busch., Chemical Reviews., (1993), 23, 847-864, incorporated by reference. More particularly, "rigid" as used in the present invention means that the MRL must be determinably stiffer than a macrocycle ("macrocycle base") that is otherwise identical (having the same size and type of ring and number of atoms in the main ring) but lacking a superstructure (especially link portions or, preferably, cross bridge portions) found in MRL. In determining the comparative stiffness of macrocycles with and without superstructures, the practitioner will use the free form (not the metal union shape) of the macrocycles. Rigidity is well known to be useful when comparing macrocycles; Appropriate tools for determining, measuring or comparing stiffness include computational methods (see, for example, Zimmer, Chemical Reviews, (1995), 95 (38), 2629-2648 or Hancock et al., Inorganic Chimica Acta, (1989) , 164, 73-84 The preferred MRLs in the present invention are a special type of ultra-rigid cross-bridge ligands.A "cross-bridge" is illustrated non-limitingly in 1.11 below. is a portion of -CH2CH2.Connects N1 and N8 in the illustrative structure.For comparison, a bridge "on the same side" for example to be introduced one between N1 and N12 in 1.11, would not be enough to constitute a "cross bridge" and accordingly, it would not be preferred The appropriate metals in the complexes of rigid ligands include Mn (ll), Mn (lll), Mn (IV), Mn (V), Fe (ll), Fe (lll), Fe ( IV), Co (l), Co (ll), Co (lll), Ni (l), Ni (ll), Nl (lll), Cu (l), Cu (ll), Cu (lll), Cr ( ll), Cr (lll), Cr (IV), Cr (V), Cr (VI), V (ll) l), V (IV), V (V), Mo (IV), Mo (V), Mo (VI), W (IV), W (V), W (VI), Pd (ll), Ru ( ll), Ru (lll), and Ru (IV). Preferred transition metals in the instant transition metal bleach catalyst include manganese, iron and chromium. More generally, the MRLs (and the corresponding transition metal catalysts) in the present invention comprise, appropriately: (a) at least one macrocycle main ring comprising four or more heteroatoms; and (b) a non-metallic superstructure covalently connected capable of increasing the stiffness of the macrocycle, preferably selected from (i) a bridge structure, such as a linking portion; (i) a cross bridge superstructure, such as a cross bridge link portion; and (iii) combinations thereof. The term "superstructure" is used in the present invention as defined in the literature by Busch et al., See, for example, the articles by Busch in "Chemical Reviews". The preferred superstructures herein not only improve the stiffness of the base macrocycle, but also favor the bending of the macrocycle to coordinate a metal in a crack. The appropriate superstructures may be extraordinarily simple, for example, a link portion such as any of those illustrated in Formula A and Formula B may be used below.
Formula A wherein n is an integer, for example 2 to 8, preferably less than 6, typically 2 to 4, or
Formula B
wherein m and n are integers of about 1 to 8, more preferably of about 1 to 3; Z is N or CH; and T is a compatible substitute, for example,
H, alkyl, trialkylammonium, halogen, nitro, sulfonate, or the like. The aromatic ring in 1.10 can be replaced by a saturated ring, in which the atom in Z that is connected to the ring can contain N; O, S or c. The appropriate MRLs are further illustrated in non-limiting manner by the following compound:
Formula C This is an MRL according to the present invention which is highly preferred, cross-linked, substituted methyl (all tertiary nitrogen atoms) derivative of cyclam. Formally, this ligand is called 5,12-dimethyl-1, 5,8,12-tetraazabicyclo [6.6.2] hexadecane using the extended von Baeyer system. See "A Guide to lUPAC Nomenclature of Organic Compounds: Recommendations 1993", R. Panic, W.H. Powell and J-C Richer (Eds.), Blackwell Scientific Publications, Boston, 1993; see especially section R-2.4.2.1. Metal transition bleach catalysts of macrocyclic rigid ligands which are suitable for use in the compositions of the invention can generally include known compounds where they conform to the definition herein, as well as, more preferably, any of a large number of new compounds expressly designated by the present laundry or washing uses, and are illustrated in a non-limiting manner by any of the following: Dichloro-5,12-dimethyl-1, 5,8,12-tetraazabicyclo [6.6.2] hexadecane Manganese (H) Diacuo-5,12-dimethyl-1, 5,8,12-tetraazabicyclo [6.6.2] hexadecane Manganese (ll) Hexafluorophosphate Acuo-hydroxy-5,12-dimethyl-1, 5,8,12- tetraazabicyclo [6.6.2] hexadecane Manganese (lll) Hexafluorophosphate
Diacuo-5,12-dimethyl-1, 5,8,12-tetraazabicyclo [6.6.2] hexadecane Manganese (M) Tetrafluoroborate Dichloro-5,12-dimethyl-1, 5,8,12-tetraazabicyclo [6.6.2] hexadecane Manganese (lll) Hexafluorophosphate Dichloro-5,12-di-n-butyl-1, 5,8,12-tetraaza bicyclo [6.6.2] hexadecane Manganese (ll)
Dichloro-5,12-dibenzyl-1, 5,8,12-tetraazabicyclo [6.6.2] hexadecane Manganese (II) Dichloro-5-n-butyl-12-methyl-1, 5,8,12-tetraaza-bicyclo [6.6.2] hexadecane Manganese (II) Dicyoro-5-n-octyl-12-methyl-1, 5,8; 12-tetraaza-bicyclo [6.6.2] hexadecane Manganese (II) Dichloro-5-n-butyl-12-methyl-1, 5,8,12-tetmaza-bicyclo [6.6.2] hexadecane Manganese (II). As a practical matter, and not as a limitation, the cleaning compositions and processes herein can be adjusted to provide in the order of at least one part per one hundred million active bleach catalyst species in the aqueous wash medium , and preferably will provide from about 0.01 ppm to about 25 ppm, more preferably from about 0.05 ppm to about 10 ppm, and most preferably from about 0.1 ppm to about 5 ppm, of the bleach catalyst species in the solution of washed. To obtain such levels in the washing solution of an automatic washing process, typical compositions of the present invention will comprise from about 0.0005% to about 0.2%, more preferably from about 0.004% to about 0.08%, of the bleaching catalyst , especially manganese or cobalt catalysts, by weight of the cleaning compositions.
Preferably, the sources of peroxygen are selected from the hydrogen peroxide sources selected from the group consisting of perborate compounds, percarbonate compounds, perphosphate compounds and mixtures thereof, and a bleach activator. Preferably, the bleach activator is selected from the group consisting of hydrophobic bleach activators as described herein. The purpose of said bleaching composition is to mitigate the undesired decomposition of the organic catalyst, and to allow the peracid to achieve the bleaching performance in a fabric that requires cleaning, such as a stained fabric, in a washing solution prior to the availability of the bleach. organic catalyst.
Detergent Compounds While not essential for the purposes of the present invention, several conventional auxiliaries illustrated below are suitable for use in instant bleach compositions and can be desirably incorporated into preferred embodiments of the invention, for example, to aid or improve the cleaning performance, for treating the substrate to be cleaned, or for modifying the aesthetics of the bleaching compositions as is the case with perfumes, colorants, dyes or the like. The precise nature of these additional compounds, and the levels of incorporation therein, will depend on the physical form of the composition and the nature of the cleaning operation for which it is to be used. Unless otherwise indicated, the bleaching compositions of the invention can be formulated, for example, in granular or powdered form for all "heavy duty" laundry uses or detergents, especially laundry detergents; washing agents in the form of gel or liquid for all uses, especially so-called heavy duty liquid types; liquid detergents for fine fabrics; hand-washing agents or light-duty cleaning agents, especially those of the high foam type; washing machine agents, including the various types in tablet, granulate, liquid and rinse aid for domestic and institutional use; liquid cleaning and disinfecting agents, including antibacterial handwashing types, laundry bars, mouthwashes, denture cleaners, shampoo for car or carpet, bathroom cleaners, hair shampoo and hair scrubbers; bath gel and foams for bath and metal cleaners; as well as cleaning aids such as bleach additives and "stick for stains or pre-treatment types.
Surfactants Preferably, the bleaching compositions according to the present invention comprise a surfactant or surfactant system wherein the surfactant may be selected from nonionic and / or anionic surfactants and / or cationic and / or ampholytic surfactants. and / or of amphoteric ion and / or semi-polar nonionic surfactants. The surfactant is typically present at a level of about 0.1%, preferably about 1%, more preferably about 5% by weight of the bleaching compositions at about 99.9%, preferably at about 80%, more preferably to about 35%, most preferably to about 30% by weight of the bleaching compositions. The surfactant can be nonionic, anionic, ampholytic,
10 of amphoteric or cationic ion. Mixtures thereof can also be used. Preferred bleaching compositions comprise anionic surfactants or mixtures of anionic surfactants with
• other surfactants, especially nonionic surfactants. The surfactant is preferably formulated to be
15 compatible with the enzyme compounds present in the composition. In liquid or gel compositions the surfactant is most preferably formulated in a manner that promotes, or at least does not degrade, the stability of any enzyme in these compositions. Non-limiting examples of suitable surfactants do not
• 20 ionic, anionic, cationic, ampholytic, amphoteric and non-ionic semi-polar ionics are described in US Patent Nos. 5,707,950 and 5,576,282. Additional examples of suitable surfactants can be found in McCutcheon, EMULSIFIERS AND DETERGENTS, North Edition
,.,. . .-- - -. .. - *. t t l America, 1997, McCutcheon Division, MC Publishing Company, in US Patents Nos. 3,929,678 and 4,259,217; in the series "Surfactant Science", Marcel Dekker, Inc., New York and Basel; in "Handbook of Surfactants", M.R Porter, Chapman and Hall, 2nd Ed., 1994; in "Sufactants in Consumer Products", Ed. J. Falbe, Springer-Verlag, 1987; and "Surface Active Agents and Detergents" (Vol. I and II by Schwartz, Perry and Berch). Highly preferred nonionic surfactants are polyhydroxy fatty acid surfactants of the formula: R2-C (O) -N (R1) -Z, wherein: R1 is H, or R1 is Cr, 2-hydroxyethyl hydrocarbyl, -hydroxypropyl, or a mixture thereof, R2 is C5-31 hydrocarbyl, and Z is a polyhydroxyhydrocarbyl having a straight hydrocarbyl chain with at least 3 hydroxyls directly connected to the chain, or an alkoxylated derivative thereof. Preferably, R1 is methyl, R2 is Cn.15 alkyl or C16-18 alkyl or straight chain alkenyl such as coconut alkyl and mixtures thereof and Z is a derivative of a reducing sugar such as glucose, fructose, maltose, lactose, in a reductive amination reaction. Highly preferred surfactants include alkoxylated alkylsulphate surfactants of which are water-soluble salts or acids of the formula RO (A) mSO3M wherein R is a hydroxyalkyl group or C10-C24 alkyl unsubstituted with an alkyl compound of C? O-C2, preferably a hydroxyalkyl or C 2 -C 2 alkyl, more preferably a hydroxyalkyl or C 2 -C 18 alkyl, A is an ethoxy or propoxy unit, m is greater than zero, typically between about 0.5 and about 6, more preferably between about 0.5 and about 3, and M is H or a cation which may be, for example, a metal cation (eg, sodium, potassium, lithium, calcium, magnesium, etc.), substituted ammonium cation or ammonium. The ethoxylated alkyl sulfates as well as the propoxylated alkyl sulphates are contemplated herein. When included, the bleaching compositions, especially laundry detergent compositions, of the present invention typically comprise from about 1%, more preferably 10% from about 3% by weight of said anionic surfactant to about 40%, more preferably a about 20% by weight of said anionic agents. Highly preferred cationic surfactants are the water-soluble quaternary ammonium compounds useful in the present composition with the formula: wherein Ri is CQ-CIQ alkyl, each R2, R3 and R4 is independently CrC alkyl, C1-C4 hydroxyalkyl, benzyl and - (C2H or) xH where x has a value of 2 to 5, and X is an anion. No more than one of R2, R3 or R4 should be
20 benzyl. When included, the bleaching compositions of the present invention typically comprise about 0.2%, more preferably about 1% by weight of said surfactants
tat? titfbaft -A. J J-I cationic at about 25%, more preferably at about
8% by weight of said cationic surfactants. When included, the bleaching compositions of the present invention typically comprise from about 0.2%, more preferably from about 1% by weight of said ampholytic surfactants to about 15%, more preferably to about
10% by weight of said ampholytic surfactants. When included, the bleaching compositions of the present invention typically comprise from about 0.2%, more preferably from about 1% by weight of said amphoteric ion surfactants to about 15%, more preferably to about 10% by weight. of said amphoteric ion surfactants. When included, the bleaching compositions of the present invention typically comprise from about 0.2%, more preferably from about 1% by weight of said semi-polar nonionic surfactants to about 15%, more preferably to about 10% by weight of said semi-polar nonionic surfactants. The bleaching compositions of the present invention may also comprise from about 0.001% to about
100% of one or more (preferably a mixture of one or more) agents
t ít ^ h ^. Sflrta ^ Aa? medium chain branched surfactants, preferably medium chain branched alkylalkoxy alcohols having the formula:
the medium chain branched alkyl sulphates have the formula:
And the medium chain branched alkoxy alkyl sulfates have the formula:
wherein the total number of carbon atoms in the primary branched alkyl portion of these formulas (including the branches R, R1 and
R2, but not including the carbon atoms comprising any alkoxy portion EO / PO), is from 14 to 20, and wherein in addition to this mixture of surfactant the total average number of carbon atoms in the primary alkyl portions Branched having the above formula is within the range of not greater than 14.5 to about 17.5 (preferably from
20 about 15 to about 17); R, R1 and R2 are independently selected from hydrogen, CrC3 alkyl, and mixtures thereof, preferably methyl; provided that R, R1 and R2 are not all hydrogen and, when z is 1, at least R or R1 is not hydrogen. M is a water-soluble cation
and may comprise more than one type of cation, for example, a mixture of sodium and potassium. The index w is an integer from 0 to 13; x is an integer from 0 to 13; and is an integer from 0 to 13; z is an integer of at least 1; provided that w + x + y + z is from 8 to 14. EO and PO represent ethyleneoxy units and propyleneoxy units having the formula:
respectively, however, other alkoxy units among them are 1,3-propyleneoxy, butoxy, and mixtures thereof as alkoxy units adhered to the middle chain branched alkyl portions. The medium chain branched surfactants are preferably mixtures comprising a surfactant system. Therefore, when the surfactant system comprises an alkoxylated surfactant, the m-index indicates the average degree of alkoxylation within the mixture of the surfactants. As such, the index m is at least about 0.01, preferably within the range of about 0.1, more preferably about 0.5, most preferably from about 1 to about 30, preferably to about 10, more preferably to about 5. When considering a medium chain branched surfactant system comprising only alkoxylated surfactants, the value of the index m represents a distribution of the average degree of alkoxylation corresponding to m, or it can be a single specific chain with alkoxylation (for example, ethoxylation and / or propoxylation) of exactly the number of units corresponding to m. Preferred medium chain surfactants of the present invention which are suitable for use in the surfactant systems of the present invention have the formula:
or the formula:
where a, b, d, and e are integers to which a + b is from 10 to 16 and d + e is from 8 to 14; M is selected from sodium, potassium, magnesium, ammonium and substituted ammonium and mixtures thereof. The surfactant systems of the present invention comprising medium chain branched surfactants are preferably formulated in two modalities. A first preferred embodiment comprises medium chain branched surfactants which are formed from a feedstock comprising 25% or less of medium chain branched alkyl units. Therefore, prior to mixing with any other conventional surfactant, the medium chain branched surfactant compound will comprise 25% or less of the surfactant molecules which are non-linear surfactants.
A second preferred embodiment comprises medium chain branched surfactants which are formed from a feedstock comprising from about 25% to about 70% of medium chain branched alkyl units. Therefore, before mixing with any other conventional surfactant, the medium chain branched surfactant compound will comprise from about 25% to about 70% of the surfactant molecules which are non-linear surfactants. The surfactant systems of the bleaching compositions of the present invention may also comprise from about 0.001%, preferably from about 1%, more preferably from about 5%, most preferably from about 10% to about 100%, preferably at about 60%, more preferably at about 30% by weight, the surfactant system, one or more (preferably a mixture of two or more) medium chain branched alkyl arisulfonate surfactants, preferably surfactants wherein the unit Aryl is a benzene ring that has the formula:
4 - . -Aaai wherein L is an acyclic hydrocarbyl portion comprising from 6 to 18 carbon atoms; R1, R2, and R3 are each independently hydrogen or CrC3 alkyl, provided that R1 and R2 do not adhere to the term of unit L; M is a water-soluble cation that has a charge q where a and b are taken together to satisfy the charge neutrality.
Additional detergent compounds The following are non-limiting examples of additional detergent compounds (auxiliary ingredients) useful in the bleaching compositions, especially laundry detergent compositions, of the present invention, said auxiliary ingredients include builders, optical brighteners, release polymers, dirt, dye transfer agents, dispersants, enzymes, suds suppressors, perfumes, dyes, filler salts, hydrotropes, photoactivators, fluorescers, fabric conditioners, hydrolyzable surfactants, preservatives, anti-oxidants, chelators, stabilizers, anti-aging agents -grippers, anti-wrinkle agents, germicides, fungicides, anti-corrosion agents, and mixtures thereof.
Detergency builders The bleaching compositions of the present invention preferably comprise one or more detergency builders or builder systems. When present, the compositions will typically comprise at least about 0.1% builder, preferably about 5%, more preferably about 10% to about 80%, preferably about 50%, more preferably about 5%. % by weight of the detergency builder. The level of the builder can vary widely depending on the final use of the composition and its desired physical form.
• When present, the compositions will typically comprise at least about 1% of the detergency builder. The formulations
Typically they will comprise from about 5% to about 50%, more typically from about 5% to about 30%, by weight, of the builder. Granulated formulations typically
• 'will comprise from about 10% to about 80%, more typically from about 15% to about 50%, by weight, of the
15 detergency builder. Lower or higher levels of the detergency builder, however, does not mean that they will be excluded. Inorganic or P-containing builders include, but are not limited to, alkali metal, ammonium and alkanolammonium salts of polyphosphates (exemplified by tripolyphosphates,
• 20 pyrophosphates, and vitreous polymeric meta-phosphates), phosphonates, phytic acid, silicates, carbonates (including bicarbonates and sesquicarbonates), sulphates, and aluminosilicates. However, non-phosphate builders are required in some locations. Importantly, the compositions in the present invention function surprisingly well even in the presence of so-called "weak" builders (as compared to phosphates) such as citrate, or in the so-called "under construction" situation that can occur with zeolite or 5 layered silicate builders. Examples of silicate builders are alkali metal silicates, particularly those having an SiO 2: Na 2 O ratio in the range of 1.6: 1 to 3.2: 1 and layered silicates, such as the layered sodium silicates described in 4,664,839 Rieck, issued on May 12, 1987. NaSKS-6 is the trademark for a crystalline layered silicate marketed by Hoechst (commonly abbreviated herein as "SKS-6"). Unlike zeolite builders, the Na SKS-6 silicate builder does not contain aluminum. NaSKS-6 has the shape of laye-Na2SiOs silicate morphology in layers. It can be prepared by 15 methods such as those described in German documents DE-A-3,417,649 and DE-A-3, 742,043. SKS-6 is a highly preferred layered silicate for use herein, but other layered silicates may be used, such as those having the general formula and H 2 O wherein M is a sodium or hydrogen, x is a number of 1.9 to 4, preferably 2, and y is
20 a number from 0 to 20, preferably 0. Several other layered silicates of Hoechst include NaSKS-5, NaSKS-7 and NaSKS-11, such as the alpha, beta and gamma forms. As noted above, the delta-Na2Si? 5 form (NaSKS-6 form) is more preferred for use herein. Other silicates can also
vrf? n?? iiMÍi, ^ iai¡ Míiítr "i?,? r '» ...., ...? ..,? ^: ~? ........, ,, ". .,. &.;.. * "• -,.? ^ ^ ^,.
be useful such as for example magnesium silicates, which can serve as a contrast enhancing agent in granulated formulations, as a stabilizing agent for oxygen bleach, and a compound of suppression control systems. Examples of carbonate builders are alkaline earth metal carbonates and alkali metal carbonates as described in German Patent Application No. 2,321,001 published November 15, 1973. Aluminosilicate builders are useful in the present invention. Aluminosilicate builders are of great importance in most commercial heavy duty granular detergent compositions, and can also be an important detergent builder ingredient in liquid detergent formulations. The aluminosilicate builders include those that have the empirical formula: [Mz (ZAIO2)?] XH2O where z and y are integers of at least 6, the molar ratio of zay is in the range of 1.0 to about 0.5, and x is a whole from about 15 to about 265. Useful aluminosilicate ion exchange materials are available. These aluminosilicates can be crystalline or amorphous in structure and can be naturally occurring aluminosilicates or synthetically derived. A method for producing aluminosilicate ion exchange materials is described in US 3,985,669, Krummel et al,
SaSa issued October 12, 1976. Synthetic crystalline aluminosilicate ion exchange materials are available under the designations Zeolite A, Zeolite P (B), Zeolite MAP and Zeolite X. In an especially preferred embodiment, the material of crystalline aluminosilicate ion exchange has the formula: Na? 2 [(AIO2) 12 (SiO2) 12] xH2O where x is from about 20 to about 30, especially about 27. This material is known as Zeolite A. Dehydrated zeolites (x = 0 -10) can also be used. Preferably, the
The aluminosilicate has a particle size of about 0.1-10 microns in diameter. Organic builders suitable for the purposes of the present invention include, but are not limited to, a wide variety of polycarboxylate compounds. As used herein, "poly carboxylate" refers to compounds having a plurality of carboxylate groups, preferably at least 3 carboxylates. The polycarboxylate builder can generally be added to the composition in acid form, but it can also be added in the form of a neutralized salt. When used in the form of salt, the
20 alkali metals, such as sodium, potassium and lithium, or alkanolammonium salts. Included among the polycarboxylate builders are a variety of useful material categories. An important category of polycarboxylate builders covers the
r. & * > The r polycarboxylates, including oxydisuccinate, as described in US 3,128,287 Berg, issued April 7, 1964, US 3,635,830 Lamberti et al., Issued January 18, 1972, and US 3,936,448 Lamberti, issued February 3, 1976. See also "TMS / TDS" detergency builders of US 4,663,071 Bush et al., issued May 5, 1987. Suitable r polycarboxylates also include cyclic compounds, particularly compounds alicyclics, such as those described in 3,923,679 Rapko, issued December 2, 1975; US 4,158,635 Crutchfield et al., issued June 19, 1979; US 4,120,874 Crutchfield et al., issued October 17, 1978; and US 4,102,903 Crutchfield et al., Issued July 25, 1978. Other useful builders include r hydroxypolycarboxylates, copolymers of maleic anhydride with lene or vinylml r, 1,3,5-trihydroxy benzene-2,4, 6-hydroxy-polycarboxylate. -trisulfonic, and carboxymloxysuccinic acid, the various alkali metals, ammonium and substituted ammonium salts of polyacetic acid such as lenediamine tetraacetic acid and nitrilotriacetic acid, as well as polycarboxylates such as melific acid, succinic acid, oxydisuccinic acid, polymaleic acid, benzene acid 1, 3, 5-tricarboxylic, carboxymloxysuccinic acid, and soluble salts thereof. Citrate builders, for example, citric acid and soluble salts thereof (particularly sodium salt) are polycarboxylate builders of particular importance for heavy-duty detergent formulations because of their availability of renewable resources and their biodegradability. The citrates can also be used in granular compositions, especially in combination with zeolite and / or silicate layer improvers. Oxydisuccinates are also especially useful in said compositions and combinations. Also suitable in the bleaching compositions of the present invention are the 3,3-dicarboxy-4-oxa-1,6-hexanedioates and the relative compounds described in US Pat. No. 4,566,984, Bush, issued January 28, 1986. Useful succinic acid detergents include succinic Cs-C2o alkyl and alkenyl acids and salts thereof. A preferred compound of this type is dodecenylsuccinic acid. Specific examples of succinate builders include: lauryl succinate, myristylsuccinate, palmitylsuccinate, 2-dodecenylsuccinate (preferred), 2-pentadecenylsuccinate, and the like. Lauryl succinates are the preferred builders of this group, and are described in European patent application 86200690.5 / 0,200,263, published November 5, 1986. Other suitable examples of polycarboxylates are described in 4,144,226, Crutchfield et al., Issued April 13, 1986. of March of 1979 and in the USA 3,308,067, Diehl, issued on March 7, 1967.-See also Diehl patent US 3,723,322. Fatty acids, for example, C12-C18 monocarboxylic acids, can also be incorporated into the compositions alone or in combination with the aforementioned builders, especially the citrate and / or succinate builders, to provide the activity of additional detergency builder. Such use of fatty acids will generally result in a decrease in suppression, which should be taken into account by the formulator. In situations where phosphorus-based builders can be used, and especially in the formulation of bars used for hand-washing operations, the various alkali metal phosphates, such as the well-known sodium tripolyphosphates, sodium pyrophosphate can be used. and sodium orthophosphate. Phosphonate builders such as ethane-1-hydroxy-1,1-diphosphonate and other known phosphonates can also be used (see, for example, patents 3,159,581; 3,213,030; 3,422,021; 3,400,148 and 3,422,137).
Guelaator Agents The bleach compositions of the present invention may also optionally contain one or more iron and / or manganese chelating agents. Such chelating agents can be selected from the group consisting of aminocarboxylates, aminophosphonates, poly-functionally substituted aromatic chelating agents and mixtures thereof, all as defined below. Without being limited by theory, it is believed that the benefit of these materials is due in part to their exceptional ability to remove iron and manganese ions from the wash solutions by forming soluble chelates. Suitable examples of such chelating agents and levels of use are described in U.S. Patent Nos. 5,576,282 and 5,728,671. A preferred biodegradable chelator for use herein is ethylene diamine disuccinate ("EDDS"), especially [S, S] isomer as described in the 4,704,233 patent, November 3, 1987, a
• Hartman and Perkins. The compositions herein may also contain methylglycedacetic acid (MGDA) salts (or acid form) as a burner or co-builder useful, for example, with insoluble builders such as zeolites, layered silicates and the like.
• 'If used, these chelating agents will generally comprise from about 0.1% by weight of the bleach compositions herein to about 15%, more preferably 3.0% by weight of the bleaching compositions herein.
Dye transfer inhibiting agents The bleaching compositions of the present invention
20 may also include one or more compounds, dye transfer inhibiting agents, to inhibit the transfer of dye from one fabric to another of solubilized and suspended dyes found during
Í. Í, A? < í Washing and conditioning operations of fabrics that involve colored fabrics. Suitable dye transfer inhibiting agents include, but are not limited to, polyvinylpyrrolidone polymers, polyamine 5 N-oxide polymers, copolymers of N-vinylpyrrolidone and N-vinylimidazole, polyvinyloxazolidones and polyvinylimidazoles or mixtures thereof. Examples of said dye transfer inhibiting agents are described in the patents Nos. 5,707,950 and 5,707,951. Additional dye transfer inhibiting agents include, but are not limited to,
10 cross-linked polymers. Interlaced polymers are polymers whose base structures are interconnected to a certain degree, these bonds can be of a chemical or physical nature, possibly with active groups in the base structure or in branches. Interlaced polymers have been described in the Journal of Polymer Science,
15 volume 22, pages 1035-1039. In one embodiment, the entangled polymers are made in such a way that they form a rigid three-dimensional structure, which can trap dyes in the pores formed by the three-dimensional structure. In another embodiment, the entangled polymers trap dyes by
20 swelling. Interlaced polymers are described in co-pending European patent application 94870213.9.
Additions of said polymers also improve the performance of the enzymes within the bleaching compositions herein. The dye transfer inhibiting agents have the ability to or adsorb dyes out of dye fabrics before the dyes have the opportunity to adhere to other articles in the wash. When present in the washing compositions herein, the dye transfer inhibiting agents are present at levels of about 0.0001%, more preferably about 0.01%, most preferably about 0.05% by weight of the compositions of the invention. bleaching at about 10%, more preferably at about 2%, most preferably at about 1% by weight of the detergent compositions.
Dispersants The bleaching compositions of the present invention may also contain dispersants. Suitable water-soluble organic salts are homo- or co-polymeric acids or their salts, in which the polycarboxylic acid comprises at least two carboxyl radicals separated from one another by not more than two carbon atoms. Polymers of this type are described in GB-A-1, 596,756. Examples of such salts are polyacrylates of MW 2000-5000 and their copolymers with maleic anhydride, said copolymers have a molecular weight of 1,000 to 100,000. Especially, acrylate and methacrylate copolymers such as 480N have a molecular weight of 4000, at a level of 0.5-20% by weight of the composition, which can be added in the detergent compositions of the present invention. The compositions of the invention may contain a lime soap peptide compound, which has a lime soap dispersion power (LSDP), as defined herein below, not greater than 8, preferably not greater than 7, more preferably not greater than 6. The lime soap peptide compound is preferably present at a level of 0% to 20% by weight. A numerical measure of the effectiveness of the lime soap peptide is provided by the dispersing power of lime soap (LSDP) 15 which is determined using the lime soap dispersant test as described in an article by H.C. Borghetty and C.A. Bergman, J. Am. Oil. Chem. Soc, volume 27, pages 88-90, (1950). This lime soap dispersion test method is widely used by practitioners in this field of the art to which, for example, in the following journal articles refers; W.N. Linfield, Surfactant science Series, Volume 7, page 3; W.N. Linfield, Tenside surf, det., Volume 27, pages 159-163, (1990); and M.K. Nagarajan, W.F. Masler, Cosmetics and Toiletries, volume 104, pages 71-73, (1989). The LSDP is the weight ratio in% of the
K ifáAm t -, a »- ^ 4444.4. .. - - ^ - • - - - .- »• -.« -, -. .. . ^ A- »«. * .- ** sodium oleate dispersing agent required to disperse lime soap deposits formed by 0.025g of sodium oleate in 30ml of water
333ppm CaC03 (Ca: Mg = 3: 2) equivalent hardness. Surfactants having a good capacity for the lime soap peptide will include certain amine oxides, betaines, sulfobetaines, alkyl ethoxy sulfates and ethoxylated alcohols. Exemplary surface active agents having an LSDP of not more than 8 for use in accordance with the present invention include dimethylamine oxide of C-iß-C-iß, C? 2-C? Alkyl alkylcytoxy sulfates with an average degree of ethoxylation of 1-5, particularly the C-2-C-5 alkylcytoxysulfate surfactant with a degree of ethoxylation of amount 3
(LSDP = 4), and ethoxylated C14-C15 alcohols with an average degree of ethoxylation of either 12 (LSDP = 6) or 30, which are sold under the tradenames Lutensol A012 and Lutensol A030 respectively, by BASF GmbH . Polymer lime soap peptizers suitable for use herein are described in the article by M.K. Nagarajan, W.F.
Masler, found in Cosmetics and Toiletries, volume 104, pages
71-73, (1989). Hydrophobic bleaches such as
4- [N-octanoyl-6-aminohexanoyl] benzenesulfonate, 4- [N-nonanoyl-6-aminonoxanoyl] benzenesulfonate, 4- [N-decanoyl-6-aminohexanoyl] benzenesulfonate and mixtures thereof; Y
atA *, *. TO.
Nonanoyloxybenzenesulfonate together with hydrophilic / hydrophobic bleach formulations can also be used as lime soap peptide compounds.
Enzymes Bleaching compositions may comprise in addition to the amylase of the present invention one or more detergent enzymes that provide cleaning performance and / or fabric care benefits. Said enzymes may include proteases, amylases, cellulases, and lipases. HE
10 can incorporate in the non-aqueous liquid bleaching compositions in the present invention in the form of suspensions, "granules or pellets". Another suitable type of enzyme comprises those in the form of suspensions of
• enzymes in nonionic surfactants, for example enzymes marketed by Novo Nordisk under the trade name "SL" or
15 microencapsulated enzymes marketed by Novo Nordisk under the name "LDP." The proper enzymes and levels of use are described in the USA. Pat. No. 5,576,282. Enzymes that are added to the compositions in the present invention in the form of conventional enzyme granules are especially
Preferred for use in the present invention. Said granules will generally vary in size from about 100 to 1000 microns, more preferably from about 200 to 800 microns and will be suspended throughout the entire non-aqueous liquid phase of the composition. The granules in the compositions of the present invention have been found, in comparison with other forms of enzymes, which exhibit especially desirable enzyme stability in terms of retention of enzymatic activity over time. Therefore, compositions using enzyme granules need not contain a conventional enzyme stabilizer as is most often used when the enzymes are incorporated in aqueous liquid detergents. Examples of suitable enzymes include, but are not limited to, hemicellulases, peroxidases, proteases, cellulases, xylanases, lipases, phospholipases, esterases, cutinases, pectinases, keratanases, reductases, oxidases, phenoloxidases, lipoxygenases, ligninases, pullulanases, tanases, pentosanas, malanases, ß-glucanases, arabinosidases, hyaluronidase, chondroitinase, laccase, and known amylases, or mixtures thereof. A preferred combination is a bleaching composition having a mixture of conventional applicable enzymes such as protease, lipase, cutinase and / or cellulase together with the amylase of the present invention. Examples of such suitable enzymes are described in U.S. Patent Nos. 5,576,282, 5,728,671 and 5,707,950. Suitable proteases are the subtilisins that are obtained from particular strains of B. subtilis and B. licheniformis (subtilisin BPN and BPN '). A suitable protease is obtained from the Bacillus strain, with a maximum activity across the pH range of 8-12, which is developed and sold as EXPECTATIONS by Novo Industries A / S of Denmark, in the
. . jta ^ &.-? a successive "Novo". The preparation of this enzyme and analogous enzymes is described in GB 1, 243,784 to Novo. Other suitable proteases include ALCALASE®, DURAZYM® and SAVINASE® from Novo and MAXATASE®, MAXACAL®, PROPERASE® and MAXAPEM® (genetically engineered protein Maxacal) from Gist-Brocades. Proteolytic enzymes also encompass modified bacterial serine protease, such as those described in European Patent Application Serial No. 87 303761.8, filed on April 28, 1987 (particularly pages 17, 24 and 98), and which is called in the present invention "Protease B", and in the European patent application 199,404, Venegas, published on October 29, 1986, which refers to a modified bacterial serine proteolytic enzyme which is called "Protease A" in the present invention. What is most preferred is the enzyme which is referred to herein as "Protease C", which is a variant of an alkaline serine protease from Bacillus in which lysine is replaced by arginine at position 27, tyrosine replaces Valine at position 104, serine replaces paragina at position 123 and the amine replaces creonine at position 274. Protease C is described in EP 90915958: 4, corresponding to WO 91/06637, published May 16, 1991. the genetically modified variants are included in the present invention in particular that of Protease C, see also a high pH protease from the Bacillus sp. NCIMB 40338 which is described in WO 93/18140 A to Novo. Enzymatic detergents comprise protease, one or more different enzymes, and a reversible protease inhibitor which is described in WO 92/03529 A to Novo. When desired, a protease that has decreased absorption and increased hydrolysis is available as described in WO 95/07791 to Procter & amp;; Gamble. A recombinant trypsin-like protease for the detergents suitable herein is described in WO 94/25583 to Novo. In more detail, the protease referred to as "Protease D" is a variant of carbonylhydrolase having a sequence of amino acids that are not found in nature, which is derived from a precursor carbonylhydrolase by substituting a different amino acid for a plurality of residues of amino acids at the position in said carbonylhydrolase equivalent to the position +76, more preferably also in combination with one or more positions of amino acid residues equivalent to those selected from the group consisting of +99, +101, +103, +104, +107, +123, +27, +105, +109, +126, +128, +135, +156, +166, +195, +197, +204, +206, +210, +216, +217 , +218, +222, +260, +265, and / or +274 according to the numeration of the subtilisin Bacillus amyloliquefacfens, as described in WO 95/10615 published April 20, 1995 by Genencor International. Also suitable for the present invention are the proteases described in patent applications EP 251 446 and W091 / 06637 and the BLAP® protease described in W091 / 02792. The proteolytic enzymes are incorporated in the bleaching compositions of the present invention at a level of from 0.0001% to 2%, preferably from 0.001% to 0.2%, more preferably from 0.005% to 0.1% pure enzyme by weight of the composition .
Useful proteases are also described in PCT publications: WO 95/30010 published November 9, 1995 by The Procter & Gamble Company; WO 95/30011 published November 9, 1995 by The Procter & Gamble Company; WO 95/29979 published November 9, 1995 by The Procter & Gamble Company. Other particularly useful proteases are multiple-substituted protease variants comprising a substitution of an amino acid residue with another amino acid residue that occurs naturally at an amino acid residue position corresponding to position 103 of the subtilisin Bacilus amyloliquefaciens in combination with a substitution of an amino acid residue with another amino acid residue that thus occurs naturally, in one or more amino acid residue positions corresponding to positions 1, 3, 4, 8, 9, 10, 12, 13, 16, 17, 18, 19, 20, 21, 22, 24, 27, 33, 37, 38, 42, 43, 48, 55, 57, 58, 61, 62, 68, 72, 75, 76, 77, 78, 79, 86, 87, 89, 97, 98, 99, 101, 102, 104, 106, 107, 109, 111, 114, 116, 117, 119, 121, 123, 126, 128, 130, 131, 133, 134, 137, 140, 141, 142, 146, 147, 158, 159, 160, 166, 167, 170, 173, 174, 177, 181, 182, 183, 184, 185, 188, 192, 194, 198, 203, 204, 205, 206, 209, 210, 211, 212, 213, 214, 215, 216 , 217, 218, 222, 224, 227, 228, 230, 232, 236, 237, 238, 240, 242, 243, 244, 245, 246, 247, 248, 249, 251, 252, 253, 254, 255 , 256, 257, 258, 259, 260, 261, 262, 263, 265, 268, 269, 270, 271, 272, 274 and 275 of the subtilisin Bacillus amyloliquefaciens; wherein each said protease variant includes a substitution of amino acid residues in the positions
, ttt A tf &h ^. * afc corresponding to positions 27, 99, 101, 104, 107, 109, 123, 128, 166, 204, 206, 210, 216, 217, 218, 222, 260, 265 or 274 of the subtilisin Bacillus amyloliquefaciens there is also a substitution of an amino acid residue at one or more amino acid residue positions different from the amino acid residue positions corresponding to positions 62, 212, 230, 232, 252 and 257 of the subtilisin Bacillus amyloliquefaciens and / or multiple-substituted protease variants comprising a substitution of a residue of one amino acid with another amino acid residue that occurs naturally at one or more amino acid residue positions corresponding to positions 27, 99, 101 , 104, 107, 109, 123, 128, 166, 204, 206, 210, 216, 217, 218, 222, 260, 265 or 274 of the subtilisin Bacillus amyloliquefaciens as described in PCT patent publication Nos. WO 99 / 20727, WO 99/20726 and WO 99120723 all filed on October 23 Tubre, 1998 by The Procter & Gamble Company. More preferably, the protease variant includes a substitution set selected from the group consisting of: 12176110311041130/222/245/261; 621103110411591232/236/245/248/252; 62/1031104/159/2131232/23612451248/252; 621101/10311041159/212/21312321236/24512481252; 68/1031104/159/232/236/245; 681103/104/159123012321236/245; 68/103/1041159120912321236/245;
68/103/104/15912321236/245/257; 68176/1031104/15912131232/2361245/260; 681103/104/159/21312321236/2451248/252; 6811031104/1591183/2321236/2451248/252; 5 681103110411591 185123212361245/2481252; 68/103/104/15911851210/232123612451248/252; 68/103/104/159121012321236/245/2481252; 68/103/104/159/213/232/236/245; 981103/1041159/232/236/245/248/252; 10 98/102/103/1041159/212/232/236/245/248/252; 101/103/104115912321236/245/2481252; 102110311041159/23212361245/2481252; 10311041159/2301236/245; 103/104/1591232/236/245/248/252; 15 103/104/1591217/2321236/245/2481252; 103/104/1301159/232/236/24512481252; 103/1041131/1591232/23612451248/252; 1031104/159/2131232123612451248/252; and ^ 103110411591232/2361245. More preferably, the protease variant includes a substitution set selected from the group consisting of: 12R / 76D1103A / 104T / 130TI222S / 245RI261 D; 62DI103A / 1041 / 159D / 232V / 236H / 245R 248D / 252K;
tii * s kAi? Aí¡ & a & tr * ¿> ® £ - < 8"- ^ • 62D1103A / 1 OLI / 159DI213R / 232V / 236H / 245R / 248D / 252K; 68AI103A / 1041 / 159D / 209W / 232V / 236H / 245R; 68A 76DI103A / 10411159D / 213R / 232V / 236H / 245R / 260A; 68A1103A / 1041 / 159D / 213E / 232V / 2361 - / 245R / 248D / 252K; 5 68A / 103A / 1041 / 159D / 183D / 232VI236H / 245R / 248D / 252K; 68A / 103A / 1041 / 159D / 232V / 236H / 245R; 68A / 103A / 10411159D / 230V / 232V / 236H / 245R; 68A / 103A / 1041 / 159D / 232V / 236H / 245R / 257V; 68A / 103A / 10411159D / 213G / 232V / 236H / 245R / 248D / 252K; 10 68A / 103A / 1041 / 159D / 185D / 232VI236H / 245R / 248DI252K; 68A / 103A / 10411159D / 185D / 21 OL / 232VI236W245R / 248D / 252K; 68A 103A / 1041 / 159D / 210L 232V / 236H / 245RI248D / 252K 68A / 103A11041 / 159D / 213G / 232V / 236H / 245R; 98L / 103A / 1041 I159D / 232V / 236H / 245R / 248D / 252K; 15 98L / 102A / 103A / 1041 / 159DI212G / 232V / 236H / 245R / 248D / 252K; 101 G / 103A / 1041 / 159DI232VI236HI245R / 248D1252K; 102A / 103A / 10411159D / 232V / 236H / 245R / 248D / 252K; 68/103/104/159/213/232/236/245; 981103/1041159 / 232/236/245/248/252; 20 98/102/103/1041159/212/232/236/245/248/252; 101/103/104115912321236/245/2481252; 10211031104 1159/23212361245/2481252; 10311041159/2301236/245;
rirffalfilftBiiW't 'frtíiiinif - -4, t -, J .. i ^ 103/104/1591232/236/245/248/252; 103/104/1591217/2321236/245/2481252; 103/104/1301159/232/236/24512481252; 103/1041131/1591232/23612451248/252; 5 1031104/159/2131232123612451248/252; and 103110411591232/2361245. More preferably, the protease variant includes the substitution group 101/103/104/159/232 / 236/245/248/252, preferably IOIG / 103A / 1041 / 159D / 232V / 236H / 245R 248D / 252K. Cellulases that can be used in the present invention include both bacterial and fungal cellulase. Preferably, they will have an optimum pH between 5 and 9.5. Suitable cellulases are described in U.S. Patent 4,435,307, Barbesgoard et al, which describes fungic cellulase produced from Humicola. Suitable cellulases are also described in 15 GB-A-2,075,028; GB-A-2,095,275 and DE-OS-2,247,832. Among the examples of said cellulases are the cellulases produced by a strain of Humicola, particularly the strain. { Humicola grísea var. thermoidea), Humicola DSM 1800. Other suitable cellulases with cellulases that are originated
20 from Humicola having a molecular weight of about 50KDa, an isoelectric point of 5.5 and containing 415 amino acids; and an endoglucanase -43kD derived from Humicola, DSM 1800, with cellulase activity; a preferred endoglucanase component has the sequence of
amino acids that is described in PCT patent application No. WO 91/17243. Also suitable cellulases are EGIII cellulases from Trichoderma longibrachiatun which is described in W094 / 21801, Genencor, published September 29, 1994. Cellulases suitable especially are cellulases which have color care benefits. Examples of said cellulases are the cellulases which are described in the application and European patent No. 91202879.2, filed on September 6, 1991 (Novo). Carezyme and Celluzyme (Novo Nordisk A / S) are especially useful. See also W091 / 17243. Peroxidase enzymes are known in the art and include, for example, horseradish peroxidase, ligninase and haloperoxidase such as chlorine and bromoperoxidase. Peroxidase-containing bleaching compositions are described, for example, in U.S. Patent No. 5,576,282, 5,728,671 and 5,707,950, PCT International Applications WO 89/099813, W089 / 09813 and in European Patent Application No. 91202882.6, filed. on November 6, 1991 and EP No. 96870013.8, filed on February 20, 1996. The enzyme laccase is also suitable. Preferred enhancers are phenoxyzine and substituted phenoxyphene 10-phenothiazinepropionic acid (PPT), acid
10-ethylphenothiazine-4-carboxylic acid (EPC), 10-phenoxazinopropionic acid (POP) and 10-methylphenoxazine (described in WO 94/12621) and substituted syringates (substituted C3-Cs alkyl syringates) and phenols. Sodium percarbonate or perborate are preferred sources of hydrogen peroxide. Said peroxidases are normally incorporated in the bleaching composition at levels of 0.0001% to 2% of the active enzyme by weight of the bleaching composition. Other preferred enzymes that may be included in the bleaching compositions of the present invention include lipases. The lipase enzymes suitable for use in detergents include those produced by microorganisms of the Pseudomonas group, such as Pseudomonas stuyzeri ATCC 19,154, as described in British Patent 1, 372,034. Suitable lipases include those which show a positive immunological reverse reaction with the lipase antibody, produced by the microorganism Pseudomonas fuorescent IAM 1057. This lipase is available from Amano Pharmaceutical Co. Ltd., Nagoya, Japan, under the trade name Lipase P "Amano," which in the following is referred to as "Amano P". Other suitable commercial lipases include Amano-CES, lipases ex Chromobacter viscosum, for example Chromobacter viscosum var. lipolyticum NRRLB 3673 from Toyo Jozo Co., Tagata, Japan; Chromobacter viscosum lipases from the USA. Biochemical Corp., U.S.A. and Disoynth Co., The Netherlands, and lipases ex Pseudomonas gladioli. Especially suitable lipases are lipases such as Ml LIPASE® and LIPOMAX® (Gist-Brocades) and LIPOLASE © and LIPOLASE ULTRA © (Novo) same as
.- ». * - have been found effective when used in combination with the compositions of the present invention. Also suitable are cutinases [EC 3.1.1.50] that can be considered as a special class of lipase, mainly lipases that do not require interfacial activation. The addition of cutinase to the bleaching compositions described in WO 88109367 has been described
(Genencor). Said peroxidases are normally incorporated in the bleaching composition at levels of 0.0001% to 2% of the active enzyme by weight of the composition. The known amylases (a and / or 13) can be included for the removal of spots based on carbohydrate. WO 94/02597, Novo Nordisk A / S published on February 3, 1994, describes cleaning compositions incorporating mutant amylases. See also W094 / 18314, Genencor, published August 18, 1994 and W095110603, Novo Nordisk A / S, published April 20, 1995. Other amylases known for use in bleaching compositions include both a- and [beta] -amylases. α-Amylases are known in the art and include those described in the EUA patent. 5,003,257; EP 252,666; WO 91100353; FR 2,676,456; EP 285,123; EP 525,610; EP 368,341; and in the detailed description of British Patent No. 1, 296,839 (Novo). Another suitable amylase would be the amylase with increased stability including PURAFACT OX AM® which is described in WO 94/18314, published August 18, 1994 and W096 / 05295, Genencor,
. »^? published on February 22, 1996 and the amylase variants of Novo Nordisk AIS, which are described in WO 95/10603, published in April at 95. Examples of commercial α-amylases products are TERMAMYL ©, BAN®, FUNGAMYL © and DURAMYL ©, all of them available from Novo Nordisk AIS Denmark. Describes other suitable amylase: W095 / 26397: α-amylases characterized by having a specific activity at least 25% higher than the specific activity of TERMAMYL® at a temperature range of 25 ° C to 55 ° C and at a pH value on the scale of 8 to 10, measured by the Phadebas © a-amylase activity test. Other amylolytic enzymes with improved properties with respect to the level of activity and the combination of thermostability at a higher activity level are described in W095 / 35382. The compositions of the present invention may also comprise a mannanase enzyme. preferably, mannanase is selected from the group consisting of: three mannan degrading enzymes:
EC -3.2.1.25: P-mannosidase, EC 3.2.1.78: Endo-1, 4-P-mannosidase, which is referred to herein after as "mannanase" and EC 3.2.1.100: 1,4-P-mannosybose and mixtures thereof. (LUPAC Classification - Enzyme Nomenclature, 1992 ISBN 0-12-227165-3 Academic Press). More preferably, the treatment compositions of the present invention, when a mannanase is present, comprise a [3-1, 4-Mannosidase (E.C. 3.2.1.78) which is referred to as Mannanase. The term "mannanase" or "galactomannanase" refers to a mannanase enzyme that is defined according to the art as a name that has been officially labeled as endo-1, 4-beta-mannosidase and has the alternative names of beta-mannanase and endo-1, 4-mananase and catalyses in the reaction: random hydrolysis of 1, 4-beta-D-mannosidics which are unions in mannans, galactomannans, glucomannans, and galactoglucomannans. In particular, mannanases (EC 3.2.1.78) constitute a group of polysaccharides that degrade mannans and denote enzymes that have the ability to cut poly chains containing mannose units, that is, they have the ability to cut glycosidic bonds and manones,, glucomannans, galactomannans and galactoglucomannans. The mannans are polysaccharides that have a base structure composed of mannose linked to β-1, 4-; glucomannans and polysaccharides that have a base structure more or less regularly alternating bound mañosa (3-1, 4 and glucose; galactomannans and galactoglucomannans are mannans and glucomannans with a lateral branches of galactaso linked to-1, 6. These compounds can be acetylated. The degradation of galactomannans and galactoglucomannans is facilitated by the total or partial removal of the galactose side chains. In addition, the degradation of mannans, glucomannans, galactomannans and acetylated galactoglucomannans is facilitated by their total or partial diacetylation. The acetyl groups can be removed by mannacetylstearases or alkaline. The oligomers that are released from the mannanases or by a combination of mannanases and α-galactosidase and / or mananacetyl esters can also be degraded to release free maltose by means of P-mannosidase and / or O-glucosidase. Mannanases have been identified in several Bacillus organisms. For example, Talbot et al., Appl. Environ. Microbiol., Vol.56, No. 11, pp. 3505-3510 (1990) describes a beta-mannanase derived from Bacillus stearothermophilus in dimeric form (o) having a molecular weight of 162 kDa and an optimum pH of 5.5-7.5. Mendoza et al., World J. Microbiol. Biotech., Vol. 10, No. 5, pp. 551-555 (1994) describes a beta-mannanase derived from Bacillus subtilis having a molecular weight of 38 kDa, an optimal activity of pH 5.0 and 55C and a pl of 4.8. JP-03047076 describes a beta-mannanase derived from Bacillus sp., Which has a measured molecular weight of 373 kDa or gel filtration, an optimum pH of 8-10 and a pl of 5.3-5.4. JP-63056289 describes the production of an alkaline, thermostable beta-mannanase that hydrolyzes the beta-1,4-D-mannopyranoside bonds for example mannans and produces hand-oligosaccharides. JP-63036774 refers to the microorganisms Bacillus FERM P-8856 which produces beta-mannanase and beta-mannosidase at an alkaline pH. JP-08051975 describes alkaline beta-mannanases from the alkalilic Bacillus sp. AM-001 species. A mannanase purified from Bacillus amyloliquefaciens useful in the bleaching of paper and pulp and the method of preparation thereof is described in WO 97/11164. WO 91/18974 describes a hemicellulase such as glucanase, xylanase or mannanase active at an extreme pH and extreme temperature. WO 94/25576 describes an enzyme from Aspergillus aculeatus, CBS 101.43, exhibits mannanase activity which may be useful for the degradation or modification of cell or plant or algal wall material. WO 93/24622 describes a mannanase isolated from Trichoderma reseei useful for the bleaching of lignocellulosic pulps. A hemicellulase capable of degrading hemicellulose containing mannan is described in W091 / 18974 and the mannanase purified from Bacillus amyloliquefaciens is described in W097 / 11164. Preferably, the mannanase enzyme will be an alkaline mannanase as defined below, more preferably, a mannanase originating from a bacterial source. Especially, the composition
The laundry detergent of the present invention will comprise an alkaline mannanase selected from the mannanase from the strain Bacillus subtilis NICMB 40482; mannanase from strain 168 of Bacillus subtilis,
• of the yght gene; mannanase from the 1633 species of Bacillus sp. AA112 from Bacillus. The most preferred mannanase for inclusion in
The detergent compositions of the present invention is the mannanase enzyme which originates from Bacillus species 1633 as described in co-pending Danish patent application No. PA 1998 01340. The terms "mannanase alkaline enzyme" means that it encompasses an enzyme which has an enzymatic activity of at least 10%,
• preference of at least 25%, more preferably at least 40% of its maximum activity at a given pH ranging from 7 to 12, preferably 7.5 to 10.5.
Alkaline mannanase from Bacillus agaradhaerens NICMB 40482 is described in co-pending US patent application No. 09/111, 256. Very specifically, this mannanase is: i) A polypeptide produced by Bacillus agaradhaerens, NCIMB 40482; or ii) a polypeptide comprising an amino acid sequence as shown in positions 32-343 of SEQ ID NO: 2 as shown in U.S. Patent Application Serial No. 09/111, 256; or iii) an analogue of the polypeptide defined in i) or ii) that is at least 70% homologous with said polypeptide, or is derived from said polypeptide by substitution, injury or addition of one or more amino acids, or is immunologically reactive with a polyclonal antibody raised against said polypeptide in purified form. Also encompassed is the corresponding isolated polypeptide having mannanase activity selects the group consisting of: (a) polynucleotide molecules encoding a polypeptide having mannanase activity and comprising a nucleotide sequence as shown in SEQ ID NO: 1 from nucleotide 97 to nucleotide 1029 as shown in U.S. Patent Application Serial No. 09/111, 256; (b) homologous species of (a); (c) polynucleotide molecules encoding a polypeptide having mannanase activity that is at least 70% identical to the amino acid sequence of SEQ ID NO: 2 of amino acid residue 32 to amino acid residue 343 as shown in the patent application USA Serial No. 09/111, 256; (d) Molecules complementary to (a), (b) or (c); and (e) degenerate nucleotide sequences of (a), (b), (c) or (d). Plasmid pSJ1678 comprising the polynucleotide molecule (the DNA sequence) encoding said mannanase has been transformed into a strain of Escherichia coli which was deposited by the inventors in accordance with the Budapest Treaty in the international recognition of the deposit of microorganisms for the purposes of patent procedures in the Deutsche Sammiung von Mikroorganismen und Zellkulturen GmbH, Mascheroder Weg Ib, D-38124 Braunschweig, Federal Republic of Germany, on May 18, 1998 under deposit No. DSM 12180. The second most preferred enzyme is the mannanase from Strain 168 of Bacillus subtifs, which is described in the co-pending US patent application Serial No. 09 / 095,163. Very specifically, mannanase is: i) encoded by the coding part of the DNA sequence shown in SED ID No. 5 which is shown in U.S. Patent Application Serial No. 09 / 095,163 or an analogue of said sequence and / or ii) a polypeptide comprising an amino acid sequence as shown in SEQ ID NO: 6 as shown in U.S. Patent Application Serial No. 09 / 095,163; or iii) an analogue of the polypeptide defined in ii) which is at least
70% homologue with said polypeptide, or is derived from said polypeptide by substitution, injury or addition of one or several amino acids, or is immunologically reactive with a polyclonal antibody raised against said polypeptide in purified form. Also encompassed is the corresponding isolated polypeptide having mannanase activity selected from the group consisting of: (a) polynucleotide molecules encoding a polypeptide having mannanase activity and comprising a nucleotide sequence as shown in SEQ ID NO: 5 and as shows in the EUA patent application Serial No. 09 / 095,163 (b) homologous species of (a); (c) polynucleotide molecules encoding a polypeptide having mannanase activity that is at least 70% identical to the amino acid sequence of SEQ ID NO: 6 as shown in U.S. Patent Application Serial No. 09 / 095,163; (d) Molecules complementary to (a), (b) or (c); and (e) degenerate nucleotide sequences of (a), (b), (c) or (d). The third most preferred enzyme is mannanase which is described in Danish co-pending patent application Serial No. PA 1998 01340. Very specifically, mannanase is: i) A polypeptide produced by Bacillus sp. 1633; 1633;
ii) a polypeptide comprising an amino acid sequence as shown in positions 33-340 of SEQ ID N0: 2 as shown in Danish patent application Serial No. PA 1998 01340; or iii) an analogue of the polypeptide defined in i) or i) that is at least 65% homologous with said polypeptide, or is derived from said polypeptide by substitution, injury or addition of one or more amino acids, or is immunologically reactive with a polyclonal antibody raised against said polypeptide in purified form. Also encompassed is the corresponding isolated polynucleotide molecule selected from the group consisting of: (a) polynucleotide molecules encoding a polypeptide having mannanase activity and comprising a nucleotide sequence as shown in SEQ ID NO: 1 from nucleotide 317 to the nucleotide 1243 as shown in the Danish patent application Serial No. PA 1998 01340; (b) homologous species of (a); (c) polynucleotide molecules that encode a polypeptide having mannanase activity that is at least 65% identical to the amino acid sequence of SEQ ID NO: 2 of amino acid residue 33 to amino acid residue 340 as shown in the patent application Danish Serial No. PA 1998 01340; (d) Molecules complementary to (a), (b) or (c); and (e) degenerate nucleotide sequences of (a), (b), (c) or (d).
1
The plasmid pBXM3 comprising the polynucleotide molecule (the DNA sequence) coding for a morning meal of the present invention has been transformed into a strain of Escherichia coli which was deposited by the inventors in accordance with the Budapest treaty in the international recognition of the deposit of microorganisms for the purposes of patent procedures in the Deutsche Sammiung von
Mikroorganismen und Zellkulturen GmbH, Mascheroder Weg Ib, D-38124 Braunschweig, Federal Republic of Germany, May 29, 1998 under deposit number DSM 12197. A fourth preferred mannanase is described in the co-pending Danish patent application Serial No. PA 1998 01341. Very specifically, mannanase is: i) A polypeptide produced by Bacillus sp. AAI 12; ii) a polypeptide comprising an amino acid sequence as shown in positions 25-362 of SEQ ID NO: 2 as shown in Danish patent application Serial No. PA 1998 01341; or ii) a polypeptide comprising an amino acid sequence as shown in positions 25-362 of SEQ ID NO: 2 as shown in Danish patent application Serial No. PA 1998 01341; or i) an analog of the polypeptide defined in i) or ii) that is at least 65% homologous with said polypeptide, or is derived from said polypeptide by substitution, injury or addition of one or more amino acids, or is
-fc m ^ Jf ixÍ immunologically reactive with a polyclonal antibody raised against said polypeptide in purified form. Also encompassed is the corresponding isolated polynucleotide molecule selected from the group consisting of: (a) polynucleotide molecules encoding a polypeptide having mannanase activity and comprising a nucleotide sequence as shown in SEQ ID NO: 1 from nucleotide 225 to nucleotide 1236
• as shown in the Danish patent application Serial No. PA 1998 01341; 10 (b) homologous species of (a); (c) polynucleotide molecules encoding a polypeptide having mannanase activity that is at least 65% identical to the amino acid sequence of SEQ ID NO: 2 from amino acid residue 25 to amino acid residue 362 as shown in the patent application Danish No. of
15 PA series 01340; (d) Molecules complementary to (a), (b) or (c); and (e) degenerate nucleotide sequences of (a), (b), (c) or (d). Plasmid pBXM3 comprising the polynucleotide molecule (the DNA sequence) encoding a mannanase of the present invention has been transformed into a strain of Escherichia coli which was deposited by the inventors in accordance with the Budapest treaty in international recognition of the deposit of microorganisms for the purposes of patent procedures in the Deutsche Sammiung von
Mikroorganismen und Zellkulturen GmbH, Mascheroder Weg Ib, D-38124 Braunschweig, Federal Republic of Germany, on October 7, 1998 under the deposit number DSM 12433. The mannanase, when present, is incorporated into the
5 treatment compositions of the present invention preferably at a level of from 0.0001% to 2%, more preferably from 0.0005% to 0.1%, more preferably from 0.001% to 0.02% pure enzyme by weight of the composition. The compositions of the present invention can also
10 comprise a xyloglucanase enzyme. Xyloglucanases suitable for the purpose of the present invention are enzymes that exhibit endoglucanase activity specific for xyloglucan, preferably at a level of 0.001.
•% to about 1%, more preferably 0.01% to about 0.5%, by weight of the composition. As used in the
In the present invention, the term "endoglucanase activity" means the ability of the enzyme to hydrolyse 1,4-β-D-glycosidic bonds present in any cellulosic material, such as cellulose, cellulose derivatives, lichenine, β-D-glucan, or xyloglucan. The endoglucanase activity can be determined according to methods known in the art, examples of which
• 20 are described in WO 94/14953 and later. One unit of endoglucanase activity (eg CMCU, AVIU, XGU or BGU) is defined as the production of 1 μmol of sugar reduction / minute from a glucan substrate, the glucan substrate is for example, CMC (CMCU), of expanded acid Avicell (AVIU), xyloglucan (XGU) or ß-glucan (BGU) of cereal. The reducing sugars are determined as described in WO 94/14953 and below. The specific activity of an endoglucanase towards a substrate is defined as units / milligrams of protein. Enzymes that exhibit XGU endoglucanase (hereinafter "specific for xyloglucan)", whose enzyme is: i) encoded by a DNA sequence comprising or included in at least one of the following partial sequences are suitable : (a) ATTCATTTGT GGACAGTGGA C (SEQ ID No: 1) (b) GTTGATCGCA CATTGAACCA (SEQ ID NO: 2) (c) ACCCCAGCCG ACCGATTGTC (SEQ ID NO: 3) (d) CTTCCTTACC TCACCATCAT (SEQ ID NO: 4) (e) TTAACATCTT TTCACCATGA (SEQ ID NO: 5) (i) AGCTTTCCCT TCTCTCCCTT (SEQ ID NO: 6) (g) GCCACCCTGG CTTCCGCTGC CAGCCTCC (SEQ ID NO:
7) (h) GACAGTAGCA ATCCAGCATT (SEQ ID NO: 8) (i) AGCATCAGCC GCTTTGTACA (SEQ ID NO: 9) 0) CCATGAAGTT CACCGTATTG (SEQ ID NO: 10) (k) GCACTGCTTC TCTCCCAGGT (SEQ ID NO: 11) ( 1) GTGGGCGGCC CCTCAGGCAA (SEQ ID NO: 12) (m) ACGCTCCTCC AATTTTCTCT (SEQ ID NO: 13) (n) GGCTGGTAG TAATGAGTCT (SEQ ID NO: 14) (or) GGCGCAGAGT TTGGCCAGGC (SEQ ID NO: 15) (p) CAACATCCCC GGTGTTCTGG G (SEQ ID NO: 16) (q) AAAGATTCAT TTGTGGACAG TGGACGTTGA 5 TCGCACATTG AACCAACCCC AGCCGACCGA TTGTCCTTCC TTACCTCACC ATCATTTAAC ATCTTTTCAC CATGAAGCTT TCCCTTCTCT CCCTTGCCAC CCTGGCTTCC GCTGCCAGCC TCCAGCGCCG
• CACACTTCTG CGGTCAGTGG GATACCGCCA CCGCCGGTGA CTTCACCCTG TACAACGACC TTTGGGGCGA GACGGCCGGC 10 ACCGGCTCCC AGTGCACTGG AGTCGACTCC TACAGCGGCG ACACCATCGC TTGTCACACC AGCAGGTCCT GGTCGGAGTA
GCAGCAGCGT CAAGAGCTAT GCCAACG (SEQ ID NO: 17) or (r)
• 'CAGCATCTCC ATTGAGTAAT CACGTTGGTG TTCGGTGGCC CGCCGTGTTG CGTGGCGGAG GCTGCCGGGA GACGGGTGGG 15 GATGGTGGTG GGAGAGAATG TAGGGCGCCG TGTTTCAGTC CCTAGGCAGG ATACCGGAAA ACCGTGTGGT AGGAGGTTTA
TAGGTTTCCA GGAGACGCTG TATAGGGGAT AAATGAGATT
GAATGGTGGC CACACTCAAA CCAACCAGGT CCTGTACATA
CAATGCATAT ACCAATTATA CCTACCAAAA AAAAAAAAAA AAAAAAAAAAA • 20 YYYY (SEQ ID NO: 18) Or a homologous sequence therein that encodes a polypeptide specific for xyloglucan with endoglucanase activity, ii) is immunologically reactive with an antibody raised against a highly purified endoglucanase encoded by the sequence
. . ^ A.IIa i, J DNA defined in i) and which is derived from Aspergillus aculeatus, CBS 101.43, and is specific for xyloglucan. Very specifically, as used in the present invention, the term "specific for xyloglucan" means that the endoglucanase enzyme exhibits its highest endoglucanase activity in a xyloglucan substrate, and preferably with a percentage less than 75%, more preferably less than 50% activity, with still greater preference less than 25% activity, or other cellulose-containing substrates such as carboxymethylcellulose, cellulose, or other glucans. Preferably, the specificity of an endoglucanase makes xyloglucan is further defined as a relative activity determined as the release of reducing sugars at optimum conditions obtained by incubation of the enzyme with xyloglucan and other substrates that are tested, respectively. For example, the specific character can be defined as xyloglucan to β-glucan activity (XGU / BGU), xyloglucan to carboxymethylcellulose activity (XGUICMCU), or xyloglucan to Avicell expandable acid activity, which is preferably greater than 50, to about 75 , 90 or 100. The term "derived from" is used in the present invention to refer not only to an endoglucanase produced by strain CBS 101.43, but also to an endoglucanase encoded by a DNA sequence isolated from strain CBS 101.43 and produced in a host organism transformed with said DNA sequence.. ,. . The term "homologous" as used in the present invention indicates a polypeptide encoded by DNA that hybridizes to the same probe as the DNA encodes a specific endoglucanase enzyme for xyloglucan under certain specified conditions (such as pre-soaking in SxSSC and 5 prehybridized for 1 hour at -40 ° C in a solution of SxSSC, dxDenhardt's solution, and 50 pg of denatured sonified calf thymus DNA, followed by hybridization in the same solution supplemented with 50 pCi labeled probe 32-P- dCTP I for 18 hours at -40 ° C and washing three times in 2xSSC, 0.2% SDS at 40 ° C for 30 minutes). Very
Specifically, the term is intended to refer to a DNA sequence that is at least 70% homologous to any of the sequences shown above coding for a xyloglucan-specific endoglucanase, including at least 75%, by at least 80 %, at least 85%, by at least 90% or even at least 95% with any of the
15 sequences shown above. The term is intended to include modifications of any of the DNA sequences shown above, such as nucleotide substitutions that do not give rise to another amino acid sequence of the polypeptide encoded by the sequence, but which correspond to the codon use of the host organism in which a
The DNA structure comprising any of the DNA sequences is introduced into or are nucleotide substitutions that give rise to a different amino acid sequence and therefore, it is possible, an amino acid sequence and therefore also possible a different structure of amino acids.
proteins that can give rise to a mutant endoglucanase with different properties than the enzyme origin. Other examples of possible modifications are the insertion of one or more nucleotides in the sequence, the vision of one or more nucleotides, either at the end of the sequence, or the elimination of one or more nucleotides at either end or within the sequence. The xyloglucan specific endoglucanase useful in the present invention is preferably one having a ratio of XGUBGU, XGU / CMU and / or XGU / AVIU (as defined above) greater than 50, such as 75, 90 or 100. 10 More still, the xyloglucan-specific endoglucanase is preferably substantially devoid of activity towards β-glucan and / or exhibits at least 25% such that at least 10% to about 5% activity towards carboxylmethylcellulose and / or Avicell when the activity towards xyoglucan is 100%. Besides, the
Specific endoglucanase for the xyloglucan of the invention is preferably substantially devoid of transferase activity, an activity that has been observed for endoglucanases specific for xyloglucan of plant origin. The endoglucanase specific for xyloglucan can be obtained
20 from the fungal species of A. aculeatus, as described in WO 94/14953. Microbial endoglucanases specific for xyloglucan have also been described in WO 94/14953. The endoglucanases specific for xyloglucan from plants have been described above, but these
enzymes have transferase activity and therefore or should be considered inferior to the microbial endoglunas specific for xyloglucan as long as extensive xyloglucan degradation is desirable. An additional advantage of a microbial enzyme is that, in general, it can be produced in larger quantities in a microbial host, than enzymes of other origins. Xyloglucanase, when present, is incorporated into the treatment compositions of the invention preferably at a level of from 0.0001% to 2%, more preferably from 0.0005% to 0.1%, with still greater preference from 0.001% to 0.02% of pure enzyme by weight of the composition. The enzymes mentioned above may be of any suitable origin, such as plant origin, animal, bacterial, fungal and yeast. The purified or non-purified forms of these enzymes can also be used. Mutants of native enzymes are also included by definition. Mutants can be obtained for example by genetic manipulation and / or proteins, chemical and / or physical modifications of source enzymes. The common practice as well as the expression of the enzyme by host organisms in which the genetic material is responsible for the production of the enzyme that has been cloned. Said peroxidases are normally incorporated in the bleaching composition at levels of 0.0001% to 2% of the active enzyme by weight of the bleaching composition. Enzymes can be added as
í .l A ..? t í. A * - * - * - - * - • * »***" separate single ingredients (granules, granules, stabilized liquids, etc. containing an enzyme) or as mixtures of two or more enzymes (eg co-granulates) Other ingredients Suitable detergents that can be added are enzymatic oxidation scavengers Examples of such enzyme oxidation scavengers are ethoxylated tetraethylenepolyamines A scale of enzyme materials and means for their incorporation into synthetic bleaching compositions are also described in WO 93/07263 and WO 93/07260 to Genencor International, WO 89/08694 to Novo, and US 3,553,139, January 5, 1971 to McCarty et al. Enzymes are also described further in US 4,101, 457, Place et al, July 18, 1978, and in US 4,507,219, Hughes, March 26, 1985. Enzyme materials useful for liquid detergent formulations, and their incorporation into such formulations are described in US 4,261, 868, Hora et al, April 14, 1981.
Enzyme stabilizers Enzymes for use in detergents can be stabilized by various techniques. Enzyme stabilization techniques are described and exemplified in US 3,600,319, August 17, 1971, Gedge et al, EP 199,405 and EP 200,586, October 29, 1986, Venegas. Enzyme stabilization systems are also described, for example in US 3,519,570. A Bacillus species, sp. AC13 that gives proteases, xylanases and
J-ii cellulases, is described in WO 9401532 to Novo. The enzymes s} which are employed in the present invention can be stabilized by the presence of water-soluble sources of calcium and / or magnesium ions in the finished compositions which provide said ions to the enzymes. The stabilizers and levels of use of suitable enzymes are described in the USA. Pat. No. 5,576,282.
Other Detergent Ingredients Bleach compositions herein may also optionally contain one or more of the following: polymer dispersion agents, clay / anti-redeposition soil removal agents, brighteners, foam suppressants, colorants, perfumes, structure-elasticizing agents , fabric softeners, vehicles, hydrotropes, processing aids and / or pigments. Suitable examples of said different detergent ingredients and levels of use can be found in U.S. Patent No. 5,576,282.
Methods for Washing Fabrics Organic catalysts and compositions containing the same ingredients in the present invention can be used almost essentially in any washing or cleaning method, including soaking methods, pretreatment methods and methods with steps of
A * * »fc rinse for which a rinse aid composition can be added separately. The method for washing fabrics that is described in the present invention preferably comprises contacting the fabrics with a laundry solution comprising an organic catalyst (either in a neat form or in the form of a bleaching composition) which may be available in a solution for laundry by means of a controlled availability method as defined in Test Protocols I, II and / or III. Optionally, but preferably the laundry solution comprises a source of peroxygen. The method of the invention is conveniently carried out in the course of the cleaning process. The preferred method is carried out at 5 ° C to 95 ° C, especially between 10 ° C and 60 ° C. The pH of the laundry solution is preferably 7 to 11.
Organic catalyst product The organic catalysts and / or bleaching compositions of the present invention can be used in various products for use in the laundry process. In a preferred embodiment, a product comprises the organic catalyst and / or bleaching compositions containing the organic catalyst of the present invention wherein the
'•' ^ - "- *" - & < - The organic catalyst is available in a washing solution containing the product by means of a controlled availability method as defined in Test Protocols 1, II and / or III, as described herein. The product also includes instructions for using the organic catalyst and / or bleaching composition to clean a fabric that needs cleaning, preferably a stained fabric. The instructions include the step of supplying a quantity of the product comprising the organic catalyst and / or bleaching composition, together with or without a source of peroxygen, to a washing solution containing the fabric, such that the organic catalyst is It is available in the wash solution by the controlled availability method as defined in Test Protocols 1, II and / or III, as described hereinafter.
Determining the controlled availability of the organic catalyst To facilitate the determination between an organic catalyst or a bleaching composition of the present invention or a product comprising an organic catalyst or bleaching composition in the present invention falls within the scope of this invention, provide below three test protocols, Test Protocols 1, II and / or III. Only if case II for protocol I, case III for protocol II and case lili for protocol III are satisfied, then the product containing organic catalyst (OCCP) does not fall within the limits of this invention. OCCP
5 Test protocol 1 General / parameter: All solutions are maintained at 25 ° C pH adjustments as required are achieved using sodium carbonate or sulfuric acid as appropriate. All solutions are stirred continuously at 250 rpm, except a small aliquot (DBS) 10 dye bleach solution (1-5 mL) is removed to measure the absorbance. The absorbance values are measured at max of the reference dye solution (RDS). • A test is carried out to determine if the d or w0CCP parameters need to be reconfigured from their default values. dbianqueo is a parameter in the final test protocol that describes the time that elapses between the formation of the dye bleaching solution (DBS) and the acquisition of data. The default value of the dbianchecking parameter is 1 minute, which can be defined as a longer time 20 according to case I below. WOCCP is a parameter in the final test protocol that describes the weight of the product containing organic catalyst (OCCP) used to form the product solution containing organic catalyst
'B'MItiltiiiii'WHBBMife?' "" miWmr i fcn. t A. *. ** "Mm. < _ ... ^. 4 »... .. ^ ..,., Fr • - (ainm ii,, tt ni nlifciriÉiito (OCCPS) The default value of the parameter is 1.00 grams, but it can be defined as a smaller quantity or weight according to with case II below, CDS is the solution of the concentrated dye, defined as the 300 ppm solution of amaranth dye (Aldrich) in deionized water at pH 10. OCCP is a product that contains fully formulated organic catalyst (as defined). in the present above) in which the organic catalyst can be present with various auxiliary ingredients OCCPS is the product solution containing organic catalyst prepared by dissolving 1.00 g of a product containing organic catalyst (OCCP) in 1.0 L of 25 ° C of deionized water, the pH thereof has been previously adjusted so that the final solution has a pH between 9.9 and 10.1 DBS is the dye bleaching solution formed from the vision of a 100 mL aliquot of the OCCP S to 10 mL of CDS, determination of Amax 100 mL, add deionized water at pH 10 to 10 mL of CDS. The absorbance of the solution of the resulting homogeneous reference dye (RDS) determined by UV visible spectroscopy at the? Ma? (approximately 518 nm) is Amax. Removal time of aliquots: The times for the aliquot removal of the OCCPS include both the fixed duration (tf) and
. «T- i defined (tdd). The values of tf are 0.5, 1.5, 2.5 and 3.5 minutes. The values of tdd are 0.25D, 0.50D and 0.75D where D is the recommended wash duration. The defined aliquots of the duration for which tdd is less than 5 minutes need not be considered. For the purposes of this test, D may be no less than 5 minutes nor more than 16 hours. If the manufacturer does not recommend a wash duration of the OCCP, then D is set to 20 minutes. For example, if the washing period is 60 minutes, the tdd required in addition to the tf are 15, 30 and 45 minutes. For a 12 minute washout period, the required data points are those associated with 0.5 aliquot removals, 1.5, 2.5, 3.5, 6 and 9 minutes. The test is developed vide infra using the default values of dbianqueo and WOCCP- From all the fixed aliquots and fixed duration, identifies an aliquot, Q that gives rise to the lowest measured absorbance, Am? N. The time (tf or tdd) to which Q is removed from the OCCPS is defined as tQ. Note by definition that this is the same point that the largest Amm shows. There are three ca depending on the Amm value. Case 1: yes A, ™ >; 0.9 Amax, re-run the test to re-establish the dbianqueo value. In this new test, the aliquot amount removed at tQ is treated as before, except that it is stirred by increments of 1 additional minute until said time is like the absorbance Am, n < 0.9 Amax. The minimum number of DBS minutes of agitation required to satisfy the absorbance condition defines the new dbianqueo for the final implementation of the test protocol. Yes, however, if a dianqueo greater than 30 minutes is required [ie, if a bleaching of 10% is not achieved in 30 minutes, even at the point where dA is greater (when the organic catalyst is present in its concentration higher)], the OCCP is not shown in protocol I as within the limits of this invention, however, it can be found that OCCP falls within the limits of the invention by means of protocols II and / or protocol III . Case 2: yes Am? N < 0.25 Amax, run the test again to set the wOCCP value again. The OCCPS will be prepared from 50% of the OCCP default amount. This procedure is repeated only until the absorbance condition described in case 3 is fulfilled (for example, reducing OCCP from 1.0 g to 0.5 g, then if necessary from 0.5 g to 0.25 g, etc.) Case 3: yes 0.25 Amax 5 Am, n 5 0.9 Amax, then the test serves as the final test protocol implementation. Under these digenqueo conditions there is no need to change from the default values used. Test protocol I: the initial step is the preparation of
OCCPS as described. The time in which OCCP is added to the deionized water to form OCCPS is stable at t = 0. At each time of removal of aliquots (tf or tdd), a 100 mL aliquot of the OCCPS is removed, immediately filtered during the period of t = (tf or tdd) at = (tf or tdd + 0.25 min) to remove undissolved OCCP, and the filtrate is added all at once t = (tfo tdd + 0.50 min) to 10.0 ml, of CDS. An aliquot of 1-5 mL, C, of the resulting DBS will be immediately fried
iAt "> * 44, (, Ml al, t?». a- "4. 4. 04» "^ £. ^., ^ ..4., - .., .. ^.? .. ^ A. .i., »^.; .. 1.4 *. T ta. Í4.
prior to the determination of absorbance (acquisition and data). The absorbance of C is measured at? Max at the conclusion of d bleaching. "The time at which the determination of absorbance (data acquisition) of the aliquot C is measured is defined as tC. that tC = (tfo tdd) + 0.50 min + d? anqueo.The absorbance value measured at tC is defined as At (C) .The symbol? At (C) is defined as Amax - At (C). if the washing period is 12 minutes, the dianqueo value is 1 minute, and the aliquot removal times are 0.5, 1.5, 2.5, 3.5, 6 and 9 minutes, then the data acquisition times (tC) are 2, 3, 4, 5, 7.5 and 10.5 minutes The tca value is any data acquisition time, tC, acquired prior to any other acquisition time, Therefore, tc «tCβ The absorbance at tca is At ( C) a, the absorbance at tCß is At (C) ß There are two cases, depending on the values of At (C) a and At (C) ß Case: If any of At (C) ß <any At ( C) a, and by definition ßAt (C ) ß > ßAt (C) a, then a product containing organic catalyst of controlled availability (OCCP) is indicated, and therefore the product containing organic catalyst of controlled availability falls within the limits of this invention. Example of case h for a 20-minute wash cycle: •
10
Case 12: If each At (C) ß > each At (C) a, and by definition dAt (C) ß <
# 'dAt (C) a, then a product containing organic catalyst of controlled availability (OCCP)? to is indicated by protocol I, without
However, it can be found that the OCCP falls within the limits of this invention by means of test protocol II and / or test protocol III. By way of example, this can be presented not only for a product containing organic catalyst of uncontrolled availability (OCCP), in which OCCP is completely dissolved in the OCCPS prior to the first tf, such
20 that the subsequent values of At (C) will remain constant. The decomposition of the organic catalyst over time, in the OCCPS (which leads to less dye consumption in the DBS over time) results in each At (C) ß being each At (C) a.
Case example l2 for a 20 minute wash cycle:
PROTOCOL OF PROOF II:
General / Parameters / Protocol: same as defined for test protocol I with the following additions: OCSPS is the segregated product of organic catalyst prepared by re-formulating the OCCP without the organic catalyst and then adding the organic catalyst to the reformulated product, so that the general composition of OCSPS is the same as OCCP. OCCPS is the product solution that contains organic catalyst prepared by dissolving 1.00 g of a product containing organic catalyst (OCCP) in 1.0 L of 25 ° C deionized water, the pH of which has been previously adjusted so that the final solution has a pH between 9.9 and 10.1. wOCCP is a parameter in the final test protocol that describes the weight of the segregated organic catalyst product (OCSP) used to form the segregated organic catalyst product solution (OCCPS). The default value of the parameter is 1.00 grams but can be defined as a smaller quantity or weight according to case II below
^^^^^ DBS2 is the dye bleaching solution formed from the addition of an aliquot of 100 mL of OCCPS to 10 mL of CDS. The aliquot removal times of the OCSPS are the same as those of the OCCPS, as described above. Test protocol II: the initial step is the completion of protocol I as described. The same procedure is repeated (except that OCSP replaces OCCP) using the same dbianqueo as defined in protocol I. The time in which OCCP is added to the deionized water to form OCCPS is stable at = 0. In each of the times of aliquot removal (tf or tdd), a 100 mL aliquot of the OCCPS is removed, immediately filtered during the period of t = (tf or tdd) at = (tf or tdd + 0.25 min) to remove undissolved OCSP , and the filtered material is added all at once t = (tfo tdd + 0.50 min) to 10.0 ml, of CDS. An aliquot of 1-5 mL, S, of the resulting DBS2 is removed immediately prior to the determination of absorbance (data acquisition). The absorbance of S is measured at (? Max at the conclusion of dianqueo - The time at which the determination of absorbance (data acquisition) of the aliquot quantity S is defined as t S. Therefore, it is required that tS = ( tfo tdd) + 0.50 min + db? anqueo = tC The absorbance value measured at tS is defined as At (S) The symbol dAt (S) is defined as Amax -At (S) For example, if the period wash time is 12 minutes, the value of dbiar, queo is 1 minute, and the aliquot removal times are 0.5,
* A *** ^ 1.5, 2.5, 3.5, 6 and 9 minutes, then the data acquisition times (tS) are 2, 3, 4, 5, 7.5 and 10.5 minutes. There are two cases, depending on the values of At (C) and At (S) for tS = tC: Case lh: if at least one At (S) < At (C), and by definition dAt (S) > dAt (C), then a product containing controlled availability organic catalyst (OCCP) is indicated, and the OCCP falls within the limits of this invention. Example of case ll2 for a 20-minute wash cycle: It is very preferable, that for protocol II, even if it is at least in one case, 1.2 x At (C), then a product containing organic catalyst is indicated. controlled availability (OCCP), and the OCCP falls within the limits of this invention. Case 112: If each At (S) > At (C), and by definition dAt (S) < dAt (C), then a product containing controlled availability organic catalyst (OCCP) is indicated by protocol II, however, it can be found that the OCCP falls within the limits of this invention by means of the test protocol I and / or test protocol III OCCP.
. - ia & , 2y? * ..., *** r, ÍÍÁÁAT? PROTOCOL OF PROOF III
General / Parameters / Protocol: same as defined for test protocol I with the following additions: peracetic acid, 32 wt% solution in dilute acetic acid available from Aldrich. OCCPS in protocol III is the product solution containing organic catalyst prepared by dissolving 1.00 g of a product containing organic catalyst (OCCP) in 1 L of deionized water at 25 ° C containing 100 mg of peracetic acid (based on the 100% activity), whose pH has been previously adjusted so that the final solution has a pH between 9.9 and 10.1. Test protocol III All steps are as in protocol I except that OCCPS is used in place of OCCPS. Case lili: If any of At (C) ß < any At (C) a, and by definition dAt (C) ß > dAt (C) a, then a product containing organic catalyst of controlled availability (OCCP) is indicated, and therefore the product containing organic catalyst of controlled availability falls within the limits of this invention. Case 1112: If each At (C) ß > each At (C) a, and by definition ßAt (C) ß < dAt (C) a, then a product containing controlled availability organic catalyst (OCCP) has not been indicated by protocol III, however, it can be found that the OCCP falls within the limits of this invention by means of the protocol of test I and / or test protocol II.
The compositions of the present invention can be suitably prepared by any method chosen by the formulator, the non-limiting examples of which are described in US Pat. No. 5,691,297 Nassano et al., Issued November 11, 1997; U.S. 5,574,005 Welch et al., Issued November 12, 1996; U.S.: 5,569,645 Dinniwell et al., Issued October 29, 1996; U.S. 5,565,422 Del Greco et al., Issued October 15, 1996; U.S.: 5,516,448 Capeci et al., Issued May 14, 1996; U.S.: 5,489,392 Capeci et al., Issued February 6, 1996; U.S.: 5,486,303 Capeci et al., Issued January 23, 1996, all of which are incorporated herein by reference. In addition to the above embodiments, the organic catalysts of the present invention can be formulated into any suitable laundry detergent composition, the non-limiting examples of which are described in US Pat. No. 5,679,630 Baeck et al., Issued October 21, 1997; U.S.: 5,565,145 Watson et al., Issued October 15, 1996; U.S.: 5,478,489 Fredj et al., Issued December 26, 1995; U.S.: 5,470,507 Fredj et al., Issued November 28, 1995; U.S.: 5,466,802 Panandiker et al., Issued November 14, 1995; U.S.: 5,460,752 Fredj et al., Issued October 24, 1995; U.S.: 5,458,810 Fredj et al., Issued October 17, 1995; U.S.: 5,458,809 Fredj et al., Issued October 17, 1995; U.S.: 5,288,431 Huber et al., Issued February 22, 1994, all of which are incorporated herein by reference.
. - A¡A ~. .i.? -.
Having described the present invention in detail with reference to the preferred embodiments, it will be apparent to those skilled in the art that various changes and modifications can be made without departing from the spirit of the invention, and the invention is not considered as
5 limited as to what is described in the detailed description.
• "^^ - -" - * - 4 *, A.4.A2? SEQUENCE OF SEQUENCES < 110 > The Procter & Gamble Company Dykstra, Robert Miracle. Gregory < 120 > Controlled availability of formulation components, compositions and laundry methods employing the same < 130 > 7749X < 150 > 60 / 151,002 < 151 > 1999-08-27 < 150 > 60 / 151,004 < 151 > 1999-08-27 < 160 > 18 < 170 > Patentln version 3.0 < 210 > 1 < 211 > 21 < 212 > DNA < 213 > Aspergillus aculeatus < 400 > 1 attcatttgt ggacagtgga c 21
< 210 > 2 < 211 > 20 < 212 > DNA < 213 > Aspergillus aculeatus < 400 > 2 gttgatcgca cattgaacca 20
< 210 > 3 < 211 > 20 < 212 > DNA < 213 > Aspergillus aculeatus < 400 > 3 accccagccg accgattgtc 20
< 210 > 4 < 211 > 20 < 212 > DNA < 213 > Aspergillus aculeatus < 400 > 4 cttccttacc tcaccatcat 20
< 210 > 5 < 211 > 20 < 212 > DNA < 213 > Aspergillus aculeatus < 400 > 5 ttaacatctt ttcaccatga 20
? t aj ^ t < 210 > 6 < 211 > 20 < 212 > DNA < 213 > Aspergillus aculeatus < 400 > 6 agctttccct tctctccctt 20
< 210 > 7 < 211 > 28 < 212 > DNA < 213 > Aspergillus aculeatus < 400 > 7 gccaccctgg cttccgctgc cagcctcc 28
< 210 > 8 < 211 > 20 < 212 > DNA < 213 > Aspergillus aculeatus < 400 > 8 gacagtagca atccagcatt 20
< 210 > 9 < 211 > 20 < 212 > DNA < 213 > Aspergillus aculeatus < 400 > 9 agcatcagcc gctttgtaca 20
< 210 > 10 < 211 > 20 < 212 > DNA < 213 > Aspergillus aculeatus < 400 > 10 ccatgaagtt caccgtattg 20
< 210 > 11 < 211 > 20 < 212 > DNA < 213 > Aspergillus aculeatus < 400 > 11 gcactgcttc tctcccaggt 20
< 210 > 12 < 211 > 20 < 212 > DNA < 213 > Aspergillus aculeatus < 400 > 12 gtgggcggcc cctcaggcaa 20
< 210 > 13 < 211 > 20 < 212 > DNA < 213 > Aspergillus aculeatus < 400 > 13 acgctcctcc aattttctct 20
< 210 > 14 < 211 > 19 < 212 > DNA < 213 > Aspergillus aculeatus < 400 > 14 ggctggtagt aatgagtct 19 < 210 > 15 < 211 > 20 < 212 > .ADN < 213 > Aspergillus aculeatus < 400 > 15 ggcgcagagt ttggccaggc 20
< 210 > 16 < 211 > 21 < 212 > DNA < 213 > Aspergillus aculeatus < 400 > 16 caacatcccc ggtgttctgg g 21
< 210 > 17 < 211 > 347 < 212 > DNA < 213 > Aspergillus aculeatus < 400 > 17 aaagattcat ttgtggacag tggacgttga tcgcacattg aaccaacccc agccgaccga 60 ttgtccttcc ttacctcacc atcatttaac atcttttcac catgaagctt tcccttctct 120 cccttgccac cctggcttcc gctgccagcc tccagcgccg cacacttctg cggtcagtgg 180 gataccgcca ccgccggtga cttcaccctg tacaacgacc tttggggcga gacggccggc 240 accggctccc agtgcactgg agtcgactcc tacagcggcg acaccatcgc ttgtcacacc 300 agcaggtcct ggtcggagta gcagcagcgt caagagctat gccaacg 347
< 210 > 18 < 211 > 294 < 212 > DNA < 213 > Aspergillus aculeatus < 400 > 18 cagcatctcc attgagtaat cacgttggtg ttcggtggcc cgccgtgttg cgtggcggag 60 gctgccggga gacgggtggg gatggtggtg ggagagaatg tagggcgccg tgtttcagtc 120 cctaggcagg ataccggaaa accgtgtggt aggaggttta taggtttcca ggagacgctg 180 tataggggat aaatgagatt gaatggtggc cacactcaaa ccaaccaggt cctgtacata 240 aaaaaaaaaa aaaa accaattata caatgcatat cctaccaaaa aaaaaaaaaa 294
.... ..l ?? .i, .i..í.?
Claims (1)
- NOVELTY OF THE INVENTION CLAIMS 1. A method for laundry, characterized in that it comprises contact a fabric that requires cleaning with an organic catalyst by means of a controlled availability method. 2. The method according to claim 1, further characterized in that said organic catalyst is selected from the group consisting of: a) aryliminium cations and aryliminium polyions, which have a net charge of around +3 to about -3, which are represented by the formula [I]: [I] where R2 and R3 are independently selected from radicals substituted or unsubstituted groups selected from the group consisting of radicals H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, • nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic, and carboalkoxy; R1 and R4 are selected from substituted or unsubstituted saturated or unsaturated radicals selected from the group consisting of H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, i k. halogen cyano, alkoxy, keto and carboalkoxy; and X- is an adequate charge balance counter ion; and v is an integer from 1 to 3; b) aryliminium zwitterions, which have a net charge of about +3 to about -3, which are represented by the formula [II]: [II] Wherein R5-R7 are independently selected from substituted or unsubstituted radicals selected from the group consisting of radicals of H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, • 'halogen, cyano, sulfonate, alkoxy, keto, carboxylic, and carboalkoxy, the radical represented by the formula is also present in this formula: wherein Zp- is covalently linked to, and Zp- is selected from the group consisting of -C02, -S03-, -OS03-, -SO2 and -OSO2- and p is 1, 2 or 3; a is selected from the group consisting of alkyl, cycloalkyl, aryl, alkaryl, • aralkyl, substituted or unsubstituted, saturated or unsaturated; and a heterocyclic ring c) modified amines, which have a net charge of about -3 to about +3, which are represented by the formulas [V] and [VI]: [V] [VI] wherein R9-R '° are independently selected from substituted or unsubstituted radicals selected from the group consisting of radicals H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic, and carboalkoxy and anionic and / or cationic charge bearing radial; R8 and R11 when present are radicals selected from the group consisting of radicals H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic, substituted or not substituted, saturated or unsaturated, and anionic radicals and / or carrying cationic charge; R12 is a leaving group, the protonated form of which has a pKa value (reference H20) that falls within the following scale: 37 > pKa > -2; with the proviso that either, R8-R12, when present, may be combined to form a fused aryl, fused carbocyclic ring or fused heterocyclic ring; the radical represented by the formula: wherein Zp- is covalently linked to, and Zp- is selected from the group consisting of -C02, -S03-, -OS03-, -SO2 and -OSO2- and p is 1, 2 or 3; a is selected from the group consisting of alkyl, cycloalkyl, aryl, alkaryl, aralkyl, substituted or unsubstituted, saturated or unsaturated; and a heterocyclic ring d) modified amine oxides, having a net charge of about -3 to about -3, which are represented by the formulas [VII] - [X]: [VIO [VIII] [IX] [X] wherein R9-R '° are independently selected from substituted or unsubstituted radicals selected from the group consisting of radicals H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic, and carboalkoxy and anionic and / or cationic-bearing radials; R8 and R11 when present are radicals selected from the group consisting of radicals H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic, substituted or not substituted, saturated or unsaturated, and anionic and / or carrying radicals - ^. _ *. «-. cationic charge; R12 is a leaving group, the protonated form of which has a pKa value (reference H20) that falls within the following scale: 37 > pKa > -2; with the proviso that either, R8-R12, when present, can be combined to form a fused aryl, fused carbocyclic ring or fused heterocyclic ring; the radical represented by the formula: where Zp- is covalently bound. a, and Zp- is selected from the group consisting of -C02, -SO3-, -OSO3-, -SO2- and -OSO2- and p is 1, 2 or 3; a is selected from the group consisting of alkyl, cycloalkyl, aryl, alkaryl, aralkyl and substituted or unsubstituted, saturated or unsaturated heterocyclic ring. e) sulfonimines, phosphonimines, N-acylimines and thiodiazole dioxide dioxides which are represented by the formulas [XXIa], [XXIb], [XXII] and [XXIII], respectively: [XXIa] [XXIb] [XXII] [XXIÜ] wherein R41-R44, when present, are independently selected from the group consisting of H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic, and which provide any of R41-R44 may together with any other R4 -R44 to form part of a common ring, including a fused aryl ring, fused carbocyclic or fused heterocyclic ring: f) axaziridinium cations and polions, which have a net charge of around +3 to about -3, which are represented by the formula [III]: [ii wherein R2 and R3"are independently selected from substituted or unsubstituted radicals selected from the group consisting of H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, alkoxy radicals , keto, carboxylic, and carboalkoxy; R1 and R4 are selected from substituted or unsubstituted saturated or unsaturated radicals selected from the group consisting of H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen radicals cyano, alkoxy, keto and carboalcoxy, and X- is a suitable charge balance counter, preferably a counter-ion compatible with bleach, g) aryliminium zwiterions, which have a net charge of about +3 to about -3, which are represented by the formula [IV]: . -A & you M wherein R5'-R7 'are independently selected from the substituted or unsubstituted radicals of the group consisting of radicals of H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, alkoxy , keto, carboxylic, and carboalkoxy, in this formula the radical represented by the formula is also present: -T -ZT wherein Zp- is covalently linked to, and Zp- is selected from the group consisting of -C02, -SO3-, -OSO3-, -SO2- and -OSO2- and p is 1, 2 or 3; a is selected from the group consisting of alkyl, cycloalkyl, aryl, alkaryl, aralkyl and substituted or unsubstituted, saturated or unsaturated heterocyclic ring g) sulfonimines oxaziridine [XXIVa], phosphonimines [XXIVb], N-acylimines [XXV] and thiodiazole dioxides [XXVI], and [XXVIII] are represented according to the following: - & ^ á. ¿, I > gi - [XXIVa] [XXIVb] [XXV] p < xvo saw where R41, -R44 ', when present, are independently selected from the substituted or unsubstituted radicals of the group consisting of radicals of H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen , cyano, sulfonate, alkoxy, keto, carboxylic, and carboalkoxy, which provide any R41, -R44 'together with any other R41, -R44' to form part of a common ring, including a fused aryl ring, fused carbocyclic or heterocyclic ring merged and, i) mixtures thereof. 3. The method according to claim 2, further characterized in that said organic catalyst is selected from the group consisting of: a) aryliminium cations and aryliminium polyions, which have a net charge of about +3 to about -3 , which are represented by the formula [XI]: b (XO where m is 1 to 3 when G is present and m is 1 to 4 when m is not present, and n is an integer from 0 to 4, each R26 is independently selected from the substituted or unsubstituted radical that is selected from the group consisting of H, alkyl, cycloalkyl, aryl, fused aryl radicals, The heterocyclic ring, fused heterocyclic ring, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic, and carboalkoxy, and any of the two adjacent R20 substituent atoms can be combined to form an aryl • fused, fused carbocyclic ring or fused heterocyclic ring; R18 can be a substituted or unsubstituted radical selected from the group of 15 radicals consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic, and carboalkoxy; also present in this formula is the radical represented by the formula: (1) -O-; (2) -N (R23) -; and (3) -N (R23R24) -; R21-R24 are substituted or unsubstituted radicals selected • independently of the group consisting of H, oxygen, straight or branched alkyl of CrC12, alkylenes, alkoxys, aryls, alkaryls, aralkyls, cycloalkyls, and heterocyclic rings; provide any of R18, R19, R20, R211- DR2M4 can be together with any other R 18, D R19, D R20, D R21 - DR2¿4 for . i ¿kk ^ .. > ... t a? *. ^. &; ** ,, forming part of a common ring, any germinal R21-R22 may be combined to form a carbonyl; any vicinal R21-R24 to form an unsaturated, fused, substituted or unsubstituted portion; X- is a counter balance of adequate load balance; and v is an integer from 1 to 3; b) aryliminium zwitterions, which have a net charge of about +3 to about -3, which are represented by the formula [XII]: where m is 1 to 3 when G is present and m is 1 to 4 when G is not •' I presented; and n is an integer from 0 to 4; each R26 is independently selected from the substituted or unsubstituted radical selected from the group Which consists of H radicals, alkyl, cycloalkyl, aryl, fused aryl, heterocyclic ring, fused heterocyclic ring, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic, and carboalkoxy, and any of the two adjacent R26 substituent atoms it may be combined to form a fused aryl, fused carbocyclic ring or fused heterocyclic ring; R25 • 20 can be a substituted or unsubstituted radical selected from the group of radicals consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic, and carboalkoxy; The radical represented by the formula is also present in this formula: wherein Zp- is covalently linked to, and Zp- is selected from the group consisting of -C02, -S03-, -OS03-, -S02 and -OS02 and p is 1, 2 or 3; a is selected from the group consisting of where q is an integer from 1 to 8; R29 is independently selected from substituted or unsubstituted radicals which are selected from the group consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, alkylene, heterocyclic ring, alkoxy, arylcarbonyl, carboxyalkyl and straight or branched amide groups; G is selected from the group consisting of (1) -O-; (2) -N (R30); and (3) -N (R30 R31) -; R27, R28, R30 and R31 are substituted or unsubstituted radicals that are independently selected from the group consisting of H, oxygen, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, (1) -O-; (2) -N (R30) -; and (3) -N (R30R31) -; R27-, R28, R30 and R31 are substituted or unsubstituted radicals independently selected from the group consisting of H, oxygen, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, alkylene, and heterocyclic rings; arylcarbonyl groups, carboxyalkyl groups and amide groups; provide any of R25, R26, R27, R28, R30 and R31 may be together with any of J AAa ÁMT L, -, .. i¡lt4t.4 tt.t ... .. t í other R25, R26, R27, R28, R30 and R31 to form part of a common ring, any germinal R27-R31 can combine to form a carbonyl; any vicinal R27-R31 to form an unsaturated, fused portion; c) modified amines which are represented by formulas [XV] and [XVI]: [XV] [xvq where m is 1 to 3 when G is present and m is 1 to 4 when G is not present; and n is an integer from 0 to 4; each R34 is independently selected from the substituted or unsubstituted radical which is selected from the group consisting of hydroxy, perhydroxy, alkoxy, peralkoxy, carboxylic, percarboxylic, sulfonate and persilphonate radicals, each substituted or unsubstituted R35 is independently selected from the group consists of H radicals, alkyl, cycloalkyl, aryl, fused aryl, heterocyclic ring, fused heterocyclic ring, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic, and carboalkoxy, and either of the two adjacent R35 substituent atoms can be combined to form a fused aryl, fused carbocyclic ring or fused heterocyclic ring; R32 may be a substituted or unsubstituted radical selected from the group of radicals consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring, ,. t u ±. ,. ~. ^ < *? silyl, nitrogen, halogen, cyano, sulfonate, aikoxi, keto, carboxylic, and carboalkoxy; R33 can be a substituted or unsubstituted radical, saturated or unsaturated, selected from the group consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring, and this formula is also present the radical represented by the formula: wherein Zp- is covalently linked to, and Zp- is selected from the group consisting of -C02, -S03-, -OS03-, -S02 and -OS02 and p is 1, 2 or 3; a is selected from the group consisting of where q is an integer from 1 to 8; R38 is independently selected from the substituted or unsubstituted radical which is selected from the group consisting of radicals of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, alkylene, heterocyclic ring, alkoxy, arylcarbonyl, carboxyalkyl and amide groups, G is selected from the group consisting of (1) -O-; (2) -N (R39); and (3) -N (R39 R40) -; R36, R37, R39 and R40 are substituted or unsubstituted and are independently selected from the group consisting of radicals H, oxygen, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, alkyl, heterocyclic ring, alkoxy, arylcarbonyl groups, carboxyalkyl groups and groups amine, provide any of R32, R33, R34, R35, R36, R37, R39 and R40 may be together with any of the other R32, R33, R34, R35, R36, R37, R39 and R40 to form part of a common ring, any germ R36 and R37 can be combined to form a carbonyl; any vicinal R36 R37, R39 and R40 to form an unsaturated, fused portion, and wherein any group of R36 substituents R37, R39 and R40 may be combined in the form of a saturated or unsaturated fused portion; d) modified amine oxides which are represented by formulas [XVII] - [XX]: [XVIO xv \\? \ [XIX] [XX] where m is 1 to 3 when G is present and m is 1 to 4 when G is not present; and n is an integer from 0 to 4; each R34 is independently selected from the substituted or unsubstituted radical which is selected from the group consisting of hydroxy, perhydroxy, alkoxy, peralkoxy, carboxylic, percarboxylic, sulfonate and persilphonate radicals, each substituted or unsubstituted R35 is independently selected from the group consists of H radicals, alkyl, cycloalkyl, aryl, fused aryl, heterocyclic ring, fused heterocyclic ring, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic, and carboalkoxy, and either of the two adjacent R35 substituent atoms can be combined to form a fused aryl, fused carbocyclic ring or fused heterocyclic ring; R32 may be a substituted or unsubstituted radical selected from the group of radicals consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, aikoxy, keto, carboxylic, and Carboalkoxy; R33 can be a substituted or unsubstituted, saturated or unsaturated radical, selected from the group consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring, and this formula is also • 'finds the radical represented by the formula: • where Zp- is covalently linked to, and Zp- is selected from the group consisting of -C02, -S03-, -OS03-, -S02 and -OS02 and p is 1, 2 or 3; a is selected from the group consisting of: where q is an integer from 1 to 8; R38 is independently selected from the substituted or unsubstituted radical which is selected from the group consisting of radicals of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, alkylene, heterocyclic ring, alkoxy, arylcarbonyl, carboxyalkyl and amide groups, G is selected from the group consisting of (1) -O-; (2) -N (R39); and (3) -N (R39 R40) -; R36, R37, R39 and R40 are substituted or unsubstituted and are independently selected from the group consisting of radicals H, oxygen, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, alkyl, heterocyclic ring, alkoxy, arylcarbonyl groups, carboxyalkyl groups and groups amine, provide any of R32, R33, R34, R35, R36, R37, R39 and R40 may be together with any of the other R32, R33, R34, R35, R36, R37, R39 and R40 to form part of a common ring, any germ R36 and R37 can be combined to form a carbonyl; any vicinal R36 R37, R39 and R40 to form an unsaturated, fused portion, and wherein any group of R36 substituents R37, R39 and R4o may be combined in the form of a saturated or unsaturated fused portion; e) sulfonimines [XXVIlla], phosphonimines] XXVIIIb], N-acylimines [XXIX] are represented below: wherein each R46 is independently selected from the substituted or unsubstituted radical selected from the group consisting of radicals of H, alkyl, cycloalkyl, aryl, fused aryl, heterocyclic ring, fused heterocyclic ring, nitrogen, halogen, cyano, sulfonate, aikoxy , keto, carboxylic, and carboalkoxy, and any two vicinal vicinal R46 may combine to form a fused aryl, fused carbocyclic ring or fused heterocyclic ring; R 45 can be a substituted or unsubstituted radical selected from the group of radicals consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, aikoxy, keto, carboxylic, and carboalkoxy; also present in this formula is the radical represented by the formula: (1) -O-; (2) -N (R47) -; and (3) -N (R47R48) -; R47-R48 are substituted or unsubstituted radicals independently selected from the group consisting of H, oxygen, linear or branched C 1 -C 2 alkyls, alkylanes, alkoxys, aryls, alkaryls, aralkyls, cycloalkyls, and heterocyclic rings; f) oxaziridinium cations and polyions, which have a net charge of about +3 to about -3, which are represented by the formula [XIII]: where m is 1 to 3 when G is present and m is 1 to 4 when G is not present; and n is an integer from 0 to 4; each R20 is independently selected from the substituted or unsubstituted radical which is selected from the group consisting of H, alkyl, cycloalkyl, aryl, fused aryl radicals, heterocyclic ring, fused heterocyclic ring, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic, and carboalkoxy, and either vicinal vicinal R20 may be combined to form a fused aryl, fused carbocyclic ring or fused heterocyclic ring; R18 may be a substituted or unsubstituted radical selected from the group of radicals consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, aikoxy, keto, carboxylic, and carboalkoxy; R19 can be a substituted or unsubstituted, saturated or unsaturated radical, selected from the group consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring, G is selected from the group consisting of (1) -O-; (2) -N (R23 '); and (3) -N (R23 'R24') -; R21'-R24 'are substituted or unsubstituted and is independently selected from the group consisting of H radicals, oxygen, linear or branched CC? 2 alkyls, alkylenes, alkoxys, aryls, alkaryls, cycloalkyls and heterocyclic rings, provide either R18 , R19, R21 -R24 may be together with any of the other R18, R19, R2 -R24 to form part of a common ring, any germinal R21-R22 may be combined to form a carbonyl; any vicinal R21'.R24 'to form a unsaturated, fused portion, and wherein any group of substituents R21'-R24 may be combined in the form of a saturated or unsaturated fused portion; and wherein any group of R21'-R24 substituents can be combined to form a saturated or unsaturated fused portion; X 'is an appropriate charge balance counter ion, and v is an integer from 1 to 3; g) Oxaziridinium zwitterions, which have a net charge of &Sk. J4l .il, i around +3 to about -3 that are represented by the formula [XIV] where m is 1 to 3 when G is present and m is 1 to 4 when G is not present; and n is an integer from 0 to 4; each R26 is independently selected from the substituted or unsubstituted radical which is selected from the group consisting of H, alkyl, cycloalkyl, aryl, fused aryl, heterocyclic ring, fused heterocyclic ring, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic, and carboalkoxy, and any vicinal R26 adjacent may be combined to form a fused aryl, fused carbocyclic ring or fused heterocyclic ring; R25 may be a substituted or unsubstituted radical selected from the group of radicals consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, aikoxy, keto, carboxylic, and carboalkoxy; the radical is represented by the formula wherein Zp- is covalently attached to, and Zp- is selected from the group consisting of -C02, -S03-, -OS03-, -S02 and -OS02 and a is 1 or 2; T0 2; is selected from the group consisting of: where q is an integer from 1 to 8; R29 is independently selected from the substituted or unsubstituted radical which is selected from the group consisting of linear or branched groups of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, alkylene, heterocyclic ring, alkoxy, arylcarbonyl, carboxyalkyl and amide groups, G is selected from the group consisting of (1) -O-; (2) -N (R30); and (3) -N (R30 'R31') -; R27 ', R28', R30 'and R31' are substituted or unsubstituted and is independently selected from the group consisting of radicals H, oxygen, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, alkyl, heterocyclic ring, alkoxy, arylcarbonyl groups, carboxyalkyl groups and amine groups, provide any of R2, R26 ', R27', R28 ', R30' and R31 'may be together with any of the other R2, R26', R27 ', R28', R30 'and R31' to form part of a common ring, any germ R27 and R28 can be combined to form a carbonyl; any vicinal R27 and R31 to form an unsaturated, fused portion, and wherein any group of substituents R27 and R31 may be combined in the form of a saturated or unsaturated fused portion; h) oxaziridinesulfonimides [XXXIa], phosphonimides [XXXIb], N-acylimines [XXXII] are represented below: [XXXIa] [XXXIb] [XXXII] wherein each R46 is independently selected from the substituted or unsubstituted radical selected from the group consisting of radicals of H, alkyl, cycloalkyl, aryl, fused aryl, heterocyclic ring, fused heterocyclic ring, nitrogen, halogen, cyano, sulfonate, aikoxi, keto, carboxylic, and carboalkoxy, and any two vicinal vicinal R46 may combine to form a fused aryl, fused carbocyclic ring or fused heterocyclic ring; R 45 can be a substituted or unsubstituted radical selected from the group of radicals consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, aikoxy, keto, carboxylic, and carboalkoxy; G, when present, is selected from the group consisting of: (1) -O-; (2) -N (R47 ') -; and (3) -N (R47 R48 ') -; R47-R48 'are substituted or unsubstituted radicals independently selected from the group consisting of H, oxygen, linear or branched alkyls of C? -C, 2, alkylene, alkoxy, aryls, alkaryls, aralkyls, cycloalkyls, and heterocyclic rings; i) and mixtures thereof. 4. The method according to claim 1, further characterized in that said fabric comprises a spot. 5. A bleaching composition characterized in that it comprises (a) a source of peroxygen; and (b) an organic catalyst; wherein 6. The bleaching composition according to claim 5, further characterized in that said source of peroxygen is selected from the group consisting of: 7. - The bleaching composition according to claim 6, further characterized in that said source of peroxygen is selected from hydrogen peroxide sources selected from the group consisting of perborate compounds, percarbonate compounds, perphosphate compounds and mixtures thereof, and a bleach activator. 8. The bleaching composition according to claim 7, further characterized in that said bleach activator is selected from the group consisting of hydrophobic bleach activators. 9. The bleaching composition according to claim 7, further characterized in that said bleach activator is selected from the group consisting of tetraacetylethylene diamine (TAED), benzoylcapropactam (BzCL), 4-nitrobenzoylcaprolactam, 3-chlorobenzoylcaprolactam, benzoyloxybenzene sulfonate (BOBS) , nonanoyloxybenzenesulfonate (NOBS), phenylbenzoate (PhBz), decanoyloxybenzenesulfonate (C10-OBS), benzoylvalerolactam (BZVL), octanoyloxybenzenesulfonate (Cß-OBS), perhydrolyzable esters, sodium salt 4- [N- (nonanoyl9-aminohexanoyloxy] -benzenesulfonate (NACA-OBS ), lauryloxybenzenesulfonate (LOBS or C12-OBS), 10-undecenoyloxybenzenesulfonate (UDOBS or C11-OBS) with unsaturation at position 10), decanoyloxybenzoic acid (DOBA) and mixtures thereof. 10. The bleaching composition according to claim 5, further characterized in that said organic catalyst is . to ? selected from the group consisting of: a) aryliminium cations and aryliminium polyions, which have a net charge of about +3 to about -3, which are represented by the formula [I]: [1] wherein R1-R2 are substituted or unsubstituted radicals independently selected from the group consisting of H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic , and carboalkoxy radicals; R1 and R4 are selected radicals of substituted or non-substituent, saturated or unsaturated selected from the group consisting of H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, alkoxy, keto , carboxylic, and carboalkoxy radicals; and X "is an appropriate charge balance counter ion, yv is an integer from 1 to 3, b) aryliminium zwitterions, which have a net charge of about +3 to about -3, which are represented by the formula [II ]: [I where R5-R7 are substituted or unsubstituted radicals independently selected from the group consisting of H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic, and carboalkoxy radicals; also presented in this formula is the radical represented by the formula: wherein Zp- is covalently linked to, and Zp- is selected from the group consisting of -C02, -S03-, -OS03-, -S02 and -OS02 and p is 1, 2 or 3; a is selected from the group consisting of a substituent or non-substituent, saturated or unsaturated alkyl, cycloalkyl, aryl, alkaryl, aralkyl and heterocyclic ring; c) modified amines, which have a net charge of about -3 to about +3, which are represented by formulas [V] and [VI]: [V] [VO wherein each R9-R10 is independently selected from the substituted or unsubstituted radical which is selected from the group consisting of radicals of H, alkyl, cycloalkyl, aryl, fused aryl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, aikoxi, keto, carboxylic, and carboalkoxy, and anionic and / or cationic charge carrier radical; R8 and R11, when present, are substituted or unsubstituted radials which are selected from the group consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, aikoxy, keto, carboxylic, and carboalkoxy; and anionic and / or cationic carrier vehicle radical; R12 is a leaving group, the protonated form which has a pKa value (reference H2O) which falls within the following scale: 37 > pKa > -2; with the proviso that any R8-R12, when present, can be combined in the form of a fused aryl, fused carbocyclic or fused heterocyclic ring; and the radical is represented by the formula: wherein Zp- is covalently linked to, and Zp- is selected from the group consisting of -C02, -S03-, -OS03-, -S02 and -OS02 and p is 1, 2 or 3; a is selected from the group consisting of a substituent or non-substituent, saturated or unsaturated alkyl, cycloalkyl, aryl, alkaryl, aralkyl and heterocyclic ring; d) modified amines, which have a net charge of about -3 to about +3, which are represented by formulas [VII] and [X]: [Vil] [Vlll] [ix] [X] wherein each R9-R10 is independently selected from the substituted or unsubstituted radical selected from the group consisting of H, alkyl, cycloalkyl, aryl, fused aryl, heterocyclic ring, silyl, nitrogen, halogen radicals , cyano, sulfonate, aikoxi, keto, carboxylic, and carboalkoxy, and anionic and / or cationic carrier vehicle radical; R8 and R11 are substituted or unsubstituted radials which are selected from the group consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, aikoxy, keto, carboxylic, and carboalkoxy; and anionic and / or radical of cationic carrier vehicle; R12 is a leaving group, the protonated form which has a pKa value (reference H2O) which falls within the following scale: 37 > pKa > -2; with the proviso that any R8-R12, when present, may be combined in the form of a fused aryl, fused carbocyclic or fused heterocyclic ring; and also presented in this formula is the radical represented by the formula: 5 where Zp- is covalently bound to, and Zp- is selected from the group that consists of -C02, -S03-, -OS03-, -S02 and -OS02 and p is 1, 2 or 3; a is selected from the group consisting of a substituent or non-substituent, > saturated or unsaturated alkyl, cycloalkyl, aryl, alkaryl, aralkyl and ring heterocyclic; e) sulfonimines, phosphonimines, N-acylimines, and thiodiazole dioxides which are represented by the formulas [XXIa], [XXIb], [XXII] and [XXIII], res ectively: [XXIa] [XXIb] [XXII] XIII] 15 wherein each R41-R44, when present, is independently selected from the substituted or unsubstituted radical selected from the group consisting of radicals of H, alkyl, cycloalkyl, aryl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, aikoxi, keto, carboxylic, and carboalkoxy; provided with any R41 and R44 may be together with any other R41-R44 to form a part of a common ring, including fused aryl, which has a net charge of about +3 to about -3, which is represented by the formula [III]: "wherein R2-R3 are substituted or unsubstituted radicals independently selected from the group consisting of H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic, and carboalkoxy radicals: R1 and R4 are radicals selected from substituents or non-substituents, saturated or unsaturated selected from the group consisting of H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic, and carboalkoxy radicals, and X "is an adequate charge balance counter ion; and v is an integer from 1 to 3; g) oxaziridinium zwitterions, which have a charge of about +3 to about -3, which are represented by the formula [IV]: [IV] wherein R5-R7 are substituted or unsubstituted radicals independently selected from the group consisting of H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic , and carboalkoxy radicals; and also presented in this formula is the radical represented by the formula: -T -Z0 wherein Zp- is covalently linked to, and Zp- is selected from the group consisting of -C02, -S03-, -OS03-, -S02 and -OS02 and p is 1, 2 or 3; a is selected from the group consisting of a substituent or non-substituent, saturated or unsaturated alkyl, cycloalkyl, aryl, alkaryl, aralkyl and heterocyclic ring; h) oxaziridine, sulfonimines [XXIVa], phosphonimines [XXIVb], N-acylimines [XXV], and thiodiazole dioxides [XXVIII] which are represented below: [XXIVa] [XXIVb] [XXV] pcxvo [XXVIO where R41 -44, when present, are substituted or unsubstituted radicals independently selected from the group consisting of H, ~ AA.l ^ - tit .t? 3tU. A & amp; alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic, and carboalkoxy radicals; provide any of R41 and R44 may be together with any other R41 and R44 to form a part of a common ring, including fused aryl, fused carbocyclic or fused carbocyclic ring; i) and mixtures thereof. 11. The bleaching composition according to claim 10, further characterized in that the organic catalyst is selected from the group consisting of a) aryliminium cations and aryliminium polyions, which have a net charge of about +3 to about -3. , which are represented by the formula [XI]: [XO where m is 1 to 3 when G is present and m is 1 to 4 when m is not present; and n is an integer from 0 to 4; each R26 is independently selected from the substituted or unsubstituted radical which is selected from the group consisting of radicals of H, alkyl, cycloalkyl, aryl, fused aryl, heterocyclic ring, fused heterocyclic ring, nitrogen, halogen, cyano, sulfonate, aikoxy, keto, carboxylic, and carboalkoxy, and any of the two adjacent R20 substituent atoms can be combined to form an aryl tA il Aü merged, fused carbocyclic ring or fused heterocyclic ring; R18 may be a substituted or unsubstituted radical selected from the group of radicals consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, aikoxy, keto, carboxylic, and carboalkoxy; also present in this formula is the radical represented by the formula: (1) -O-; (2) -N (R23) -; and (3) -N (R23R24) -; R21-1124 are substituted or unsubstituted radicals independently selected from the group consisting of H, oxygen, linear or branched C 1 -C 2 alkyls, alkyls, alkoxys, aryls, alkaryls, aralkyls, 10 cycloalkyls, and heterocyclic rings; provide any of Rl8, R19, R20, R21-R24 may be together with any of the other R18, R19, R20, R21-R24 to form part of a common ring, any germinal R21-R22 may be combined to form a carbonyl; any vicinal R21-R24 to form an unsaturated, fused, substituted or unsubstituted portion; X- is a 15 contraction of adequate load balance; and v is an integer from 1 to 3; b) aryliminium zwitterions, which have a net charge of about +3 to about -3, which are represented by the formula [XII]: [XII] , - t. & tk ^ where m is 1 to 3 when G is present and m is 1 to 4 when G is not present; and n is an integer from 0 to 4; each R26 is independently selected from the substituted or unsubstituted radical which is selected from the group consisting of radicals of H, alkyl, cycloalkyl, aryl, fused aryl, heterocyclic ring, fused heterocyclic ring, nitrogen, halogen, cyano, sulfonate, aikoxy, keto, carboxylic, and carboalkoxy, and either of the two adjacent R26 substituent atoms can be combined to form a fused aryl, fused carbocyclic ring or fused heterocyclic ring; R25 may be a substituted or unsubstituted radical selected from the group of radicals consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, aikoxy, keto, carboxylic, and carboalkoxy; The radical represented by the formula is also present in this formula: - T wherein Zp- is covalently linked to, and Zp- is selected from the group consisting of -C02, -S03-, -OS03-, -S02 and -OS02 and p is 1, 2 or 3; a is selected from the group consisting of where q is an integer from 1 to 8; R29 is independently selected from substituted or unsubstituted radicals which are selected from the group consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, alkylene heterocyclic ring, aikoxy, arylcarbonyl, carboxyalkyl and straight or branched amide groups; G is selected from the group consisting of (1) -O-; (2) -N (R30); and (3) -N (R30 R31) -; R27, R28, R30 and R31 are substituted or unsubstituted radicals that are independently selected from the group consisting of H, oxygen, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, (1) -O-; (2) -N (R30) -; and (3) -N (R30R31) -; R27-, R28, R30 and R31 are substituted or unsubstituted radicals independently selected from the group consisting of H, oxygen, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, alkylene, and heterocyclic rings; arylcarbonyl groups, carboxyalkyl groups and amide groups; provide any of R25, R26, R27, R28, R30 and R31 may be together with any of the other R25, R26, R27, R28, R30 and R31 to form part of a common ring, any germ R27-R31 may be combined to form a carbonyl; any vicinal R27-R31 to form an unsaturated, fused portion; c) modified amines which are represented by formulas [XV] and [XVI]: [XV] [xvo where m is 1 to 3 when G is present and m is 1 to 4 when G is not present; and n is an integer from 0 to 4; each R34 is independently selected from the substituted or unsubstituted radical selected from the group .i j.4H 4t = - .. 't ... .H JAAÍ * consisting of hydroxy, perhydroxy, alkoxy, peralkoxy, carboxylic, percarboxylic, sulfonate and persilphonate radicals, each substituted or unsubstituted R35 is independently selected from the A group consisting of H radicals, alkyl, cycloalkyl, aryl, fused aryl, heterocyclic ring, fused heterocyclic ring, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic, and carboalkoxy, and any of the two adjacent R35 substituent atoms may combine to form a fused aryl, fused carbocyclic ring or fused heterocyclic ring; R32 may be a substituted or unsubstituted radical selected from the group of radicals consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, aikoxy, keto, carboxylic, and carboalkoxy; R33 can be a substituted or unsubstituted radical, saturated or unsaturated, selected from the group consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring, and this formula is also present the radical represented by the formula: wherein Zp- is covalently linked to, and Zp- is selected from the group consisting of -C02, -S03-, -OS03-, -S02 and -OS02 and p is 1, 2 or 3; a is selected from the group consisting of Í, A..Í1Í ... i? T? i & L .í. *. £ a¡b.l, where q is an integer from 1 to 8; R38 is independently selected from the substituted or unsubstituted radical which is selected from the group consisting of radicals of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, alkylene, heterocyclic ring, alkoxy, arylcarbonyl, carboxyalkyl, and amide groups, select from the group consisting of (1) -O-; (2) -N (R39); and (3) -N (R39 R40) -; R36, R37, R39 and R40 are substituted or unsubstituted and are independently selected from the group consisting of radicals H, oxygen, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, alkyl, heterocyclic ring, alkoxy, arylcarbonyl groups, carboxyalkyl groups and groups amine, provide any 10 of R32, R33, R34, R35, R36 R37, R39 and R40 may be together with any of the other R32, R33, R34, R35, R36 R37, R39 and R40 to form part of a common ring, any germ R36 and R37 they can be combined to form a carbonyl; any vicinal R36 R37, R39 and R40 to form an unsaturated, fused portion, and wherein any group of substituents R36 R37, R39 and R40 may be combined in the form of a saturated or unsaturated fused portion; d) modified amine oxides which are represented by formulas [XVII] - [XX]: • 20 [xvio pcviq [XIX] [XX] where m is 1 to 3 when G is present and m is 1 to 4 when G is not present; and n is an integer from 0 to 4; each R34 is independently selected from the substituted or unsubstituted radical which is selected from the group consisting of hydroxy, perhydroxy, alkoxy, peralkoxy, carboxylic, percarboxylic, sulfonate and persilphonate radicals, each substituted or unsubstituted R35 is independently selected from the group consists of H radicals, alkyl, cycloalkyl, aryl, fused aryl, heterocyclic ring, fused heterocyclic ring, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic, and carboalkoxy, and either of the two adjacent R35 substituent atoms can be combined to form a fused aryl, fused carbocyclic ring or fused heterocyclic ring; R32 may be a substituted or unsubstituted radical selected from the group of radicals consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring, kíí -A.aa t A. lA ^,.!., -L. silyl, nitrogen, halogen, cyano, sulfonate, aikoxi, keto, carboxylic, and carboalkoxy; R33 can be a substituted or unsubstituted, saturated or unsaturated radical, selected from the group consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring, and this formula is also 5 finds present the radical represented by the formula: wherein Zp- is covalently linked to, and Zp- is selected from the group consisting of -C02, -S03-, -OS03-, -S02 and -OS02 and p is 1, 2 or 3; a is 10 selected from the group consisting of: where q is an integer from 1 to 8; R38 is independently selected from the substituted or unsubstituted radical selected from the group consisting of radicals of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, alkylene, heterocyclic ring, alkoxy, arylcarbonyl, carboxyalkyl, and amide groups, select from the group consisting of (1) -O-; (2) -N (R39); and (3) -N (R39 R40) -; R36, R37, R39 and R40 are substituted or unsubstituted and independently • 20 selected from the group consisting of radicals H, oxygen, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, alkylene, heterocyclic ring, alkoxy, arylcarbonyl groups, carboxyalkyl groups and amine groups, provide any of R32, R33, R34, R35, R36 R37, R39 and R40 may be together with any of other R32, R33, R34, R35, R36 R37, R39 and R40 to form part of a common ring, any germ R36 and R37 can be combined to form a carbonyl; any vicinal R36 R37, R39 and R40 to form an unsaturated, fused portion, and wherein any group of R36 substituents R37, R39 and R4o may be combined in the form of a saturated or unsaturated fused portion; e) sulfonimines [XXVIlla], phosphonimines] XXVIIIb], N-acylimines [XXIX] are represented below: wherein each R46 is independently selected from the substituted or unsubstituted radical selected from the group consisting of radicals of H, alkyl, cycloalkyl, aryl, fused aryl, heterocyclic ring, fused heterocyclic ring, nitrogen, halogen, cyano, sulfonate, aikoxy , keto, carboxylic, and carboalkoxy, and any two vicinal vicinal R46 may combine to form a fused aryl, fused carbocyclic ring or fused heterocyclic ring; R 45 can be a substituted or unsubstituted radical selected from the group of radicals consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, aikoxy, keto, carboxylic, and carboalkoxy; also present in this formula is the radical represented by the formula: (1) -O-; (2) -N (R47) -; and (3) -N (R47R48) -; R47-R48 are radicals substituted or not substituted independently selected from the group consisting of H, oxygen, linear or branched C 1 -C 2 alkyls, alkylanes, alkoxys, aryls, alkaryls, aralkyls, cycloalkyls, and heterocyclic rings; f) oxaziridinium cations and polyions, which have a net charge of about +3 to about -3, which are represented by the formula [XIII]: where m is 1 to 3 when G is present and m is 1 to 4 when G is not present; and n is an integer from 0 to 4; each R20 is independently selected from the substituted or unsubstituted radical which is selected from the group consisting of radicals of H, alkyl, cycloalkyl, aryl, fused aryl, heterocyclic ring, fused heterocyclic ring, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic, and carboalkoxy, and any of the two adjacent vicinal R20 may be combined to form a fused aryl, fused carbocyclic ring or fused heterocyclic ring; R18 may be a substituted or unsubstituted radical selected from the group of radicals consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, aikoxy, keto, carboxylic, and carboalkoxy; R19 can be a substituted or unsubstituted radical, saturated or unsaturated, selected from the group consisting of H, alkyl, cycloalkyl, I ..A ^., AA..A .A.? AA ?. J jj j alkaryl, aryl, aralkyl, heterocyclic ring, G is selected from the group consisting of (1) -O-; (2) -N (R23); and (3) -N (R23 'R24') -; R21'-R24 'are substituted or unsubstituted and is independently selected from the group consisting of H, oxygen, linear or branched alkyl radicals of CrC, 2, alkyls, alkoxys, aryls, alkaryls, cycloalkyls and heterocyclic rings, provide any R 8, R19, R21 -R24 may be together with any other R18, R19, R21-R24 to form part of a common ring, any germinal R21-R22 can be combined to form a carbonyl; any vicinal R21.R24 to form an unsaturated, fused portion, and wherein any group of substituents R21'-R24 'may be combined in the form of a saturated or unsaturated fused portion; and wherein any group of R21'-R24 'substituents can be combined to form a saturated or unsaturated fused portion; X "is an appropriate charge balance counter ion, and v is an integer from 1 to 3, g) oxaziridinium zwitterions, which have a net charge of about +3 to about -3 which are represented by the formula [XIV]: [XIV] where m is 1 to 3 when G is present and m is 1 to 4 when G is not present; and n is an integer from 0 to 4; each R26 is independently selected from the substituted or unsubstituted radical which is selected from the group consisting of H, alkyl, cycloalkyl, aryl, aplo merged radicals, heterocyclic ring, fused heterocyclic ring, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic, and carboalkoxy, and any vicinal R26 adjacent may be combined to form a fused aryl, fused carbocyclic ring or fused heterocyclic ring; R25 may be a substituted or unsubstituted radical selected from the group of radicals consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, aikoxy, keto, carboxylic, and carboalkoxy; the radical is represented by the formula - T - 9 wherein Zp- is covalently attached to, and Zp- is selected from the group consisting of -C02, -S03-, -OS03-, -S02 and -OS02 and a is 1 or 2; T0 2; is selected from the group consisting of: where q is an integer from 1 to 8; R29 is independently selected from the substituted or unsubstituted radical which is selected from the group consisting of linear or branched groups of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, alkylene, heterocyclic ring, alkoxy, arylcarbonyl, carboxyalkyl and amide groups, G is selected from the group consisting of (1) -O-; (2) -N (R30); líl .l JL. hxtt j-l.ii An A. «. «- > . .-ufe. »> 4". < • »- 4 < . - > *. . ~ - l * i, * ** -? R '. * ?? eAtaBi? Ullb AttA - * i ?? - ttJ * lAl and (3) -N (R30 'R31') -; R27 ', R28', R30 'and R3 are substituted or unsubstituted and are independently selected from the group consisting of radicals H, oxygen, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, alkyl, heterocyclic ring, alkoxy, arylcarbonyl groups, carboxyalkyl and amine groups, provide any of R2, R26 ', R27', R28 ', R30' and R31 'may be together with any of the other R2, R26', R27 ', R28', R30 'and R31' to form part of a common ring, any germinal R27 and R28 can be combined to form a carbonyl; any vicinal R27 and R31 to form an unsaturated, fused portion, and wherein any group of substituents R27 and R31 may be combined in the form of a saturated or unsaturated fused portion; h) oxaziridinesulfonimides [XXXIa], phosphonimines [XXXIb], N-acylimines [XXXII] are represented below: [XXXIa] [XXXIb] [XXXI] wherein each R46 is independently selected from the substituted or unsubstituted radical which is selected from the group consisting of radicals of H, alkyl, cycloalkyl, aryl, fused aryl, heterocyclic ring, fused heterocyclic ring, nitrogen, halogen, cyano, sulfonate, aikoxy , keto, carboxylic, and carboalkoxy, and any two adjacent vicinal R46 can combine to form a fused aryl, carbocyclic ring fused or ivi .íSáf; A, .t &i .i i- 4¿L < 4.. ,-. »-" -.r -A .. fused heterocyclic ring; R 45 can be a substituted or unsubstituted radical selected from the group of radicals consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, aikoxy, keto, carboxylic, and carboalcoxy; G, when present, is selected from the group consisting of: (1) -O-; (2) -N (R47 ') -; and (3) -N (R47 R48 ') -; R47'-R48 'are substituted or unsubstituted radicals independently selected from the group consisting of H, oxygen, linear or branched alkyls of CrC? 2, alkylenes, alkoxys, aryls, alkaryls, aralkyls, cycloalkyls, and heterocyclic rings; i) and mixtures thereof. 12. The bleaching composition according to claim 5, further characterized in that said bleaching composition comprises one or more of the following detergent components selected from the group consisting of: surfactants, solvents, pH regulators, enzymes, agents dirt release agents, dirt release removal agents, dispersing agents, brighteners, foam suppressors, fabric cleaners, organic foam catalysts, enzyme stabilizers, builders, chelating agents, other bleaching agents, including metal catalysts , other organic catalysts, inks, ink transfer inhibiting agents, perfumes and mixtures thereof. 13. A product characterized in that it comprises an organic catalyst, the product also including instructions for using said compound to clean a fabric that so requires, the instructions include * • ** • '* - * - * -Mil fiiii rti t »! mu '- "- * -'" - - - - "JA" ^ • • * • * - * the step of contacting said fabric with a washing solution comprising the product where the organic catalyst 14.- The product of conformity with claim 13, further characterized in that said product is a laundry detergent. 15. - The product according to claim 13, further characterized in that said product is an additive for laundry. 16. A modified amine compound selected from the group consisting of modified amine oxides having the general formula [VII] - [X]: [VIO [VIIQ [IX] P < ] wherein R8-R '° are independently selected from substituted or unsubstituted radicals selected from the group consisting of radicals H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic, and carboalkoxy and anionic radials and / or carrying cationic charge; R11 when present are radicals selected from the group consisting of H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic, substituted or unsubstituted radicals, saturated or unsaturated, and anionic radicals and / or carrying cationic charge; R 2 is a leaving group, the protonated form of which has a pKa value (reference H20) that falls within the following scale: 37 > pKa > -2; with the proviso that either, R8-R12, when present, can be combined to form a fused aryl, fused carbocyclic ring or fused heterocyclic ring. 17. The modified amine compound according to claim 16, further characterized in that R11 is represented by the formula: wherein Zp- is covalently bound to, and Zp- is selected from the group consisting of -C02, -S03 -, -OS03-, -S02 and -OS02 is already 1 or 2; T0 2; is selected from the group consisting of a substituent or non-substituent, saturated or unsaturated alkyl, cycloalkyl, aryl, alkaryl, aralkyl and heterocyclic ring. 18. The modified amine compound according to claim 16, further characterized in that for R12, the pKa value is greater than 3 and less than 23. 19. - The modified amine compound according to claim 17, further characterized in that for R12, the pKa value is greater than 9 and less than 21. 20. The modified amine compound according to claim 18, further characterized in that R12, the pKa value is greater than 11 and less than 17. 21. The modified amine compound according to claim 16, further characterized in that R12 is selected from the group consisting of hydroxy, perhydroxy, alkoxy and substituted alkoxy or peralkoxy radicals. not sutituted, saturated or unsaturated. 22. The modified amine compound according to claim 21, further characterized in that R12 is selected from the group consisting of hydroxy or perhydroxy. 23. The modified amine compound according to claim 16, further characterized in that said modified amine compound has the general formula [XXVII] - [XX]: [XIX] [XX] where m is 1 to 3 when G is present and m is 1 to 4 when G is not present; and n is an integer from 0 to 4; R34 is a leaving group, the protonated form of any pKa value (reference H2O) that falls within the following scale: 37 > pKa > -2; each R 35 is independently selected from the substituted or unsubstituted radical which is selected from the group consisting of H, alkyl, cycloalkyl, aryl, fused aryl, heterocyclic ring, fused heterocyclic ring, nitrogen, halogen, cyano, sulfonate, aikoxy, keto, carboxylic, and carboalkoxy, and either of the two substituent atoms R33 may be a substituted or unsubstituted radical selected from the group of radicals consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring, including bearing radicals of anionic charge and / or a cationic charge. 24. - The modified amine compound according to claim 23, further characterized in that R33 is represented by the formula: wherein Zp- is covalently linked to, and Zp- is selected from the group consisting of -C02, -S03-, - OS03-, -S02 and -OS02 is already 1 or 2; T0 2; is selected from the group consisting of: where q is an integer from 1 to 8; R38 is independently selected from the substituted or unsubstituted radical which is selected from the group consisting of linear or branched groups of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, alkylene, heterocyclic ring, alkoxy, arylcarbonyl, carboxyalkyl and amide groups, G is selected from the group consisting of (1) -O-; (2) -N (R39); and (3) -N (R39 R40) -; R38, R37, R39 and R40 are substituted or unsubstituted and are independently selected from the group consisting of radicals H, oxygen, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, alkylene, heterocyclic ring, alkoxy, arylcarbonyl groups, carboxyalkyl groups and groups amine, provide any of R32, R33, R34, R35, R36, R37, R39 and R40 may be together with any of the other R32, R33, R34, R35, R36, R37, R39 and R40 to form part of a common ring, any germ R36 and R37 can be combined to form a carbonyl; any vicinal R36, R37, R39 and R40 to form a I? .I? A .I.? I? * - .. 4 > a.-ai. unsaturated, fused portion, and wherein any group of substituents R36, R37, R39 and R40 may be combined in the form of a saturated or unsaturated fused portion. 25. The modified amine compound according to claim 23, further characterized in that for R34, the pKa value is greater than 3 and less than 23. 26.- The modified amine compound according to claim 25, further characterized because for R34, the pKa value is greater than 11 and less than 17. 27.- The modified amine compound according to claim 23, further characterized in that R34 is selected from the group consisting of hydroxy, perhydroxy, alkoxy and peralkoxy radicals. substituted or unsubstituted, saturated or unsaturated. 28. The modified amine compound according to claim 27, further characterized in that R34 is selected from the group consisting of hydroxy or perhydroxy radicals. 29. The modified amine compound according to claim 16, further characterized in that said modified amine compound has the general formula [XV] - [XVI]: [XV] [XVI] tíj.-l .j ... Í. - .... t Á. ¡Icfta,. *?TO. Í. Where m is 1 to 3 when G is present and m is 1 to 4 when G is not present; and n is an integer from 0 to 4; R34 is a leaving group, the protonated form of any pKa value (reference H2O) that falls within the following scale: 20 > pKa > -10; each R35 is independently selected from the substituted or unsubstituted radical which is selected from the group consisting of H, alkyl, cycloalkyl, aryl, fused aryl, heterocyclic ring, fused heterocyclic ring, nitrogen, halogen, cyano, sulfonate, aikoxy, keto, carboxylic, and carboalkoxy, and any vicinal R35 may be combined in the form of a fused aryl, fused carbocyclic or fused heterocyclic ring; R32 is a radial selected from the group consisting of H or Me; R33 is a substituent or non-substituent, saturated or unsaturated, a radical selected from the group consisting of C3-C? -alkyl, C3-C? -C? Cycloalkyl, and radicals bearing an anionic and / or cationic charge. 30. The modified amine compound according to claim 29, further characterized in that R33 is represented by the formula: wherein Zp- is covalently attached to, and Zp- is selected from the group consisting of -C02, -S03-, -OS03-, -S02 and -OS02 and a is 1 or 2; t'0 2; is selected from the group consisting of: where q is an integer from 1 to 8; R38 is independently selected from the substituted or unsubstituted radical which is selected from the group consisting of linear or branched groups of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, alkylene, heterocyclic ring, alkoxy, arylcarbonyl, carboxyalkyl and amide groups, G is selected from the group consisting of (1) -O-; (2) -N (R39); and (3) -N (R39 R40) -; R36, R37, R39 and R40 are substituted or unsubstituted and are independently selected from the group consisting of radicals H, oxygen, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, alkyl, heterocyclic ring, alkoxy, arylcarbonyl groups, carboxyalkyl groups and groups amine, provide any of R32, R33, R34, R35, R38, R37, R39 and R40 may be together with any of the other R32, R33, R34, R35, R36, R37, R39 and R40 to form part of a common ring, any germ R36 and R37 can be combined to form a carbonyl; any vicinal R36, R37, R39 and R40 to form an unsaturated, fused portion, and wherein any group of substituents R36, R37, R39 and R40 may be combined in the form of a saturated or unsaturated fused portion. 31. The modified amine compound according to claim 29, further characterized in that R34 is selected from the group consisting of hxy or perhxy radicals. 32. A bleaching composition characterized in that it comprises an amine compound modified in conjunction with or without a source of peroxide, wherein said modified amine compound is selected from the group consisting of amines having the general formula [V] I-i- and / or [VI], modified amine oxides having the general formula [VII] - [X], and mixtures thereof: [V] [VO [IX] [X] wherein R8-R10 are independently selected from substituted or unsubstituted radicals selected from the group consisting of radicals H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic, and carboalkoxy and anionic and / or cationic charge bearing radial; R11 when present, are radicals selected from the group consisting of H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen radicals, halogen, cyano, sulfonate, alkoxy, keto, carboxylic, substituted or unsubstituted, saturated or unsaturated, and anionic radicals and / or carrying cationic charge; R12 is a leaving group, the protonated form of which has a pKa value (reference H20) that falls within the following scale: 37 > pKa > -2; with the proviso that either, R8-R12, when present, can be combined to form a fused aryl, fused carbocyclic ring or fused heterocyclic ring. 33. The bleaching composition according to claim 32, further characterized in that R11 is represented by the formula: where Zp- is covalently linked to, and Zp- is selected from the group that • 'consists of -C02, -S03-, -OS03-, -S02 and -OS02 and a is 1 or 2; T0 2; is selected from the group consisting of substituents or non-substituents, saturated or unsaturated alkyl, cycloalkyl, aryl, alkaryl, aralkyl and heterocyclic ring. 34. The modified amine compound according to claim 32, further characterized in that for R12, the pKa value is greater than 3 and less than 23. • 20 35. The modified amine compound according to claim 34, further characterized because for R12, the pKa value is greater than 9 and less than 21. 36. - The modified amine compound according to claim 35, further characterized in that for R12, the pKa value is greater than 11 and less than 17. 37.- The modified amine compound according to claim 32, further characterized in that R12 it is selected from the group consisting of substituted or unsubstituted hydroxy, perhydroxy, alkoxy and peralkoxy radicals, saturated or unsaturated. 38.- The modified amine compound according to claim 37, further characterized in that R12 is selected from the group consisting of hydroxy or perhydroxy radicals 39.- The modified amine compound according to claim 32, further characterized in that said compound of modified amine comprises from about 0.001% to about 10% by weight of said composition, and said peroxygen source, when present, comprises from about 0.01% to about 60% by weight of said composition. 40. The bleaching composition according to claim 32, further characterized in that said source of peroxygen, when present, is selected from the group consisting of (a) preformed peracid compounds selected from the group consisting of salts and acids of percarboxyl, acids and percarbonic salts, acids and perimidic salts, acids and salts of peroxymonosulfuric acid, and mixtures thereof; (b) sources of hydrogen peroxide selected from the group aláMí e. it consists of perborate compounds, percarbonate compounds, perfosphate compounds and mixtures thereof; and a bleach activator. 41.- A bleaching composition, characterized in that said modified amine compound has the general formula [XV] - [XX]: [XV] [XVO [XVIO [XVII] [XIX] [XX] where m is 1 to 3 when G is present and m is 1 to 4 when G is not present; and n is an integer from 0 to 4; R34 is a leaving group, the protonated form of any pKa value (reference H2O) that falls within the following scale: 37 > pKa > -2; each R35 is independently selected from the substituted or unsubstituted radical which is selected from the group consisting of H, alkyl, cycloalkyl, aryl, fused aryl, heterocyclic ring, fused heterocyclic ring, nitrogen, halogen, cyano, sulfonate, aikoxy , keto, carboxylic, and carboalkoxy, and either of the two substituent atoms R33 may be a substituted or unsubstituted radical that is 10 selects from the group of radicals consisting of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, heterocyclic ring, including anionic charge and / or cationic radicals. 42. The bleaching composition according to claim 41, further characterized in that R33 is represented by the 15 formula: wherein Zp- is covalently linked to, and Zp- is selected from the group consisting of -C02, -S03-, -OS03-, -S02 and -OS02 and a is 1 or 2; T0 2; is 20 selected from the group consisting of: The .1. J. Í? Lt.ii, < .t: -f-A. & ?? -. ^? .. ... i? ^ where q is an integer from 1 to 8; R38 is independently selected from the substituted or unsubstituted radical which is selected from the group consisting of linear or branched groups of H, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, alkylene, heterocyclic ring, alkoxy, arylcarbonyl, carboxyalkyl and 5 amide groups, G is selected from the group consisting of (1) -O-; (2) -N (R39); and (3) -N (R39 R40) -; R38, R37, R39 and R40 are substituted or unsubstituted and it is independently selected from the group consisting of radicals H, oxygen, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, alkyl, heterocyclic ring, alkoxy, arylcarbonyl groups, carboxyalkyl groups and groups 10 amine, provide any of R32, R33, R34, R35, R38, R37, R39 and R40 may be together with any of the other R32, R33, R34, R35, R36, R37, R39 and R40 to form part of a common ring , any germ R36 and R37 can be combined w to form a carbonyl; any vicinal R36, R37, R39 and R40 to form an unsaturated, fused portion, and wherein any substituent group 15 R36, R37, R39 and R40 may be combined in the form of a fused portion saturated or unsaturated. 43.- The modified amine compound according to claim 41, further characterized in that for R12, the pKa value is greater than 3 and less than 23. 20 44.- The amine compound modified in accordance with claim 43, further characterized because for R12, the pKa value is greater than 11 and less than 17. 45. The bleaching composition according to claim 41, further characterized in that R34 is selected from the group consisting of substituted or unsubstituted hydroxy, perhydroxy, alkoxy and peralkoxy radicals, saturated or unsaturated. 46. The bleaching composition according to claim 45, further characterized in that R34 is selected from the group consisting of hydroxy or perhydroxy radicals. 47. The bleaching composition according to claim 32, further characterized in that said bleaching composition comprises one or more of the following detergent components selected from the group consisting of: surfactants, solvents, pH regulators, enzymes, agents dirt release agents, dirt release removal agents, dispersing agents, brighteners, foam suppressors, fabric cleaners, organic foam catalysts, enzyme stabilizers, builders, chelating agents, other bleaching agents, including metal catalysts , other organic catalysts, inks, ink transfer inhibiting agents, perfumes and mixtures thereof. 48. The bleaching composition according to claim 47, further characterized in that said bleaching composition further comprises a surfactant. 49. The bleaching composition according to claim 48, further characterized in that said surfactant is a branched surfactant. 50. The bleaching composition according to claim 49, further characterized in that said branched surfactant is a medium chain branched surfactant. 51. The bleaching composition according to claim 48, further characterized in that said surfactant is an anionic surfactant. 52.- The bleaching composition according to claim 41, further characterized in that said bleaching composition further comprises a chelating agent. 53. The bleaching composition according to claim 41, further characterized in that said bleaching composition further comprises other bleaching agents selected from the group consisting of perborates, perfosphates and mixtures thereof. 54.- The bleaching composition according to claim 53, further characterized in that said bleaching composition further comprises a bleach activator. 55.- The bleaching composition according to claim 54, further characterized in that said bleach activator is selected from the group consisting of hydrophobic bleach activators. ^ - »and-At it 'i 56.- The bleaching composition according to claim 55, further characterized in that said hydrophobic bleach activators selected from the group consisting of tetraacetylethylenediamine (TAED), benzoylcapropactam (BzCL), 4-nitrobenzoylcaprolactam , 3-chlorobenzoylcaprolactam, benzoyloxybenzenesulfonate (BOBS), nonanoyloxybenzenesulfonate (NOBS), phenylbenzoate (PhBz), decanoyloxybenzenesulfonate (C10-OBS), benzoylvalerolactam (BZVL), octanoyloxybenzenesulfonate (Cß-OBS), perhydrolyzable esters, sodium salt 4- [N- (nonanoyl-9-aminohexanoyloxy] -benzenesulfonate (NACA-OBS), lauryl-oxybenzenesulfonate (LOBS or C? 2-OBS), 10-ur? denoxyloxybenzenesulfonate (UDOBS or Cn-OBS) with unsaturation in position 10), decanoyloxybenzoic acid (DOBA) and mixtures of the same. 57. The bleaching composition according to claim 41, further characterized in that said bleaching composition further comprises an enzyme. 58. The bleaching composition according to claim 57, further characterized in that said enzyme is selected from the group consisting of cellulases, lipases, amylases, phospholipases, proteases, peroxidases and mixtures thereof. 59. A method for washing fabric that so requires, characterized in that it comprises that the fabric makes contact with a washing solution having a bleaching composition as claimed in claim 32. 60. - A laundry addition product characterized in that it comprises a modified amine compound selected from the group consisting of modified amine compounds having the general formula [V] - [X], and mixtures thereof: [V] [vo [IX] [X] wherein R8-R10 are independently selected from substituted or unsubstituted radicals selected from the group consisting of radicals H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic, and carboalkoxy and anionic and / or cationic-bearing radials; R11 when present are radicals selected from the group consisting of H, alkyl, cycloalkyl, aryl, alkaryl, aralkyl, heterocyclic ring, silyl, nitrogen, halogen, cyano, sulfonate, alkoxy, keto, carboxylic, substituted or unsubstituted radicals , saturated or unsaturated, and anionic radicals and / or carrying cationic charge; R12 is a leaving group, the protonated form of which has a pKa value (reference H20) that falls within the following scale: 37 > pKa > -2; with the proviso that either, R8-R12, when present, can be combined to form a fused aryl, fused carbocyclic ring or fused heterocyclic ring. 61.- The addition product for laundry in accordance with # claim 60, further characterized in that R11 is represented by the formula: wherein Zp- is covalently linked to, and Zp- is selected from the group consisting of -C02, -S03-, -OS03-, -S02 and -OS02 and p is 1, 2 or 3; a is , selected from the group consisting of a substituent or non-substituent, 20 saturated or unsaturated alkyl, cycloalkyl, aryl, alkaryl, aralkyl and heterocyclic ring. 62.- The laundry addition product according to claim 60, further characterized in that said addition product Í? . ,? .M ».MI?? A .. A. ^. * L .. • iilii rrt? Lfcinm" '* --- ***** - - * .- ^ * &. * * **? * -R -, .. "-....., *" ..-, um *? N for laundry is in the form of a dose selected from the group consisting of pill, tablet, ampule, capsule or other form of individual dose 63. The laundry addition product according to claim 60, further characterized in that said laundry addition product also includes an appropriate vehicle. ^ Bp F
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15100499P | 1999-08-27 | 1999-08-27 | |
US15100299P | 1999-08-27 | 1999-08-27 | |
PCT/US2000/023323 WO2001016263A2 (en) | 1999-08-27 | 2000-08-25 | Controlled availability of formulation components, compositions and laundry methods employing same |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA02002122A true MXPA02002122A (en) | 2002-10-17 |
Family
ID=26848232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02002122A MXPA02002122A (en) | 1999-08-27 | 2000-08-25 | Controlled availability of formulation components, compositions and laundry methods employing same. |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1206513A2 (en) |
JP (1) | JP2003508581A (en) |
CN (1) | CN100383230C (en) |
AR (1) | AR028162A1 (en) |
AU (1) | AU6935800A (en) |
BR (1) | BR0013608A (en) |
CA (1) | CA2382280A1 (en) |
CZ (1) | CZ2002723A3 (en) |
MA (1) | MA25603A1 (en) |
MX (1) | MXPA02002122A (en) |
TR (1) | TR200201062T2 (en) |
WO (1) | WO2001016263A2 (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7169744B2 (en) | 2002-06-06 | 2007-01-30 | Procter & Gamble Company | Organic catalyst with enhanced solubility |
US7557076B2 (en) | 2002-06-06 | 2009-07-07 | The Procter & Gamble Company | Organic catalyst with enhanced enzyme compatibility |
DE60319845T2 (en) | 2002-09-09 | 2009-03-05 | The Procter & Gamble Company, Cincinnati | USE OF CATIONIC CELLULOSIS TO INCREASE THE RELEASE OF TEXTILE PRODUCTS |
US20050159327A1 (en) * | 2004-01-16 | 2005-07-21 | The Procter & Gamble Company | Organic catalyst system |
AR051659A1 (en) | 2005-06-17 | 2007-01-31 | Procter & Gamble | A COMPOSITION THAT INCLUDES AN ORGANIC CATALYST WITH IMPROVED ENZYMATIC COMPATIBILITY |
AR059154A1 (en) | 2006-01-23 | 2008-03-12 | Procter & Gamble | A COMPOSITION THAT INCLUDES A LIPASE AND A WHITENING CATALYST |
ATE465230T1 (en) * | 2006-01-23 | 2010-05-15 | Procter & Gamble | COMPOSITION CONTAINING PREFORMED PERACID AND A BLEACH CATALYST |
JP2009523904A (en) | 2006-01-23 | 2009-06-25 | ザ プロクター アンド ギャンブル カンパニー | Composition comprising lipase and bleach catalyst |
BRPI0710140A2 (en) | 2006-04-13 | 2011-08-02 | Procter & Gamble | liquid laundry detergents containing cationic hydroxy ethyl cellulose polymer |
BRPI0714057A2 (en) | 2006-07-07 | 2012-12-18 | Procter & Gamble | composition comprising a cellulase and a bleach catalyst |
KR20120034666A (en) | 2009-05-22 | 2012-04-12 | 엑셀리시스, 인코포레이티드 | Benzoxazepines based p13k/mtor inthibitors against proliferative diseases |
CN102459248A (en) | 2009-05-26 | 2012-05-16 | 埃克塞里艾克西斯公司 | Benzoxepin as PI3K/mTOR inhibitors and methods of their use and manufacture |
PT2464645T (en) | 2009-07-27 | 2017-10-11 | Gilead Sciences Inc | HETEROCYCLIC COMPOUNDS FUSIONED AS ION CHANNEL MODULATORS |
EP2292725B2 (en) | 2009-08-13 | 2022-08-24 | The Procter & Gamble Company | Method of laundering fabrics at low temperature |
EP2365052B1 (en) | 2010-03-12 | 2016-07-13 | The Procter & Gamble Company | pH tuneable-gellant for use in consumer product compositions |
AR080507A1 (en) | 2010-03-12 | 2012-04-11 | Procter & Gamble | COMPOSITIONS OF LIQUID DETERGENTS THAT INCLUDE A DIAMID GELIFIER AND PROCESSES TO PREPARE THEM |
US20110240510A1 (en) | 2010-04-06 | 2011-10-06 | Johan Maurice Theo De Poortere | Optimized release of bleaching systems in laundry detergents |
KR101911560B1 (en) | 2010-07-02 | 2018-10-24 | 길리애드 사이언시즈, 인코포레이티드 | Fused heterocyclic compounds as ion channel modulators |
EP2457988A1 (en) | 2010-11-25 | 2012-05-30 | The Procter & Gamble Company | Improved bleaching of food stains |
SI2707361T1 (en) | 2011-05-10 | 2017-12-29 | Gilead Sciences, Inc. | Fused heterocyclic compounds as sodium channel modulators |
UY34171A (en) | 2011-07-01 | 2013-01-31 | Gilead Sciences Inc | FUSIONED HETEROCYCLIC COMPOUNDS AS IONIC CHANNEL MODULATORS |
NO3175985T3 (en) | 2011-07-01 | 2018-04-28 | ||
EP2737045A1 (en) | 2011-07-27 | 2014-06-04 | The Procter and Gamble Company | Multiphase liquid detergent composition |
US20130303427A1 (en) | 2011-09-13 | 2013-11-14 | Susana Fernandez Prieto | MICROCAPSULE COMPOSITIONS COMPRISING pH TUNEABLE DI-AMIDO GELLANTS |
CN108925586A (en) * | 2018-08-24 | 2018-12-04 | 成都特普生物科技股份有限公司 | A kind of antimicrobial composition preparation improving plant pest management effect |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4194987A (en) * | 1978-12-26 | 1980-03-25 | Fmc Corporation | Peroxygen bleaching and compositions therefor |
GB9022999D0 (en) * | 1990-10-23 | 1990-12-05 | Bp Chem Int Ltd | Bleach activators |
US5370826A (en) * | 1993-11-12 | 1994-12-06 | Lever Brothers Company, Division Of Conopco, Inc. | Quaternay oxaziridinium salts as bleaching compounds |
AU8106694A (en) * | 1993-11-12 | 1995-05-29 | Unilever Plc | Activation of bleach precursors with imine quaternary salts |
CA2176227C (en) * | 1993-11-12 | 2006-08-15 | Stephen Alan Madison | Imine quaternary salts as bleach catalysts |
US5576282A (en) * | 1995-09-11 | 1996-11-19 | The Procter & Gamble Company | Color-safe bleach boosters, compositions and laundry methods employing same |
DE19633305A1 (en) * | 1996-08-19 | 1998-02-26 | Clariant Gmbh | Sulphonylimine derivatives as bleaching catalysts |
US5817614A (en) * | 1996-08-29 | 1998-10-06 | Procter & Gamble Company | Color-safe bleach boosters, compositions and laundry methods employing same |
CA2273088A1 (en) * | 1996-11-29 | 1998-06-04 | The Clorox Company | N-alkyl ammonium acetonitrile salts, methods therefor and compositions therewith |
DE19746290A1 (en) * | 1997-10-20 | 1999-04-22 | Clariant Gmbh | Use of aminonitrile-N-oxides as bleach activators |
-
2000
- 2000-08-25 TR TR2002/01062T patent/TR200201062T2/en unknown
- 2000-08-25 WO PCT/US2000/023323 patent/WO2001016263A2/en active Application Filing
- 2000-08-25 BR BR0013608-5A patent/BR0013608A/en active Pending
- 2000-08-25 EP EP00957790A patent/EP1206513A2/en not_active Withdrawn
- 2000-08-25 CA CA002382280A patent/CA2382280A1/en not_active Abandoned
- 2000-08-25 CN CNB008149917A patent/CN100383230C/en not_active Expired - Fee Related
- 2000-08-25 AU AU69358/00A patent/AU6935800A/en not_active Abandoned
- 2000-08-25 MX MXPA02002122A patent/MXPA02002122A/en active IP Right Grant
- 2000-08-25 CZ CZ2002723A patent/CZ2002723A3/en unknown
- 2000-08-25 JP JP2001520812A patent/JP2003508581A/en active Pending
- 2000-08-28 AR ARP000104449A patent/AR028162A1/en unknown
-
2002
- 2002-02-27 MA MA26532A patent/MA25603A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
BR0013608A (en) | 2002-05-21 |
CA2382280A1 (en) | 2001-03-08 |
CN1384866A (en) | 2002-12-11 |
AR028162A1 (en) | 2003-04-30 |
WO2001016263A2 (en) | 2001-03-08 |
MA25603A1 (en) | 2002-12-31 |
WO2001016263A3 (en) | 2001-06-07 |
JP2003508581A (en) | 2003-03-04 |
EP1206513A2 (en) | 2002-05-22 |
TR200201062T2 (en) | 2003-02-21 |
CZ2002723A3 (en) | 2002-10-16 |
CN100383230C (en) | 2008-04-23 |
AU6935800A (en) | 2001-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA02002122A (en) | Controlled availability of formulation components, compositions and laundry methods employing same. | |
US6919304B2 (en) | Stability enhancing formulation components, compositions and laundry methods employing same | |
US20050070454A1 (en) | Fast-acting formulation components, compositions and laundry methods employing same | |
EP1210332B1 (en) | Bleach boosting components, compositions and laundry methods | |
MXPA02002128A (en) | Stable formulation components, compositions and laundry methods employing same. | |
US6818607B1 (en) | Bleach boosting components, compositions and laundry methods | |
EP1206515B1 (en) | Formulation components resistant towards decomposition by aromatization, compositions and laundry methods employing same | |
US6903060B1 (en) | Stable formulation components, compositions and laundry methods employing same | |
JP2003508588A (en) | Color safe washing method using cationic prescription ingredients | |
JP2003508589A (en) | Color-safe washing method using zwitterionic prescription ingredients | |
US6825160B1 (en) | Color safe laundry methods employing cationic formulation components | |
US6821935B1 (en) | Color safe laundry methods employing zwitterionic formulation components | |
US7109156B1 (en) | Controlled availability of formulation components, compositions and laundry methods employing same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |